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ABSTRACT 
Solution structure of the RING finger domain from the human splicing-associated protein 
RBBP6 using heteronuclear Nuclear Magnetic Resonance (NMR) Spectroscopy 
 
Abidemi Mautin Kappo 
 
PhD (Biotechnology) thesis, Department of Biotechnology, Faculty of Natural Sciences, 
University of the Western Cape 
 
Retinoblastoma-binding protein 6 (RBBP6) is a multi-domain human protein known to play a 
role in mRNA splicing, cell cycle control and apoptosis. The protein interacts with tumour 
suppressor proteins p53 and pRb and recent studies have shown that it plays a role in the 
ubiquitination of p53 by interacting with Hdm2, the human homologue of mouse double minute 
protein 2 (Mdm2), in which the RING finger domain plays an essential role. Recently, RBBP6 
has been shown to ubiquitinate the mRNA-associated proteinYB-1 through its RING finger 
domain, causing it to be degraded in the proteasome.  
 
RING (Really Interesting New Gene) fingers are small commonly-occurring domains of 
approximately 70 amino acids in length which coordinate two zinc ions in a cross-brace fashion. 
They are characterized by a conserved pattern of eight Cysteine or Histidine residues which are 
involved in coordinating the zinc ions. In terms of this conserved consensus, the RING finger 
from RBBP6 is expected to coordinate the zinc ions through eight Cysteine residues, making it a 
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“C4C4” RING finger similar to those identified in transcription-associated proteins CNOT4 
(CCR4-NOT transcription complex, subunit 4) and p44 (interferon-induced protein 44). The 
amino acid sequence of the domain also shares many similarities with the U-box family of 
domains, which have an identical three-dimensional structure despite not requiring zinc ions in 
order to fold. 
 
This thesis reports the bacterial expression of a fragment containing the RING finger domain 
from human RBBP6, and determination of its structure using heteronuclear Nuclear Magnetic 
Resonance (NMR) spectroscopy. Preliminary NMR analysis of the fragment revealed that the 
domain was folded, but that it was preceded by an unstructured region at the N-terminus. A 
shortened fragment was therefore expressed and used for structural studies. Isotope-enriched 
protein samples were generated by growing bacteria in minimal media supplemented with 15N-
NH4Cl and 13C-glucose and purified using a combination of glutathione agarose affinity 
chromatography, anion exchange and size exclusion chromatography. A complete set of 
heteronuclear NMR data was collected at 600 MHz from which almost complete assignment of 
the backbone, side-chain and aromatic resonances was achieved. By exchange of Zn2+ with 
113Cd2+ we managed to confirm that the domain binds two Zn2+ ions, and confirm that they are 
coordinated in the expected cross-brace manner. Structural data in the form of 2-Dimensional 
Nuclear Overhauser Enhancement Spectroscopy (2D-NOESY), 15N-separated NOESY and 13C-
separated NOESY spectra were recorded and used to determine the structure using restrained 
molecular dynamics on the Combined Assignment and Dynamics Algorithm for NMR 
Applications (CYANA) platform.  
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As expected, the structure contains a triple-stranded β-sheet packing against an α-helix and two 
zinc-stabilized loops as found in all RING fingers. However, it also contains a C-terminal helix 
which packs against an N-terminal loop which is similar to that found in many U-box domains. 
A search using the DALI server revealed that the structure is most similar to the U-box from 
CHIP (C-terminus of Hsp70-interacting protein), an E3 ligase that cooperates with Hsp70 to 
degrade unfolded proteins that cannot be refolded.  Using NMR we showed that the domain 
dimerizes with a KD of approximately 200 Μm, which means that it is dimeric at the 
concentrations used for NMR structure determination. Chemical shift analysis showed the 
dimerization interface to be very similar to that identified in U-box domains found in C-terminus 
of Hsp70 interacting proteins (CHIP). 
 
The structural similarities reported here between the RING finger from RBBP6 and the U-box 
family lead us to conclude that RBBP6 may, like CHIP, play a role in protein quality control.  
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
1.1 General Introduction 
Retinoblastoma binding protein 6 (RBBP6), also known as p53-Associated Cellular Protein 
Testes-derived (PACT), Proliferation Potential-Related Protein (P2P-R) and Retinoblastoma-
Binding Q protein 1 (RBQ-1) is a 250 kDa multi-domain nuclear protein (Pugh et al., 2006; 
Witte and Scott, 1997; Sakai et al., 1995). This protein has been shown to be involved in pre-
mRNA processing and splicing in yeast (Vo et al., 2001) and human (Shi et al., 2009), to interact 
in vivo with tumour suppressor proteins p53 and pRb in both human and mouse (Simons et al., 
1997; Witte and Scott, 1997), to regulate apoptosis and cell cycle progression (Li et al., 2007), to 
be upregulated in a number of cancers, including oesophageal and breast cancers and to be a 
promising target for immunotherapy against oesophageal cancer (Yoshitake et al., 2004). 
Through its RING finger domain RBBP6 plays an essential role in the ubiquitination of p53 by 
Hdm2, although it does not appear to be directly involved in the ubiquitination, prompting the 
suggestion that it has E4 rather than E3 ligase activity. However, recent studies have shown that 
RBBP6 can also act as an E3 ubiquitin ligase, interacting with YB-1 through both its DWNN and 
RING finger domains, leading to the ubiquitination and subsequent degradation of YB-1 by the 
proteasome (Chibi et al., 2008).  
 
RING fingers are small cysteine-rich domains of about 70 amino acids in length which bind two 
zinc ions through a set of eight conserved cysteine (C) or histidine (H) residues. The zinc ions 
are coordinated in a “cross-brace” fashion, meaning that the first and the third pair of the C/H 
residues coordinates the first zinc ion, while the second and fourth C/H pair coordinate the 
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second zinc ion. The general consensus sequence of zinc-coordinating residues can be written as 
Cys-X(2)-Cys-X(9-39)-Cys-X(1-3)-His-X(2-3)-Cys-X(2)-Cys-X(4-48)-Cys-X(2)-Cys, where X can be any 
amino acid. A number of common motifs have been identified, including C3HC4, C3HHC3, 
C2H2C4 and C4C4. RING domains are characterized by a basic fold consisting of two long zinc-
stabilized loops and a central α-helix which both pack against a short 3-stranded -sheet 
(Dominguez et al., 2004). The same fold is also found in the U-boxes even though they do not 
bind zinc and their zinc-coordinating residues are replaced by hydrophobic residues (Ohi et al., 
2003). In addition to the basic fold, U-boxes also contain a C-terminal helix which packs against 
an N-terminal loop, and which forms the interface for the formation of homodimers (Xu et al., 
2006; Andersen et al., 2004). 
 
RING fingers have been found in proteins involved in a range of diverse cellular processes 
including apoptosis, viral infections, oncogenesis and ubiquitination (Borden, 2000). Many 
RING fingers possess E3 ubiquitin ligase activity, catalyzing the transfer of ubiquitin from an E2 
enzyme to a substrate protein. Although originally thought to function exclusively as E4 
enzymes, catalyzing the extension of pre-existing poly-ubiquitin chains in an E2-independent 
manner, U-boxes have more recently been shown to also possess E3 ligase activity (Hatakeyama 
and Nakayama, 2003; Cyr et al., 2002; Koegl et al., 1999). Protein quality control via interaction 
with various chaperones remains one of the specialized functions of U-box containing proteins, 
but a role for Prp19 in the splicing of pre-mRNA has also been reported (Ohi et al., 2005). 
 
Based on analysis of the pattern of eight cysteine residues conserved across the RBBP6 family, 
the RING finger was expected to be a C4C4 RING finger similar to those found in the 
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transcription-related proteins CNOT4 and p44. However, previous bioinformatics analyses had 
shown that the domain could also be classified as a U-box due to the presence of certain 
conserved hydrophobics. One of the aims of this work was to determine the structure using 
heteronuclear NMR. It was also hoped that a structure of the domain would serve as a framework 
for interpretation of the interaction studies involving RBBP6 which are on-going in our 
laboratory.   
1.2 Retinoblastoma-binding protein 6 (RBBP6) 
Retinoblastoma (Rb) is a tumor suppressor gene that has been implicated in a variety of human 
cancers. Mutagenesis studies have shown that its protein product, pRb, exhibits growth-
inhibitory activity by binding to other cellular proteins via a conserved domain containing the 
amino acid motif LXCXE (Morris and Dyson, 2001). The adenovirus E1A protein, SV40 large T 
antigen and human papilloma virus E7 proteins have all been shown to bind and inactivate pRb 
(Morris and Dyson, 2001). Generally, tumor suppressor proteins elicit their cellular functions via 
protein-protein interactions, prompting searches for proteins that interact with either p53 or pRb. 
RBBP6 is one of few proteins known to interact with both p53 and pRb. p53 pulled the mouse 
form of RBBP6 out of a mouse testis expression library, while pRb pulled a truncated form of 
the human protein out of a small lung carcinoma H69c expression library (Simons et al., 1997; 
Saijo et al., 1995). 
 
RBBP6, also known as PACT (p53-Associated Cellular protein-Testes derived), P2P-R 
(Proliferation Potential protein-Related) or RBQ-1 (RB-binding Q-protein-1), is a 250 kDa 
highly basic splicing-associated nuclear protein encoded by a 6853 bp gene at position 12.2 on 
chromosome 16 (16p12.2). Analysis of expressed transcripts reveals that the gene gives rise to 
 
 
 
 
 
 
4 
three major transcripts of length 6.1, 6.0 and 1.1 kb respectively. These give rise to proteins of 
1792, 1758 and 118 amino acids respectively, which are designated RBBP6 isoforms 1, 2 and 3 
respectively (Genbank accession numbers: NP_008841, NP_061173 and NP_116015). 
 
Genomic analysis shows that the protein does not occur in prokaryotes, but occurs at single copy 
in every eukaryotic genome. A number of conserved domains can be identified, as shown in Fig. 
1.1. All eukaryotes contain the first three domains: the N-terminal DWNN domain, a zinc 
knuckle and a RING finger domain. In higher eukaryotes, the protein also contains a long C-
terminal containing the p53- and pRb-binding domains, a proline-rich domain and an SR domain 
(Pugh et al., 2006). 
 
Simons and co-workers (Simons et al., 1997) showed that RBBP6 can interact with both p53 and 
pRb, confirming the earlier work of Sakai and co-workers (Sakai et al., 1995). They also showed 
that RBBP6 binds hypophosphorylated pRb but not phosphorylated pRb. The binding was shown 
to be disrupted by adenovirus E1A protein suggesting that RBBP6 binds to the pocket domain of 
pRb which in turn suggests that the binding may be of physiological significance (Saijo et al., 
1995). 
 
Western blot analysis using anti-p53 antibodies of recombinant His-tagged RBBP6 precipitated 
with nickel-sepharose from cell lysates revealed the formation of a complex with wild type p53 
but not with mutant p53. This binding interferes with the ability of p53 to bind DNA (Simons et 
al., 1997).  
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Fig. 1.1: Domain organization of the RBBP6/PACT family of proteins (from Pugh et al., 2006). All 
eukaryotic homologues contain the ubiquitin-like DWNN domain, a zinc knuckle and a RING finger domain 
as the core arrangement. RBBP6 homologues in higher eukaryotes include a long C-terminal extension 
containing the p53- and pRB-interacting domains. The protein also exists as a short form of 118 amino acids 
consisting of the DWNN domain alone and having a poorly conserved C-terminal extension. 
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It was also shown that the protein can interact with p53 and pRb in vivo as they co-precipitate in 
immunocomplexes, suggesting that both tumor suppressor proteins bind RBBP6 simultaneously. 
The protein localizes to nuclear speckles, which are sites of pre-mRNA splicing, and also 
associates with Sm antigens in nuclear extracts. Combined with the presence of an SR domain in 
the protein, the above reports suggest a regulatory role for RBBP6 in pre-mRNA splicing (Vo et 
al., 2001; Simons et al., 1997). 
 
Witte and Scott (Witte and Scott, 1997) established that RBBP6 functions in the control of RNA 
metabolism, apoptosis, and p53-dependent transcription. Low to moderate levels of an 8.0 kb 
mRNA transcript of RBBP6 were found across various tissues tested, with the highest level of 
expression was detected in the testes (Scott et al., 2003; Witte and Scott, 1997). RBBP6 was 
found to interact both with splicing-associated complexes known as heterogeneous nuclear 
ribonucleoprotein (hnRNP) particles, as well as pRb. The binding to pRb was blocked by 
adenovirus E1A protein, which is known to specifically bind to the pocket domain of pRb 
thereby excluding other cellular proteins from interacting with the region. RBBP6 expression 
was shown to be markedly repressed during terminal differentiation in multiple murine tissues 
and in proliferating 3T3T cells (Witte and Scott, 1997).  
 
Gao and co-workers (Gao et al., 2002) showed that stable transfection and over-expression of 
near full length RBBP6 promotes prometaphase arrest in mitosis and mitotic apoptosis in Saos2 
cells. Since human Saos2 cells lack functional p53 and pRb, they concluded that RBBP6 must 
promote apoptosis in a manner independent of these tumor suppressor proteins. Using confocal 
microscopy, they established that RBBP6 localizes primarily to the nucleoli in interphase cells 
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and to the periphery of chromosomes in mitotic cells lacking nucleoli. This finding is consistent 
with previous studies that proposed a role for RBBP6 in RNA metabolism (Gao et al., 2002; Vo 
et al., 2001). Gao and Scott further elucidated the existence of a pro-apoptotic region in RBBP6 
overlapping with the p53-binding region. Over-expression of this region has been shown to 
promote camptothecin-induced apoptosis in MCF-7 cells and was also shown to bind single-
stranded nucleic acids (Gao and Scott, 2003). 
 
 A study by Yoshitake and co-workers (Yoshitake et al., 2004) using DNA microarray analysis 
revealed high levels of expression of RBBP6 in oesophageal cancer cells. They also reported that 
high levels of expression correlate with higher rates of proliferation in cultured oesophageal 
cancer cells and low survival rates in cancer patients. Cytotoxic T cells specific for RBBP6-
derived peptides were able to lyse oesophageal cancer cells in culture, and to produce regression 
of oesophageal tumours in mice xenograft models. These results suggest that RBBP6 may be a 
promising target for anti-cancer therapy. In support of the above findings, Perkins and co-
workers (Perkins et al., 1999) through the use of E. coli SOS induction assay (Heitman and 
Model, 1991) identified RBBP6 as one of the many genes that plays a role in genome stability, 
hence reducing carcinogenesis either by altering transcription altogether, or by changing the 
protein structure. 
  
The yeast homologue of RBBP6, named Mpe1p, was identified in Saccharomyces cerevisiae by 
Vo and colleagues (Vo et al., 2001). It has a coding sequence of 441 amino acids and a 
molecular weight of 49.5 kDa. The protein is essential for cell viability and has been shown to 
interact with the PCF11 protein, which encodes a subunit of cleavage factor 1 (CF1), which is 
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responsible for the specific cleavage and polyadenylation of pre-mRNA. Vo and colleagues 
further demonstrated that Mpe1p is a subunit of the yeast cleavage and polyadenylation factor 
(CPF) complex, and together with the poly(A)-binding protein Pab1p is essential for 3’-end 
mRNA processing although it is not involved in the overall stability of the CPF. 
 
Pugh and co-workers (Pugh et al., 2006) determined the structure of the conserved N-terminal 
domain using NMR and found it to be ubiquitin-like. Combined with the presence of the RING 
finger, they hypothesized that RBBP6 functions as an ubiquitin ligase. Using a yeast 2-hybrid 
screen, Chibi and co-workers (Chibi et al., 2008) identified the splicing-associated protein YB-1 
as a substrate for ubiquitination by RBBP6, leading to its degradation in the proteasome. The 
RING finger interacts directly with YB-1 and is capable of catalyzing the ubiquitination on its 
own. Since YB-1 functions anti-apoptotically, promoting cell survival and being positively 
correlated with tumorigenesis (Chibi et al., 2008), this result suggests that RBBP6 functions pro-
apoptotically in respect of YB-1. On the other hand, Li and co-workers (Li et al., 2007) have 
reported that RBBP6 promotes the ubiquitination and destruction of p53 by interacting with 
Hdm2. Since p53 promotes apoptosis, RBBP6 would appear to be acting anti-apoptotically in 
respect of p53. Further investigation will be required in order to resolve this apparent 
contradiction.  
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1.3 RING finger domains 
RING is an acronym for Really Interesting New Gene 1, a human gene found proximal to the 
major histocompatibility complex (MHC) regions on chromosome six (Dominguez et al., 2004; 
Freemont, 1993). The RING finger domain is one of the most common zinc-binding, cysteine-
rich motifs, containing the general consensus sequence: Cys-X(2)-Cys-X(9-39)-Cys-X(1-3)-His-X(2-
3)-Cys-X(2)-Cys-X(4-48)-Cys-X(2)-Cys, where X can be any amino acid, and the numbers refer to 
the lengths of the intervening sequences. The eight cysteine/histidine residues coordinate two 
zinc ions in a characteristic “cross-brace” topology, with the first and third cysteine/histidine 
pairs coordinating the first zinc ion, and the second and fourth pairs coordinating the second zinc 
ion (Nalepa et al., 2006; Ardley and Robinson, 2005; Dominguez et al., 2004). Based on 
consensus sequence and structural information, a unique feature of all RING finger domains is 
the ~14 Å distance between the two zinc atoms exemplified by the conserved close spacing 
between the second and third zinc coordinating pairs. A hydrophobic cluster has also been shown 
to be essential in maintaining the ternary structures of all RING fingers (Dominguez et al., 2004; 
Capili et al., 2001; Hanzawa et al., 2001; Freemont, 2000; Borden, 1998). 
 
The cross-brace motif is not only found in RING domains. A number of other domains also 
exhibit this zinc-coordinating topology, among which is the PHD (Capili et al., 2001), FYVE 
(Stenmark et al., 2002) and U-box domains (see Fig. 1.2). The LIM domain (Aasland et al., 
1995) also coordinates two zinc ions but not in a cross-brace topology. Instead, it adopts a 
tandem zinc finger topology in which the first four coordinating residues sequentially bind to one 
zinc ion and the next four to the other zinc atom.  
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Fig. 1.2: Zinc coordination scheme for RING and related domains. Depicted in A, B, C and D are 
RING (Borden and Freemont, 1996), LIM (Dawid et al., 1998), PHD (Aasland et al., 1995) and FYVE 
(Stenmark et al., 2002) domains respectively. All four domains coordinate two zinc ions and exhibit the 
“cross brace” motif in all cases apart from the LIM domain. Figure adapted from Dominguez et al., 
2004. 
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Although RING and PHD domains are very similar, the arrangement of some secondary 
structure elements differs between them. However, the FYVE domain, although it shares the 
same topology, has a very different structure. The U-box domain has a structure essentially 
identical to that of the RING fingers, although it lacks the signature zinc-coordinating residues 
and does not bind zinc ions. Generally, RING domains are structurally characterized by a βαβ 
fold, although variations in the number of β-strands and the positioning of β-sheets have been 
observed in some RING structures. These variations have been the basis of classifying the 
domain into groups, as described below. 
1.3.1 Classification of RING finger domains 
Based on sequence homology, zinc ion coordination, and the presence and length of secondary 
structure elements, RING finger domains can be classified into the following subclasses: 
C3HC4, C3HHC3, C2H2C4 and C4C4 (Dominguez et al., 2004). 
 
The classical RING domain, which is also the most common, has the C3HC4 consensus 
sequence. Barlow and co-workers (Barlow et al., 1994) solved the first C3HC4 RING domain 
structure from immediate-early EHV-1 protein (IEEHV) using two-dimensional proton nuclear 
magnetic spectroscopy (Fig. 1.3). The structure has a secondary structure that is composed of 
three anti-parallel β-strands packed against a central α-helix, thus adopting a ββαβ global fold. 
The structure is stabilized by conserved residues within the secondary structure elements which 
are involved in the formation of a hydrophobic cluster. The zinc-binding scheme of this protein 
revealed Cys24, His26, Cys43 and Cys46 all cluster around the first zinc ligation site, while 
Cys8, Cys11, Cys29 and Cys32 all cluster around the other zinc site establishing the cross-brace 
topology (Barlow et al., 1994). 
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The C3HHC3 subclass, also known as RING-H2, is the second largest group of RING finger 
proteins. The main difference between this group and the classical RING finger domain (C3HC4 
motif) is the replacement of a cysteine residue at position 4 by a histidine (Katoh et al., 2003; 
Borden and Freemont, 1996). An example of the C3HHC3 motif is EL5, a protein structurally 
related to the proteins of the A. thaliana ATL family (see Fig. 1.4). EL5 is organized into four 
domains: a transmembrane domain (domain I), a basic domain (domain II), a conserved domain 
(domain III) and a RING-H2 domain (domain IV).  The solution structure of the EL5 RING-H2 
finger revealed a three dimensional structure with a ββα fold, which is stabilized by two 
tetrahedrally coordinated zinc ions. The secondary structure consists of a two-stranded β-sheet, 
an α-helix and two long N- and C-terminal flexible loops (Katoh et al., 2003). NMR titration 
experiments showed that Val136, Cys137, Leu138, Val162, Trp165 and Leu174 of the protein 
form a highly conserved hydrophobic core which is critical for hydrophobic interaction with an 
E2, thus confirming the role of the domain in ubiquitination (Katoh et al., 2003). 
 
A new class of RING domain different from the classical RING motif is the novel C2H2C4 
RING motif exemplified by the Hdm2 protein. Human double minute 2 (Hdm2), a human 
homologue of mdm2, is an E3 ubiquitin protein ligase that controls the activity, stability and 
concentration of p53 within cell by regulating its ubiquitination and degradation (Kostic et al., 
2006). 
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Fig. 1.3: Cartoon representation of the tertiary structure of the C3HC4 RING domain from 
immediate-early EHV-1 protein determined by NMR spectroscopy (PDB: 1CHC). The secondary 
structure consists of triple-stranded anti-parallel β-sheets (shown in yellow) packing against a central α-
helix (shown in red) and two symmetrical loops (shown in green) stabilized by two zinc ions (depicted 
in cyan). The first zinc ion is coordinated by Cys24, His26, Cys43 and Cys46, and the second zinc ion 
coordinated by Cys8, Cys11, Cys29 and Cys32 leading to a C3HC4 topology. The thiol group of 
cysteine residues is shown in orange while the nitrogen group of histidine imidazole is depicted in blue. 
Figure adapted from Barlow et al., 1994, and created using The PyMOL Molecular Graphics System 
(2003). DeLano Scientific, LLC, USA. http://www.pymol.org 
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The full-length Hdm2 consists of six domains comprising of an N-terminal p53-binding domain, 
a nuclear localization signal, a nuclear export signal, a non-conserved acidic domain, a zinc 
finger domain and a C-terminal C2H2C4 RING finger domain (Kostic et al., 2006). The 
ubiquitin protein ligase activity of the protein is carried out by the RING finger domain.  
 
The structures of the C4C4 RING finger domain from p44 (Kellenberger et al., 2005) and 
CNOT4 (Hanzawa et al., 2001) were determined by NMR spectroscopy (see Fig. 1.5). Both play 
a role in transcriptional regulation. The structure of the CNOT4 RING domain from the human 
CCR4-NOT transcription complex consists of three loops (designated L1, L2 and L3 
respectively) and a α-helix between the second and third loop, with no regular β-sheet. 
Substitution by 113Cd2+ was used to investigate the coordination of zinc ions, showing that 
Cys14, Cys17, Cys38 and Cys41 all coordinate one zinc ion, while Cys31, Cys33, Cys53 and 
Cys56 coordinate the other; the distance between the two zinc ions was found to be 15 Å instead 
of the 14 Å seen in C3HC4 RING domain structures (Hanzawa et al., 2001). Apart from Cys38 
and Cys41, which are located at the end loop L2 and in the α-helix respectively, all other zinc-
coordinating residues are located in the three loops (see Fig.1.5).  
 
A sequence alignment of the RING domain from RBBP6 against other related RING and RING-
like domains is shown in Fig. 1.6. It shows eight conserved cysteines suggesting that it may be a 
C4C4 RING. Cysteine 3 and 4 are unusual in that they are immediately adjacent, something 
which has not been seen in any previous RING finger structure, raising the question as to 
whether this is a geometrically-feasible coordination pattern. 
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Fig. 1.4: Cartoon representation of the tertiary structure of the RING-H2 finger domain of EL5, 
a rice protein determined by NMR spectroscopy (PDB: 1IYM). The secondary structure is made up 
of two-stranded β-sheets (shown in yellow) packed against an α-helix (shown in red) and two large N- 
and C-terminal loops (shown in green) stabilized by two zinc ions (depicted in cyan). The first zinc ion 
is coordinated by Cys153, His155, Cys172 and Cys175, and the second zinc ion coordinated by 
Cys134, Cys137, His158 and Cys161 leading to a C3HHC3 topology. The thiol group of cysteine 
residues is shown in orange while the nitrogen group of histidine imidazole is depicted in blue. Figure 
adapted from Katoh et al., 2003, and created using The PyMOL Molecular Graphics System (2003). 
DeLano Scientific, LLC, USA. http://www.pymol.org 
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The position usually occupied by histidine (H) in C3HC4 RINGs is taken here by an asparagine 
(N), raising the possibility that what we have is a C3NC4 RING. The side-chain NH2 group of 
asparagines is know to be able to coordinate metal di-cations Mg2+, Mn2+ and Ca2+, but 
coordination of Zn2+ by asparagines is considered highly unlikely (Dudev et al., 2003).     
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Fig. 1.5: Structure of the C4C4-type RING domain of CNOT4 protein from the human CCR4-
NOT transcription complex solved by NMR spectroscopy (PDB: 1E4U). The secondary structure 
consists of a α-helix (shown in red) linked by three loops (depicted in green), with the helix occurring 
between the second and third loop. Two zinc ions depicted in cyan stabilize the structure, with the first 
zinc ion coordinated by Cys14, Cys17, Cys38 and Cys41, and the second zinc ion coordinated by 
Cys31, Cys33, Cys53 and Cys56. The thiol group of cysteine residues is shown in orange. Figure 
adapted from Hanzawa et al., 2001, and created using The PyMOL Molecular Graphics System (2003). 
DeLano Scientific, LLC, USA. http://www.pymol.org 
 
C31 
C53 
C56 
C33 
C 
C41 
C38 
C17 
C14 
N 
 
 
 
 
 
 
18 
Fig. 1.6: Sequence alignment of RBBP6 RING domain against selected RING finger domains and RING 
domain-like proteins. Conserved zinc ion-coordinating residues are coloured pink, while highly conserved 
hydrophobic residues are shaded cyan. The high conservation of hydrophobic residues between the RBBP6 
RING finger and U-boxes such as AtPUB14 and Prp19 has led to classification of the domain as a U-box. The 
following proteins are included in the alignment: C3HC4 RING fingers: IEEHV (1CHC, 1-68), MAT1 (1G25, 1-
65), hTRIM34 (2EGP, res 1-79), zinc finger protein 183-like (2CSY, res 1-81), RING finger protein 126 (2ECT, 
res 1-78), human RING finger protein 141 (2ECN, res 1-70), Pc RING finger protein 6 (2DJB, res 1-72), human 
RING finger protein 146 (2D8T, res 1-71), human RING finger protein 4 (2EA6, res 8-69), RING finger of cell 
growth regulator 1 (2EA5, res 8-62)  and PML (1BOR, res 1-56); C3HHC3 (RING-H2) RING domains: Hdm2 
(2HDP, res 1-63), EL5 (1IYM, res 1-55) and Pirh2 (2JRJ, res 1-52); C4C4 RING domain: CNOT4 (1E4U, res 1-
78); C4HC2D RING domain: human TRAF6 (2JMD, res 1-63); U-box domain: AtPUB14 (1T1H, res 1-78). The 
alignment was created and displayed using ClustalX (Jeanmougin et al., 1998). 
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1.3.2 Other RING-like domains 
1.3.2.1 PHD (Plant homeodomain) domain 
The plant homeodomain (PHD) or leukemia associated protein (LAP) domain is a small but 
conserved functional motif of ~60 amino acids found in more than 400 eukaryotic proteins, 
many of which are localized in the nucleus. PHD domains are involved in protein-protein 
interactions, regulation of transcription and in the maintenance of chromatin structure. PHD-
dependent E3 ligase activity has also been shown in the cellular kinase MEKK1 (Bienz, 2006; 
Bottomley et al., 2005; Capili et al., 2001). The domain was first identified in a homeodomain 
protein involved in plant root development (Dul et al., 2007), giving rise to the name. The 
consensus sequence of the PHD domain is an interleaved arrangement of seven cysteine and one 
histidine residues spatially coordinated to two zinc ions resulting in a C4HC3 topology (Dul et 
al., 2007; Bienz, 2006; Dominguez et al., 2004; Capili et al., 2001). The ligation of the 
conserved cysteine and histidine residues to the zinc ions is cooperatively coupled to the folding 
of the domain in a “cross-brace” manner similar to the arrangement seen in RING fingers as 
depicted in Fig. 1.3 (Bottomley et al., 2005; Dominguez et al., 2004; Capili et al., 2001). 
 
The three-dimensional structure of the PHD domain from the KAP-1 corepressor was determined 
by Capili and co-workers (Capili et al., 2001) using standard homonuclear and heteronuclear 
NMR spectroscopy (see Fig. 1.7). The structure revealed a globular domain binding two zinc 
atoms in a characteristic cross-brace fashion similar to RING fingers. Cys628, Cys631, His648 
and Cys651 are all ligated to the first zinc-binding site which located in the N-terminal loop and 
at the beginning of the second loop, while Cys640, Cys643, Cys666 and Cys669 are ligated to 
the second zinc-binding site which is located in the turn between the first two β-strands and at 
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the end of the third β-strand (Capili et al., 2001). Furthermore, a tightly-packed hydrophobic core 
with Phe647 at the centre surrounded by Val638, Leu656, His652 and Trp664 stabilizes the 
structure. The presence of the highly conserved tryptophan residue (Trp664) at the hydrophobic 
core confirmed that this highly conserved residue is a common feature of all PHD domains 
(Bottomley et al., 2005, Capili et al., 2001). 
1.3.2.2 FYVE domain 
The FYVE domain is a cysteine-rich zinc-binding module having zinc coordination topology 
similar to that of the PHD and RING finger domains, but with a different ternary fold (Cho and 
Stahelin, 2005; Dominguez et al., 2004). The FYVE domain is a small domain consisting of 
approximately 70-80 amino acids, which specifically binds phosphatidylinositol 3-phosphate, 
PI(3)P, and has been identified in about 300 proteins from yeast to man (Hurley, 2006; 
Kutateladze, 2006; Cho and Stahelin, 2005). Fab1p, YOTB, Vac1p and EEA1 were the first four 
proteins in which the domain was identified, giving rise to the name “FYVE” (Kutateladze, 
2006; Gillooly et al., 2001; Driscoll, 2001). FYVE domain-containing proteins are involved in 
endocytic membrane trafficking and phosphoinositide metabolism, receptor signaling and actin 
cytoskeleton regulation (Cho and Stahelin, 2005).  
 
FYVE domains consist of eight conserved cysteine residues that coordinate two zinc ions in a 
‘cross-brace’ topology. Two of these conserved cysteine residues (third and fourth) are part of 
the core motif, R(R/K)HHCRXCG (where X is any amino acid) which forms the PI(3)P binding 
site and structurally distinguishes the domain from other related domains (Kutateladze, 2006; 
Lee et al., 2005; Gillooly et al., 2001). 
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Fig. 1.7: Cartoon representation of a 3D structure of the PHD RING-like domain from the KAP-
1 transcriptional corepressor determined by NMR spectroscopy (PDB: 1FPO). The secondary 
structure consists of two loops (the N-terminal loop distinguishingly long) shown in green; and a three-
stranded β-sheets (shown in yellow) of which the first and the second sheet adopt an anti-parallel 
position to each other. There is no evidence of a central α-helix characteristic of the RING domains. 
However, two zinc ions (shown in cyan) stabilize the structure; and are coordinated by Cys628, 
Cys631, H648 & Cys651 at the first site and Cys640, Cys643, Cys666 & Cys669 at the second site 
leading to a C4HC3 topology. The thiol group of cysteine residues is shown in orange while the 
nitrogen group of histidine imidazole is depicted in blue. Figure adapted from Capili et al., 2001, and 
created using The PyMOL Molecular Graphics System (2003). DeLano Scientific, LLC, USA. 
http://www.pymol.org 
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The solution structure of the FYVE domain of early endosome antigen 1 (EEA1) protein (amino 
acid residues 1346-1410) was determined using heteronuclear NMR spectroscopy (see Fig.1.8). 
The secondary structure of the domain in the unbound state consists of two double-stranded anti-
parallel β-sheets (β1: residues 1370-1372; β2: residues 1379-1382; β3: residues 1387-1391; β4: 
residues 1394-1400) stabilized by two zinc ions and a C-terminal α-helix (α2: residues 1402-
1408). Overall, the tertiary structure of the domain consists of the secondary structure together 
with two β-hairpins and a mobile N-terminal 310-helix (α1: residues 1350-1354) held together by 
the two zinc coordination clusters (Kutateladze and Overduin, 2001). 
 
The FYVE domain performs its function by being recruited to membranes through the insertion 
of a conserved hydrophobic loop (Phe1364-Ser1365-Val1366-Thr1367-Val1368) into the lipid 
bilayer, forming a weak complex. This leads to the opening and priming of the binding pocket of 
the inositol headgroup resulting in the specific recognition and binding of PI(3)P (Kutateladze 
and Overduin, 2001; Driscoll, 2001). The binding pocket is made up of arginine residues which 
are proximal (Arg1369 & Arg1370) and distal (Arg1374 & Arg1399) to the conserved 
hydrophobic loop (Hurley, 2006; Kutateladze and Overduin, 2001). 
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Fig. 1.8: Cartoon representation of the solution structure of the FYVE domain of early endosome 
antigen 1 (EEA1) protein determined by heteronuclear NMR spectroscopy (PDB: 1HYJ). The 
secondary structure consists of four β-strands (shown in yellow), a standard α-helix and a 310 helix 
(shown in red) stabilized by two zinc ions (depicted in cyan). The first zinc ion is coordinated by 
Cys1357, Cys1360, Cys1381 & Cys1384, and the second zinc ion by Cys1373, Cys1376, Cys1401 & 
Cys1404 leading to a C4C4 topology. The thiol group of cysteine residues is shown in orange. Figure 
adapted from Kutateladze and Overduin, 2001 and created using The PyMOL Molecular Graphics 
System (2003). DeLano Scientific, LLC, USA. http://www.pymol.org 
 
C 
N 
C1357 
C1360 
C1381 
C1384 
C1373 
C1376 
C1401 
C1404 
 
 
 
 
 
 
24 
1.3.2.3 LIM domain 
The cross-brace zinc topology seen in RING finger domains and some other related domains is 
replaced in the LIM domain by a tandem zinc finger-like topology, as shown in Fig. 1.2B 
(Dominguez et al., 2004; Saurin et al., 1996; Borden and Freemont, 1996). The acronym ‘LIM’ 
is derived from the first letter of each of the three homeodomain proteins in which this domain 
was first identified: Linl-1, Isl-1 and Mec-3 (Zheng and Zhao, 2007; Velyvis et al., 2001; Bach, 
2000). The LIM domain is a cysteine-rich, zinc-coordinating domain with 50-60 amino acids, 
which is made up of two-tandemly repeated zinc fingers separated by only two amino acids. The 
two zinc fingers are separate structural entities held together by hydrophobic interactions (Zheng 
and Zhao, 2007; Bach, 2000; Dawid et al., 1998). The domain consists of a loosely conserved 
consensus sequence defined as CysX2-CysX(16-23)-HisX2-CysX2-CysX2-CysX(16-21)-CysX2-
(C/H/D)X, where X can be any amino acid, and the numbers refer to the lengths of the 
intervening sequences. LIM domain-containing proteins are involved in gene regulation and cell 
fate determination, cytoskeleton organization, cell adhesion, cell motility, tumour formation and 
signal transduction (Zheng and Zhao, 2007; Kadrmas and Beckerle, 2004). 
 
The solution structure of the focal adhesion adaptor PINCH LIM1 domain (amino acid residues 
1-70) was determined using heteronuclear NMR spectroscopy as shown in Fig. 1.9 (Velyvis et 
al., 2001). PINCH (particularly interesting new cysteine- and histidine-rich protein) is an 
adaptor protein containing five LIM domains, which functions by mediating integrin signaling 
by interacting with an integrin-linked kinase (ILK). This interaction is crucial for the focal 
adhesion localization of ILK, integrin and growth factor signaling (Velyvis et al., 2001).  
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The domain can be divided into two zinc fingers (zinc finger 1: residues 9-35 and zinc finger 2: 
residues 38-61), with the first finger consisting of an N-terminal loop and a double-stranded β-
sheet, and the second finger consisting of two α-helices flanking a double-stranded β-sheet 
(Velyvis et al., 2001).  
 
Even though both LIM and RING domains both bind two zinc ions, the overall fold of the LIM 
domain is less compact than the core structure of the RING domain, which may be due to the 
difference in the zinc coordination topology. In addition, the central α-helix in RING domains is 
absent from LIM domains (Dominguez et al., 2004). The PINCH protein functions by protein-
protein interaction between its LIM domain and other interacting partners like the ankyrin repeat 
domain of integrin-linked kinase. The binding surface involved in this scaffolding has been 
mapped by NMR to involve a hydrophobic patch near to the C-terminus of the protein which 
involves Tyr51, Phe53, Tyr58, Phe63 and Leu66 (Velyvis et al., 2001). 
1.3.2.4 U-box domain 
The U-box motif is a peptide chain of ~70 amino acid residues which was first identified in the 
yeast protein UFD2 (ubiquitin fusion degradation protein 2) (Hatakeyama and Nakayama, 2003) 
but has since been shown to be present in other eukaryotes. The domain was designated as a 
member of a new class of ubiquitinating enzymes, E4, and was shown to be required for multi-
ubiquitination of proteins (Pringa et al., 2001; Aravind and Koonin, 2000; Koegl et al., 1999). 
Essentially, they lack their own substrates but serve as scaffolds which aid the transfer of 
ubiquitin from an E2 enzyme to an already conjugated ubiquitin i.e. they play a role in the 
elongation of the polyubiquitin chains. 
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Fig. 1.9: Solution structure of the LIM1 domain of PINCH, an adaptor protein determined by 
NMR spectroscopy (PDB: 1G47). The secondary structure is made up of two β-stranded anti-parallel 
sheets (shown in yellow), a long N-terminal loop and a C-terminal helix (shown in red) resulting in a 
β1-β2-β3-β4-α tandem zinc finger fold stabilized by two zinc ions (depicted in cyan). The first zinc ion is 
coordinated by Cys10, Cys13, His32 and Cys35 leading to a CCHC zinc finger, and the second zinc ion 
by Cys38, Cys41, Cys59 and His61 leading to a CCCH zinc finger topology. The thiol group of 
cysteine residues is depicted in orange while the nitrogen group of histidine imidazole is depicted in 
blue. Figure adapted from Velyvis et al., 2001, and created using The PyMOL Molecular Graphics 
System (2003). DeLano Scientific, LLC, USA. http://www.pymol.org 
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However, a number of U-box containing proteins have more recently been shown to act as E3 
ubiquitin ligases, including the mammalian homologue of yeast UFD2 (Hatakeyema and 
Nakayama, 2003). Hence U-box domains, like RING fingers and HECT domains, may act as E3 
ubiquitin ligases (Ardley and Robinson, 2005; d’Azzo et al., 2005; Liu, 2004).  
 
U-boxes adopt the same topology and three-dimensional structure as RING domains even in the 
absence of zinc coordination which is critical for proper folding and stability of RING domains. 
U-boxes lack the conserved cysteine residues required for metal chelation, and do not bind zinc 
(Tu et al., 2007; Zhang et al., 2005; Houben et al., 2005; Andersen et al., 2004; Ohi et al., 2003). 
However, the zinc coordinating residues seen in RING fingers are replaced by highly conserved 
hydrophobic residues which stabilize the protein via a system of salt-bridges and hydrogen bonds 
(Andersen et al., 2004; Ardley and Robinson, 2005; Aravind and Koonin, 2000). These 
conserved hydrophobic residues are also seen in RING finger domains, but the degree of 
conservation is higher in the U-box domains. Based on these conserved hydrophobic residues, 
the RBBP6 RING domain has been classified as a U-box domain (Aravind and Koonin, 2000). 
However, the presence of eight conserved cysteine residues suggests that the domain binds zinc 
and is indeed a RING finger domain rather than a U-box domain.  
 
The three-dimensional structure of the U-box domain from the PUB14 protein from Arabidopsis 
thaliana was determined by Andersen and co-workers (Andersen et al., 2004) using 
heteronuclear NMR spectroscopy (see Fig.1.10). AtPUB14 consists of a U-box domain followed 
by an Armadillo repeat region (ARM), which is short leucine-rich protein-interaction motif. 
 
 
 
 
 
 
 
28 
The secondary structure of the U-box domain consists of two α-helices (designated helix 1: 
Gln274-Gly285 and helix 2: Tyr305-Asn318), a three-stranded anti-parallel β-sheets (β1: 
Pro2664-267; β2: Gln271-Glu274; β3: Thr302-Asn304) and two long N- and C-terminal loops 
(loop 1: Tyr251-Asp263; loop 2: His286-Leu301). Two pairs of salt bridges connecting the N- 
and C-termini (Lys262-Glu321 and Asp263-Lys308), together with a network of hydrogen bonds 
involving residues from two hydrophobic interaction cores, stabilize the structure. With the 
exception of the C-terminal helix, the structure adopts the same ββαβ fold seen in the Prp19p U-
box and in all RING finger domains (Andersen et al., 2004).  
 
The AtPUB14 U-box domain undergoes dimerization in solution due to the presence of aromatic 
residues exposed at the N-terminus and within the C-terminal α-helix. Chemical shift changes 
experienced in the NMR spectrum of the protein implicates Tyr251 & Phe252 (N-terminal 
aromatic residues), and Leu313 & Trp314 (C-terminal α-helix residues) in this process. The C-
terminal α-helix has also been shown to be present in the RING finger domain of RAG1 
(Andersen et al., 2004) and in the U-box domain of CHIP, a protein shown to be involved in 
protein “quality control”. In both cases, the C-terminal helix played an important role in homo-
dimerization of the domain.          
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Fig. 1.10: Cartoon representation of the tertiary structure of the U-box domain from Arabidopsis 
PUB14 protein determined by NMR spectroscopy (PDB: 1T1H). The secondary structure consists 
of two helices (shown in red), three-stranded anti-parallel β-sheets (shown in yellow), and two long 
loops (shown in green). The structure assumed a globular shape in which one helix packed against the 
anti-parallel β-sheets and the other helix packed against the N-terminal loop. Two strands of the β-
sheets form a β-hairpin. The structure is stabilized by a network of hydrogen bonds instead of the zinc 
ion binding scheme seen in RING motifs. Figure adapted from Andersen et al., 2004, and created using 
The PyMOL Molecular Graphics System (2003). DeLano Scientific, LLC, USA. http://www.pymol.org 
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1.3.3 Chemistry of zinc ion coordination in RING fingers 
Zinc is an essential trace metal with a broad range of stability, reactivity and functions in 
biological systems. Zinc can either play a catalytic role by its interaction with substrates during 
transformation or a structural role in the maintenance of structural configuration of proteins e.g. 
zinc coordination is critical in metalloproteins for proper folding and stability, and functional 
activity (Houben et al., 2005; Sakharov and Lim, 2005). Examples of proteins in which zinc 
plays a purely structural role have been found in RING fingers, zinc fingers, steroid-thyroid 
hormone receptor superfamily, tumour suppressor proteins like p53, and the human growth 
hormone-prolactin receptor complex. These proteins along with many others may adopt 
tetrahedral, pentahedral or octahedral zinc coordination schemes in which four, five or six 
ligands respectively from the side chains of cysteine, histidine, and in some cases, aspartate and 
glutamate, are ligated to the metal ion (Dudev and Lim, 2003; Berg and Shi, 1996). 
 
Chemically, zinc exists as a divalent cation (Zn2+) and hybridizes completely having a filled 
d shell of 10 d electrons and atomic radius of 0.74 Å. Consequently, zinc is classified as a 
borderline acid in terms of the hard-soft-acid-base theory, conferring on it the ability to interact 
with a variety of ligands such as sulphur from cysteine, nitrogen from histidine, and oxygen from 
glutamate, aspartate, and water (Berg and Shi, 1996). Due to its filled d shell, zinc ions have 
stabilization energy when coordinated by ligands in any geometry. The result is that zinc ions 
tend to favour tetrahedral geometry (the most stable) in solvent-inaccessible cases such as 
proteins, and because polarized cysteine side chains tend to transfer more charges than water, 
thus neutralizing the positive charges on zinc ions (Dudev and Lim, 2003; Berg and Shi, 1996). 
Some heavy metals such as cadmium (Cd), mercury (Hg) and lead (Pb) are able to replace zinc 
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in zinc-binding proteins. Various studies have utilized this ability of zinc ions to be substituted 
by cadmium ions to investigate the topology of zinc binding in RING finger proteins (Houben et 
al., 2005; Kellenberger et al., 2005; Hanzawa et al., 2001).  
 
Yang and co-workers (Yang et al., 2008) posited that metal ions in homonuclear binding sites as 
seen in RING finger proteins are separated by shorter (M-M) distance (3-5 Å) due to a high 
oxidation state (Zn2+-Zn2+). This is due to smaller ionic radius and shorter metal-ligand distances, 
leading to a more compact structure of the binding site when compared to cations in a lower 
oxidation state (Cu+-Cu+). Furthermore, they found that a given metal ion preference in either a 
homobinuclear or mononuclear protein exhibit similar characteristics provided the metal ion 
played the same role (structural or catalytic) in both metal-binding sites. Moreover, Bombarda 
and co-workers (Bombarda et al., 2001) showed that in zinc-binding proteins the four 
coordinating residues are de-protonated when they bind zinc. Hence, in RING fingers the 
cysteine residues are all expected to be de-protonated.  
1.4 Role of RING fingers in ubiquitination 
1.4.1 Ubiquitination machinery 
Ubiquitination is the process by which ubiquitin is covalently linked to other proteins. This 
involves the formation of an iso-peptide bond between the C-terminal glycine residue of 
ubiquitin and the ε-amino group of a lysine residue from the acceptor protein. Conjugated 
ubiquitin can then be the substrate for further ubiquitination reactions. Most substrates, however, 
appear to be modified by multiubiquitin chains in which multiple ubiquitin molecules are linked 
via iso-peptide bonds (Kerscher et al., 2006; Vrij et al., 2004; Pickart, 2001; Hochstrasser, 
1996). Monoubiquitination is the attachment of a single ubiquitin to a protein while the 
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attachment of single ubiquitin molecule to different lysine residues of the target protein is known 
as multiubiquitination. Polyubiquitination involves the addition of a chain of ubiquitin molecules 
formed by linking the C-terminal glycine of one molecule to the same or different lysine residues 
on the next ubiquitin molecule (Mukhopadhyay and Riezman, 2007). Since the lysines involved 
may be different, there is possibility that heterogeneous chains may be formed in this way.  
 
Ubiquitination controls a number of fundamental cellular functions such as antigen processing, 
apoptosis, cellular differentiation and proliferation, cell-cycle progression, DNA repair, 
inflammation, intracellular protein trafficking, metabolism, neural and muscular degeneration, 
organelle biogenesis, quality control in the endoplasmic reticulum, receptor modulation, signal 
transduction, stress responses and transcriptional activation (Deriziotis and Tabrizi, 2008; Li and 
Ye, 2008; Kerscher et al., 2006; Glickman and Ciechanover, 2002; Pickart, 2001; Weissman, 
2001).  
 
The classical ubiquitin pathway (also known as ubiquitin-proteasome mediated proteolysis) 
shown in Fig. 1.11 occurs via two distinct and successive steps: covalent attachment of multiple 
ubiquitin molecules to target protein, and the degradation of the tagged protein by the 26S 
proteasome. The process of ubiquitination involves three sequential reactions catalyzed by an 
ubiquitin-activating enzyme (E1), an ubiquitin-conjugating enzyme (E2) and an ubiquitin-protein 
ligase (E3) enzyme (Wertz and Dixit, 2008; Nalepa et al., 2006; Hegde, 2004). The number of 
ubiquitin moiety added and the topology of the ubiquitin-ubiquitin linkage determines the fate of 
modified proteins e.g. Lys48-tagged polyubiquitination leads to degradation by the 26S 
proteasome (Kerscher et al., 2006; Nalepa et al., 2006; Willis and Patterson, 2006; Hatakeyama 
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and Nakayama, 2003), Lys63-tagged polubiquitination leads to regulation of transcriptional 
activity, endocytosis and DNA repair (Haglund and Dikic, 2005). 
1.4.1.1 Ubiquitin-activating enzyme (E1) 
The E1 enzyme encodes two isoforms of 110 and 117 kDa from a single E1 gene (Weissman, 
2001). In mammals and yeast, there exists a single E1 enzyme (Pickart, 2001). The activation of 
ubiquitin by the E1 enzyme occurs via a two-step intra-molecular and ATP-dependent reaction, 
in which AMP and a high-energy E1-thiol-ester-ubiquitin intermediate is generated and 
transferred to the active cysteine of the E2 (Petroski, 2008; Hegde, 2004; Glickman and 
Ciechanover, 2002). 
1.4.1.2 Ubiquitin-conjugating enzymes (E2’s) 
E2s catalyzes the second step of the ubiquitination cascade which involves either the covalent 
attachment of ubiquitin directly to a target protein or the transfer of activated ubiquitin to a high-
energy E3-ubiquitin intermediate (Vrij et al., 2004; Glickman and Ciechanover, 2002). Essential 
to their function is a core structure of ~150 amino acids called the ubiquitin-conjugating (Ubc) 
domain, which contains interfaces for ubiquitin interaction. The active cysteine of the Ubc 
domain then forms a thioester bond with the activated ubiquitin intermediate transferred from the 
E1. The genome of Saccharomyces cerevisiae encodes 13 E2s designated Ubc1-13. However, 
Ubc9 functions in sumoylation while Ubc12 is involved in rubylation rather than ubiquitination.  
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Fig. 1.11: Overview of the Ubiquitin-like protein (UBL) conjugation pathway (taken from Kerscher et al., 
2006). Immature ubiquitin-like proteins (including ubiquitin) originally get processed by either deubiquitinating 
enzymes (DUBs) or by UBL-specific proteases (ULPs) to yield an active protein with an exposed C-terminal 
glycine which is critical for conjugation. The mature UBL becomes adenylated on its C-terminal glycine by an 
E1 enzyme yielding a high-energy UBL~intermediate which is then covalently bound by the catalytic cysteine of 
same E1enzyme, in a reaction in which AMP is released. Thereafter, activated UBL via a transthiolation 
reaction, is passed on to the catalytic cysteine of one of the several distinct E2 enzymes, and subsequently 
transferred to an E3 enzyme which facilitates the ligation of the UBL to a substrate. Two classes of E3s: RING 
E3s and HECT E3s determine the mechanism of ligation between activated UBL and the substrate. Finally, the 
DUBs and ULPs then hydrolyzes and removes ubiquitin moieties from the substrate protein before they are then 
recycled. Monoubiquitination, as well as polyubiquitination via specific Lys commits the substrate to specific 
physiological function.     
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There are more than 30 E2s in Drosophila melanogaster and about 20-30 E2s exists in mammals 
(Hegde, 2004; Liu, 2004; Vrij et al., 2004; Glickman and Ciechanover, 2002; Pickart, 2001). 
Substrate specificity is conferred by the involvement of Phe63, Pro97 and Ala98 which interact 
with a hydrophobic groove in the RING finger domain in E3 ligases between the central α-helix 
and the two zinc-stabilized loops (Xu et al., 2008). 
1.4.1.3 Ubiquitin-protein ligases (E3’s) 
The crucial role of selective and specific recognition of the protein to be degraded remains an 
important function of the E3s. The ubiquitin-protein ligase binds both the E2 enzyme and the 
substrate, either directly or indirectly via ancillary proteins (Liu, 2004; Glickman and 
Ciechanover, 2002). E3s are classified into three major groups: the Homology to the E6-
associated protein Carboxyl Terminus (HECT) domain-containing E3s, RING domain-
containing E3s and the U-box domain-containing E3s (Segref and Hoppe, 2009; Nalepa et al., 
2007; Zolk et al., 2006; Liu, 2004). In HECT domain-containing E3s, the activated ubiquitin 
moiety is transferred directly from the E2 enzyme to an internal cysteine residue on the E3 
before conjugation to an amino group in the target protein (Kee and Huibregtse, 2007; Ardley 
and Robinson, 2005; d’Azzo et al., 2005; Vrij et al., 2004; Wong et al., 2003). An example of 
ubiquitination reaction catalyzed by the HECT domain-containing E3 is the binding of E6-
associated protein (E6-AP) to the human papilloma virus (E6) oncoprotein to ubiquitinate and 
degrade p53 (Scheffner et al., 1993).   
 
On the other hand, RING finger E3s serve as scaffolds that bring E2 enzymes and substrates into 
close proximity for the efficient and effective transfer of activated ubiquitin to the substrates. 
They are characterized by the presence of a RING domain consisting of conserved cysteines and 
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histidines that coordinates two zinc ions in their active site, which is critical for correct folding 
and activity of the E3 (Hegde and Upadhya, 2007; Ardley and Robinson, 2005; Hedge, 2004; 
Weissman, 2001). They can exist either as monomers, in which the RING domain and the 
substrate recognition site are contained within the same protein (e.g. Mdm2, Parkin and Ubr1), or 
as complexes having multiple subunits (e.g. APC-anaphase promoting complex).  
1.4.2 Non proteasome-dependent ubiquitin signalling 
1.4.2.1 Transcriptional regulation and Chromatin structure 
Nuclear processes such as gene expression, DNA repair and replication can be controlled at the 
cellular level by post-translational modification of histones including monoubiquitination, 
methylation and acetylation (Welchman et al., 2005). Early contribution to this concept by 
Robzyk and co-workers (Robzyk et al., 2000) carried out in yeast showed the existence of 
functional interplay between ubiquitinated histone H2B and acetylated histone H3, in which the 
modification of one histone is required in trans for the same effect on the other histone. 
Elsewhere, Sun and Allis (Sun and Allis, 2002) showed that Rad6-mediated Lys123 (K123) 
monoubiquitination of histone H2B regulates Lys4 (K4) methylation of histone H3, resulting in 
gene silencing in Saccharomyces cerevisiae. Furthermore, Pray-Grant and co-workers (Pray-
Grant et al., 2005) recently showed that the yeast Spt-Ada-Gcn Acetyltransferase (SAGA) and 
SLIK (SAGA-like) enzymes are two conserved multi-subunit histones acetyltransfreases which 
acetylate histones H3 and H2B, as well as deubiquitinate histone H2B. They identified chd1 
(chromodomain-helicase-domain-DNA-binding-domain-1) domain, as a component of the 
SAGA/SLIK enzyme complex, which specifically interacts with Lys4-methylated histone H3 to 
control transcriptional activity. 
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Histone H1 is the subject of monoubiquitination in Drosophila melanogaster embryos. In vitro, 
this modification depends on TAF250 (a subunit of the TF11D). Mutations in TAF250 which 
inhibit ubiquitination lead to defective transcriptional activation in the embryos of these flies, 
indicating that TAF250-dependent H1 ubiquitination might control gene expression (Pham et al., 
2000). Histone modification also plays a role in the silencing of gene expression in humans. 
Monoubiquitylation of histone H2A, as carried out by the human Polycomb repressive complex-
1-like (E3 complex) is linked to the Polycomb silencing of gene expression (Wang et al., 2004). 
Moreover, transcriptional regulation is not limited to histone modification alone. As exemplified 
by the F-box protein Dsg1/Mdm30, post-translational modification of transcription factors also 
controls gene expression. The F-box protein is required for the ubiquitination of the yeast 
transcription factor Gal4, thereby stimulating Gal4 turnover and thereby affecting its 
transcriptional activity (Muratani et al., 2005).  
1.4.2.2 Post-replicational DNA repair 
DNA polymerases are enzymes which catalyze DNA replication. As soon as a site of DNA 
damage is detected, replication stops and the process of DNA repair is initiated by the RAD6 
protein family. The process of DNA repair involves translesion synthesis by the Polξ and Polף 
DNA polymerases leading to one of the three possible mechanisms: error prone repair, error free 
repair or error free template-switching, a process involving the use of undamaged sister 
chromatids. All three mechanisms are regulated by K164-linked ubiquitination of the replicative 
processivity factor (PCNA) which forms a clamp that encircles DNA during replication 
(Welchman et al., 2005; Sun and Chen, 2004; Johnson, 2002).  
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The first step in PCNA modification involves monoubiquitination at Lys164 by Rad6, an E2, and 
Rad18, a RING domain E3 ligase. Monoubiquitinated PCNA then associates with translesion 
polymerases to trigger error prone DNA repair. Alternatively, Ubc13-Mms2, a heterodimeric E2, 
and Rad5, another RING domain E3 ligase, initiate the polyubiquitination of monoubiquitinated 
K164-linked PCNA by the addition of a K63-linked ubiquitin chain. This K63-linked-
polyubiquitinated PCNA then activates repair of damaged DNA by polymerases via the error-
free bypass (template switching) pathway (Herrmann et al., 2007; Mukhopadhyay and Riezman, 
2007; Welchman et al., 2005). The ubiquitin-like protein, SUMO has been shown to conjugate 
Lys164, preventing ubiquitination of this site, thereby suppressing the Rad5-dependent DNA 
repair mechanism (Haracska et al., 2004; Hoege et al., 2002; Johnson, 2002).  
1.4.2.3 Protein Kinase activation via NF-kB signaling  
The role played by ubiquitination in intracellular signaling can best be explained using protein 
kinase activation as an example. In unstimulated cells, NF-kB is kept inactive in the cytoplasm 
by its association with the inhibitor, IkBα. However, in the presence of proinflammatory 
cytokines such as TNFα and IL-1β, IkBα becomes rapidly phosphorylated by IKK (IkB kinase) 
and subsequently K48-polyubiquitinated, leading to degradation in the proteasome, thereby 
allowing NF-kB to access the nucleus and turn on the expression of many target genes. This 
same mechanism of activation is exhibited by the c-jun kinase (Kirkin and Dikic, 2007; 
Welchman et al., 2005; Karin and Ben-Neriah, 2000). 
 
A different but unique mechanism of activation is employed in the activation of the regulatory 
subunit of IkB kinase, IkKγ/NEMO (NF-kB essential modulator). TGF-β-activated kinase 
(TAK1) first undergo Lys63-polyubiquitination by TRAF6 (an E3 ubiquitin ligase) before it can 
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activate IkK. More so, NEMO undergoes the same K63-linked polyubiquitination leading to the 
activation of IkK and subsequently, NF-kB. Consequently, TAK1-binding proteins (TAB1, 
TAB2 and TAB3), which is in a complex with TAK1 recognizes ubiquitin-K63 modified 
NEMO, immediately brings TAK1 to close proximity with IkK and thereby facilitate TAK1-
mediated activation of the IkK/NF-kB pathway (Haglund and Dikic, 2005). TRAF6 has been 
shown to be essential for signaling of the IL-1 receptor, CD40 and all Toll-like receptors 
involved in innate immune responses through this same pathway (Mukhopadhyay and Riezman, 
2007; Ravid and Hochstrasser, 2004; Sun and Chen, 2004; Schnell and Hicke, 2003). Switching 
off the NF-kB signaling system is through deubiquitination, which involves cleaving off the K63-
linked chains from TRAF6 (and in some instances TRAF2) by the tumour suppressor-CYLD 
(cylindromatosis) and protein A20 (Wertz et al., 2004). 
1.4.2.4 Endocytosis and Sorting 
The endosomal system functions in the trafficking of endocytosed plasma membrane proteins, 
newly synthesized proteins destined for the lysosome/yeast vacuole and the delivery of these 
proteins to the plasma membrane. After activation, growth factor receptors are removed from the 
cell surface and transported to the endosomal compartment from where they are recycled or 
targeted for degradation by the acidic hydrolases of the mammalian lysosomes/yeast vacuoles 
(Kirkin and Dikic, 2007; Mukhopadhyay and Riezman, 2007; Holler and Dikic, 2004; Hicke and 
Dunn, 2003; Schnell and Hicke, 2003; Katzmann et al., 2002). Mono- and multi-ubiquitination 
have been shown to be required for endosomal trafficking of membrane proteins, provide 
important signals at a number of steps in the process. 
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Ubiquitination facilitates both plasma membrane internalization and the endosomal protein 
sorting process. Growth hormone receptors, platelet-derived growth factor receptors, as well as 
transporters such as uracil and maltose permeases in Saccharomyces cerevisiae are 
predominantly monoubiquitinated or multi-ubiquitinated (Herrmann et al., 2007; Aguilar and 
Wendland, 2003; Haglund et al., 2003). Emerging evidence has also shown that short K63-
linked polyubiquitin chains might also play a role in vacuolar/lysosomal targeting, which in the 
long term ensures cell stability and smooth progression through the cell cycle (Hicke, 2001). 
Monoubiquitination is also required for endocytic sorting of receptors into luminal vesicles of 
late endosomes/multivesicular bodies (MVB), committing them to the vacuolar/lysosomal 
pathway (Herrmann et al., 2007; Mukhopadhyay and Riezman, 2007; Welchman et al., 2005; 
d’Azzo et al., 2005; Johnson, 2002; Marx, 2002). Moreover, several endocytic regulators contain 
ubiquitin-binding domains that interact with monoubiquitin, recognizing ubiquitinated cargoes 
even before endosomal sorting (Hicke et al., 2005). 
1.5 AIMS OF THE STUDY 
Although RING finger domains play an essential role in ubiquitination, their exact mechanism of 
action is still poorly understood. Determination of the structure of the RBBP6 RING domain 
protein will add to the understanding of these important domains and act as a framework for 
future functional studies in RBBP6. Hence, the objectives of this study are as follows: 
 Overexpress 15N- and 13C-enriched soluble samples of RING finger in E.coli. 
 Investigate the state of folding of the domain; define optimal boundaries of the domain 
for structure determination, and investigate whether the domain is monomeric or dimeric 
in solution. 
 Investigate whether the domain requires zinc ions in order to fold. 
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 Determine residues involved in zinc coordination to establish whether it is a C4C4 or a 
C3NC4 structure. 
 Determine the 3-dimensional structure of the domain using heteronuclear NMR in order 
to confirm that it is similar to previously determined RING structures. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 General stock solutions, buffers and media 
Ammonium Persulphate: A 10 % stock solution was prepared in deionised water. The solution 
was stored at 4 °C. 
Ampicillin: A 100 mg/ml stock solution was prepared in deionised water. The solution was 
filter-sterilized using a 0.22 micron filter and stored at -20 °C. 
Bradford Dye Stock: 0.1 % Coomassie brilliant blue G 250, 8.5 % phosphoric acid and 4.75 % 
ethanol. The solution was stored at 4 °C and diluted 5 times with deionized water before use. 
Cell Lysis Buffer: 1 % Triton X-100, 100 µg/ml DNAse 1, 100 µg/ml lysozyme, 1 mM PMSF, 
1 mM DTT, 50 µM ZnSO4 and 1 tablet of CompleteTM EDTA-free protease inhibitor cocktail in 
25 ml of PBS. 
Chloramphenicol: A 34 mg/ml stock solution was prepared in ethanol. The solution was stored 
at 4 °C until needed. 
Coomassie Staining Solution: 0.25 g Coomassie Blue R-250, 40 % methanol and 10 % acetic 
acid in 2000 ml deionised water. 
Destaining Solution: 15 % (v/v) acetic acid. 
10X DNAse 1 Buffer: 0.5 M Tris-HCl pH 7.5, 0.1 M MnCl2, 0.5 mg/ml Bovine Serum Albumin 
(BSA). This buffer was sterilized by filtration and stored at -20 °C. The buffer was diluted 
10 times with deionised water before use. 
DNAse free RNAse buffer: 0.1 M sodium acetate anhydrate, 0.1 mM EDTA, pH 4.8. This 
buffer was stored at -20 °C. 
DTT: A 1 M stock solution was prepared in 0.01 M sodium acetate, pH 5.2. The solution was 
sterilized by filtration, divided into 1 ml aliquots and stored at -20 °C. 
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Ethidium Bromide: 10 mg/ml stock solution was prepared in water, and stored in the dark at 
4 °C. 
6X Glycerol BPB Gel-loading Buffer: 30 % Glycerol, 0.25 % Bromophenol Blue and 0.25 % 
Xylene cyanol in 1X TBE. 
GTE: 50 mM Glucose, 50 mM Tris-HCl and 10 mM EDTA pH 8.0. 
IPTG: A 1 M stock solution was prepared in deionised water. The solution was filter-sterilized, 
aliquoted and stored at -20 °C. 
Luria Agar: 10 g/l Tryptone powder, 5 g/l Yeast extract, 5 g/l NaCl and 14 g/l Bacteriological 
agar. 
Luria Broth: 10 g/l Tryptone powder, 5 g/l Yeast extract, 5 g/l NaCl and 2 g/l Glucose.  
Lysis Solution:  200 mM NaOH and 1 % SDS. 
Minimal Media: 12.8 g/l Na2HPO4-7H2O, 3 g/l KH2PO4, 1 g/l NH4Cl and 0.5 g/l NaCl. The pH 
of this media was adjusted to 7.0 with NaOH and the solution was autoclaved. Immediately prior 
to use, the solution was supplemented with 2 ml of autoclaved 1 M MgSO4, 100 µl of autoclaved 
1 M CaCl2 and 10 ml of filter-sterilized 20 % Glucose. The solution was stored at room 
temperature. 
Neutralization Solution: 3 M Potassium acetate, pH 5.0. 
NMR Buffer: 100 mM Sodium phosphate buffer pH 6.0, 50 mM NaCl, 5 mM DTT and 0.02 % 
sodium azide. 
PBS: 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4-7H20 and 1.5 mM KH2PO4. The pH was 
adjusted to 7.4 with HCl and the solution was sterilized by autoclaving. 
PBST: PBS containing 1 % Triton X-100. 
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Phenol/Chloroform: 1 part Tris-saturated phenol and 1 part chloroform. The solutions were 
mixed together and used fresh. 
PMSF: A 10 mM stock solution was prepared in isopropanol. The solution was aliquoted and 
stored at -20 °C. 
PreScissionTM Protease Cleavage Buffer: 50 mM Tris-HCl pH 7.0 containing 150 mM NaCl, 
1 mM DTT and 0.01 % Triton X-100. The buffer was prepared fresh immediately prior to use. 
Protein Elution Buffer: 15 mM Glutathione and 50 mM Tris-HCl pH 8.0. 
RNAse (DNAse-free): A 20 mg/ml stock solution was prepared in a buffer containing 0.1 M 
sodium acetate, 0.3 mM EDTA and then adjusted to pH 4.8, with glacial acetic acid. The 
solution was boiled for 15 minutes and quickly cooled by placing it in ice water. It was then 
aliquoted and stored at -20 °C. 
2X SDS PAGE Sample Buffer: 4 % SDS, 0.125 M Tris-HCl pH 6.8, 15 % Glycerol and 
1 mg/ml Bromophenol Blue. The buffer was stored at room temperature and 100 mM freshly 
prepared DTT was added immediately prior to use. 
5X SDS PAGE Electrophoresis Buffer: 25 mM Tris-HCl, 0.1 % SDS and 250 mM Glycine, 
pH 8.3. The buffer was stored at room temperature and diluted 5-fold when needed. 
Separating Buffer: 1.5 M Tris-HCl, adjusted to pH 8.8 with HCl. The buffer was stored at 4 °C. 
4X Stacking Buffer: 0.5 M Tris-HCl, adjusted to pH 6.8 with HCl. The buffer was stored at 
4 °C. 
10X TBE: 0.9 M Tris-HCl, 0.89 M Boric acid and 25 mM EDTA, pH 8.3. The solution was 
diluted 10-fold with deionised water prior to use. 
TBS: 20 mM Tris-HCl and 150 mM NaCl, pH 7.4. 
TE: 10 mM Tris-HCl and 1 mM EDTA, pH 7.4. 
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Tfb1 Buffer: 30 mM Potassium acetate, 50 mM MnCl2, 0.1 M KCl, 6.7 mM CaCl2 and 15 % 
Glycerol (v/v). 
Tbf2 Buffer: 9 mM MOPS, 50 mM CaCl2, 10 mM KCl and 15 % Glycerol (v/v). 
TYM Broth: 20 g/l Tryptone powder, 5 g/l Yeast extract, 3.5 g/l NaCl and 2 g/l MgCl2. 
2.2 Bacterial strains used 
1. E.coli MC1061 (Casadabhan and Cohen, 1980): 
    F-, araD139, (ara leu) 7697, Δlacx74, galU-, galK-, hs-, hsm+, strA  
2. E.coli BL21 StarTM pLysS (DE3) (Stratagene): 
    F- omp T hsdSB (rB-mB-) gal dcm rne131 (DE3) 
2.3 Preparation of competent E. coli BL21 (DE3) pLysS cells for 
transformation 
E. coli BL21 (DE3) pLysS cells from a glycerol stock were streaked on a Luria agar plate 
containing 10 mM MgCl2 and incubated at 37 °C overnight. A single colony was picked and 
used to inoculate 20 ml TYM broth. The culture was incubated at 37 °C until the optical density 
at 550 nm (OD550) reached 0.2. 100 ml fresh TYM broth was added to the culture, which was 
incubated at 37 °C until an OD550 of 0.2 was again reached. The culture was transferred to a 2 
litre flask and an additional 400 ml of fresh TYM broth was added and the culture incubated at 
37 ˚C until an OD550 of between 0.4-0.6 was reached. The culture was rapidly cooled in iced 
water by gentle swirling and centrifuged at 5520 xg for 10 minutes at 4 °C in a Beckman J2-21 
centrifuge. The supernant was discarded and the cell pellet re-suspended in 100 ml ice-cold Tfb1 
buffer for 30 minutes, after which it was centrifuged at 5520 xg for 10 minutes at 4 °C. The cell 
pellet was gently re-suspended in 50 ml of Tfb2 buffer, and then dispersed into 1.5 ml tubes in 
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300 µl aliquots which were snap-frozen liquid nitrogen. The aliquots of competent cells were 
stored at -80 °C until required. 
2.4 Large scale preparation of plasmid DNA using the CsCl density 
gradient method 
E. coli MC 1061 cells transformed with plasmid DNA were streaked out on Luria agar plates 
containing 100 µg/ml of ampicillin and incubated at 37 °C overnight. A single colony was used 
to inoculate 1000 ml of Luria broth containing 100 µg/ml of ampicillin. The culture was grown 
overnight at 37 °C with constant shaking at 210 rpm. In the morning, the cells were harvested by 
centrifugation in a Beckman J2-21 centrifuge at 3840 xg at 4 °C for 10 minutes and the cell 
pellet was re-suspended in 4 ml GTE and incubated on ice for 10 minutes. The cells were then 
lysed by the addition of 15 ml of Lysis Solution (200 mM NaOH containing 1 % SDS) with 
gentle swirling and incubated on ice for an additional 10 minutes, after which 15 ml of 
Neutralization Solution (3 M Potassium Acetate) was added. The suspension formed was gently 
mixed and further incubated on ice for 10 minutes after which it was centrifuged at 3840 xg at 
4 °C for 30 minutes. The supernatant was collected, an equal volume of isopropanol added to 
precipitate nucleic acids were precipitated and the mixture incubated at -20 °C for 30 minutes. 
The precipitate was recovered by centrifugation at 15 300 xg at 4 °C for 15 minutes and 
resuspended in 4.5 ml of 1x TE containing 4 mg ethidium bromide (EtBr2) and 5.75 g cesium 
chloride were added and the density adjusted to 1.61 g/ml. The mixture was centrifuged at 
22 100 xg for 10 minutes at 20 °C and the pellet discarded. 
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The supernatant was transferred to Beckman OptiSeal™ Polyallomer tubes and centrifuged at 
298 000 xg for 18 hours at 20 °C in a Beckman Ultracentrifuge equipped with an NVi 65 rotor. 
The plasmid DNA was visualized with a 360 nm UV lamp to avoid job and the upper band 
removed using a 5 ml syringe. An equal volume of salt-saturated isopropanol was added, the 
mixture was vortexed well, centrifuged briefly in a desktop centrifuge to separate the phases and 
the top phase (containing the ethidium bromide and giving it its pinkish colour) was extracted 
and discarded. This extraction step was done four times. Two volumes of water and 1 volume of 
isopropanol were added, the mixture was mixed well, incubated on ice for 20 minutes and the 
DNA recovered by centrifugation at 15 300 xg for 15 minutes. The supernatant was discarded 
and the pellet washed twice with 200 µl of 70 % ethanol and air-dried. The pellet was then re-
suspended in 200 µl of 1X TE and stored at -20 °C until required. 
2.5 Small scale preparation of plasmid DNA (minipreps) using the 
RNAse method   
A single colony from an overnight plate of transformed E. coli competent cells was used to 
inoculate 10 ml of Luria broth containing 100 µg/ml of ampicillin and grown overnight with 
continuous shaking at 37 °C. The overnight culture was harvested by centrifugation at 3840 xg 
for 10 minutes. The supernatant was discarded and the bacterial pellet re-suspended in 200 µl 
GTE. The mixture was incubated at room temperature after which 400 µl of Lysis Solution 
(200 mM NaOH containing 1 % SDS) was added. The mixture was gently mixed and incubated 
at room temperature for a further 5 minutes. The mixture was then neutralized by the addition of 
300 µl Neutralizing Solution (3 M Potassium Acetate), mixed gently by inverting a few times 
and centrifuged at 16 100 xg for 15 minutes. The pellet was discarded and the supernatant 
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transferred into a fresh tube where 0.6 volumes of isopropanol were added. The mixture was 
incubated at -20 °C for 30 minutes to precipitate nucleic acids after which it was centrifuged at 
16 100 xg for 10 minutes. The resultant pellet was washed with 500 µl of 70 % ethanol, air-dried 
and then dissolved in 500 µl of 1X TE. 100 µg/ml of RNAse was added to the plasmid and 
incubated in a waterbath at 37 °C for 1 hour. The nuclease-treated plasmid was extracted with 
phenol:chloroform (1:1) and the upper aqueous phase containing the DNA recovered. 0.3 M 
sodium acetate was added and the mixture incubated at -20 °C for 30 minutes to precipitate the 
plasmid DNA. The precipitate was centrifuged at 16 100 xg for 10 minutes, washed with 70 % 
ethanol, air-dried and re-dissolved in 100 µl 1X TE. 
2.6 Transformation of E. coli BL21 (DE3) pLysS cells with pGEX-
6P-2-RING expression constructs  
Frozen competent cells of the strain E. coli BL21 (DE3) pLysS were thawed on ice and 100 µl of 
these cells were added to 2 µl of plasmid (pGEX-6P-2-RING) DNA to make a transformation 
mixture (designated the experimental tube). Another tube was set up with only competent cells 
and no plasmid DNA (designated the control tube). The mixtures were incubated on ice for 
20 minutes after which the cells were heat-shocked by incubation in a water-bath for 1 minute at 
42 °C. Thereafter, the mixtures were placed back on ice for an additional 5 minutes after which 
900 µl of pre-warmed Luria broth without ampicillin was added to both tubes, followed by a 
further incubation step at 37 °C for 1 hour. 50 µl of the transformed cells were plated on Luria 
agar plates containing 100 µg/ml of ampicillin and incubated at 37 °C overnight. 
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2.7 Small-scale expression screen of E. coli BL21 (DE3) pLysS 
transformed with pGEX-6P-2-RING 
Single colonies of E. coli BL21 (DE3) pLysS cells were used to inoculate five 5 ml cultures of 
Luria broth containing 100 µg/ml ampicillin which were then incubated for 4 hours at 37 °C with 
vigorous shaking. Thereafter, 1 ml was removed from each culture and transferred to a clean 
15 ml tube to serve as the un-induced control, and another 1 ml was transferred to a clean 15 ml 
tube and 0.5 mM isopropyl β-D-thiogalactoside (IPTG) added to serve as the induced culture. 
Both un-induced and induced cultures were incubated for a further 2 hours at 37 °C with 
vigorous shaking after which the cells from both cultures were harvested by centrifugation at 
16 100 xg for 10 minutes. The cell pellets were re-suspended in 50 µl PBS containing 1 % Triton 
X-100 (PBS-T). 20 µl from each sample was analyzed by SDS-PAGE electrophoresis. The 
remaining 3 ml of the best expressing culture was used to make glycerol stocks which were later 
used for large-scale recombinant protein expression. 
2.8 Recombinant production of RING domain 
2.8.1 Expression  
100 µl of the best expressing clone from the expression screen was used to inoculate 100 ml of 
Luria broth containing 100 µg/ml ampicillin and 50 µg/ml chloramphenicol. The RING domain 
is under ampicillin selection while chloramphenicol is used to maintain the high copy number of 
the RING finger plasmid. This culture was grown overnight on a rotary shaker at 37 °C, shaking 
at 210 rpm. The following day, 100 µl of the overnight culture was used to sub-culture 100 ml of 
Minimal Media (12.8 g/l Na2HPO4.7H2O, 3 g/l KH2PO4, 0.5 g/l NaCl, 2 ml 1 M MgSO4 and 
0.1 ml 1 M CaCl2) containing 100 µg/ml of ampicillin with vigorous shaking for 16 hours at 
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37 °C. After this incubation period, 900 ml of the remaining Minimal Media containing 
100 µg/ml of ampicillin was added to the primary culture and the cells grown at 37 °C until the 
OD550 was between 0.4 and 0.6. Recombinant expression of RING domain was induced by the 
addition of IPTG to a final concentration of 0.5 mM with gentle shaking at 25 °C for 20 hours. 
Prior to induction, the culture was supplemented with 100 µM of filter-sterilized ZnSO4 solution 
to allow for the incorporation of Zn2+ ions into the protein.  Thereafter, the total culture volume 
was transferred to 250 ml polypropylene tubes and the cells were harvested by centrifugation at 
3840 xg at 4 ˚C for 10 minutes. The harvested cells were then frozen at -70 °C until required. 
 
For heteronuclear isotope labeling of recombinant RING domain samples, 14NH4Cl and 12C-
glucose were replaced by 15NH4Cl and 13C-glucose respectively (Spectra Gases). Otherwise the 
procedure for expression was identical to that described above. 
2.8.2 Extraction 
Frozen cell pellets (described in Section 2.8.1) were thawed on ice and re-suspended in 15 ml of 
Cell Lysis buffer (PBS containing 1 % Triton X-100, 100 µg/ml DNAse 1, 100 µg/ml Lysozyme, 
1 mM PMSF, 1 mM DTT, 50 µM ZnSO4 and 1X EDTA-free protease inhibitor cocktail). The 
cells were lysed by three cycles of freeze-thawing (incubating cell suspension at -70 °C for 
10 minutes, followed by incubation at 37 °C for 10 minutes). The total bacterial lysate containing 
cell debris and other particulate matter was cleared by centrifugation at 15 300 xg for 30 minutes 
at 4 °C. The clear supernatant containing soluble GST-RING domain fusion protein was 
decanted into a fresh 50 ml tube. Sodium azide was added to a final concentration of 0.02 % if 
not further purified immediately to prevent bacterial growth before storage at 4 °C. 
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2.8.3 Affinity Purification 
A 5 ml glutathione-agarose (SIGMA® Aldrich) column was prepared by weighing out the 
required amount of the glutathione-linked agarose beads, suspending it in deionised water and 
allowing it to swell overnight at 4 °C. The following day, the slurry formed was poured into a 
15x1 cm Econo® Chromatography Column (Amersham Pharmacia) of 20 mm diameter and 
allowed to pack well by standing at 4 °C for 45 minutes. Thereafter, the column was equilibrated 
with 3 column volumes (3 CV) of PBS pH 7.4. The bacterial lysate was then poured unto the 
pre-equilibrated column and allowed to pass through by gravity flow. The resultant flow-through 
was collected and kept on ice. The column was then washed with 5 column volumes (5 CV) of 
PBS pH 7.4, after which the bound GST-RING domain protein was eluted with 3 column 
volumes (3 CV) of elution buffer (50 mM Tris-HCl, pH 8.0 containing 15 mM reduced 
glutathione). The eluted GST-RING domain fusion protein was stored at 4 °C after 1 mM PMSF, 
1 mM Dithiothreitol (DTT) and 0.02 % sodium azide has been added to it. After protein elution, 
the glutathione-agarose column was washed with 3 column volumes (3 CV) of 2 M NaCl to 
remove any non-specific bound proteins on the beads and 5 column volumes (5 CV) of deionized 
water  to further clean-up the affinity column before storage at 4 °C. The various affinity purified 
GST-RING domain protein fractions were analyzed by SDS-PAGE electrophoresis. 
2.8.4 PreScission Protease cleavage and recovery of RING domain  
GST-RING domain fusion protein fractions were pooled together, poured into a Snake Skin® 
Pleated Dialysis tubing (Perbio, USA) with molecular weight cut off (MWCO) of 3500 Da and 
dialyzed for 4 hours at 4 °C in a freshly-prepared PreScissionTM Protease Cleavage buffer 
(50 mM Tris-HCl pH7.0, 150 mM NaCl, 1 mM DTT and 0.01 % Triton X-100). 10 µl of 
PreScission 3C protease and 0.01 % Triton X-100 were added and incubated at 4 °C with 
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continuous stirring for 18-24 hours in a PreScissionTM Protease Cleavage buffer. The RING 
domain protein and the corresponding cleaved RING protein fraction were analyzed by SDS-
PAGE electrophoresis. 
 
Following cleavage, the sample was returned to the glutathione agarose column and the RING 
domain collected in the flow-through. Bound GST and GST-3C protease was eluted as described 
in Section 2.8.3. 
2.8.5 Purification by anion exchange chromatography 
Residual GST in the protein sample following the affinity purification step was removed by 
anion exchange chromatography using a 1.6 ml column packed with 20 HQ POROS media 
(PerSeptive Biosystems, Inc. USA). The procedure was carried out at a flow-rate of 
15 ml/minute in an automated fashion on a BIOCAD Sprint Chromatography system, using the 
following protocol: 10 CV equilibration step (50 mM Tris-HCl, pH 7.0 + 10 mM NaCl), manual 
injection of the protein sample, 10 CV wash step (50 mM Tris-HCl, pH 7.0 + 10 mM NaCl), 
15 CV gradient step (50 mM Tris-HCl, pH 7.0 + 0-0.5 M NaCl), 10 CV clean step (50 mM Tris-
HCl, pH 7.0 + 2 M NaCl) and 10 CV re-equilibration step (50 mM Tris-HCl, pH 7.0 + 10 mM 
NaCl). Absorbance readings at 280 nm and salt concentration were monitored by in-line UV and 
conductivity meters respectively. 1 ml elution fractions were collected using a Gilson® 203B 
fraction collector and analyzed by SDS-PAGE electrophoresis, using the chromatogram as a 
guide.  
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2.8.6 Purification by size exclusion chromatography 
Fractions from anion exchange-containing RING domain protein were pooled and concentrated 
to a final volume of 600 µl using Vivaspin ultrafiltration devices (MWCO 5 000 Da, 
VivaScience). This was loaded onto a 150 x 1.8 cm Econo® Column packed with Sephacryl 
S100 gel (Amersham Pharmacia Biotech) equilibrated with 1.5 CV of NMR buffer (100 mM 
sodium phosphate buffer pH 6.0 containing 50 mM NaCl, 5 mM DTT and 0.02 % sodium azide) 
and running at a flow rate of 1 ml/minute. 1 ml fractions were collected as before and analyzed 
on a 16 % SDS PAGE gel using the chromatogram as a guide. Fractions containing RING 
domain were pooled together (typically 12 ml in total) and concentrated to a final volume of 
600 µl using Vivaspin ultrafiltration devices (VivaScience), lyophilized and kept at 4 °C until 
needed for NMR analysis. 
2.9 SDS Polyacrylamide gel electrophoresis  
16 % SDS polyacrylamide gels were prepared according to Laemmli’s method (Laemmli, 1970), 
using the ingredients set out in Table 2.1. 20 µl of each protein sample to be analyzed was mixed 
with 10 µl of 2x SDS PAGE sample buffer, boiled for 5 minutes at 95 °C, centrifuged for 
1 minute at 16 100 xg, and electrophoresed in 1x SDS electrophoresis buffer (25 mM Tris-HCl 
pH 8.3, 192 mM Glycine, 0.1 % SDS) at a constant voltage of 100 V/cm using a Hoefer Mighty 
Small™ gel electrophoresis system (Amersham Pharmacia Biotech). The voltage was increased 
to 150 V/cm once the Bromophenol dye front had reached the separating gel and set to zero 
when the dye front reached the bottom of the gel. The gel was stained by incubation in 
Coomassie staining solution (0.25 g Coomassie Blue R 250, 45 % methanol and 10 % glacial 
acetic acid) for 15 minutes, and destained overnight in destaining solution (45 % methanol, 10 % 
glacial acetic acid). 
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Table 2.1 Summarized composition of a 16 % SDS PAGE gel 
 Separating gel Stacking gel 
Deionised water 3.20 ml 3.17 ml 
Separating buffer 2.63 ml - 
4X Stacking buffer - 1.25 ml 
40  % Bis Acrylamide 37.5:1 4.00 ml 0.50 ml 
Ammonium Persulphate 50.00 µl 25.00 µl 
10 % SDS 105.00 µl 50.00 µl 
TEMED 7.50 µl 5.00 µl 
 
2.10 Determination of protein concentrations 
Protein concentrations were determined using the Bradford colorimetric assay (Bradford, 1976) 
modified for a 96-well microtitre plate and using BSA (Bovine Serum Albumin) as the standard 
protein. Prior to use, a stock solution of the Bradford assay dye (0.01 % Coomassie Brilliant 
Blue G 250, 8.5 % phosphoric acid and 4.75 % ethanol) was diluted to a 1X concentrate with 
deionised water and thereafter, 1 N NaOH was added. From a BSA stock of 1000 µg/ml prepared 
from commercially available lyophilized sample dissolved in NMR buffer, five samples of BSA 
at concentrations 10.0 µg/ml, 20.0 µg/ml, 30.0 µg/ml, 40.0 µg/ml and 50.0 µg/ml were prepared. 
Serial dilutions of the sample to be tested were prepared using NMR buffer. All samples were 
prepared in duplicate. 
 
20 µl of each BSA standard and of each diluted protein sample were added to a different well of 
a 96-well microtitre plate. 20 µl of NMR buffer was included to serve as a blank. 180 µl of the 
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filtered Bradford assay reagent was then added to each well and the plate incubated at room 
temperature for 5 minutes. The absorbance of each well was measured simultaneously at 595 nm 
using a Multiskan® BIOCHROMATIC Microtitre Plate Reader (Labsystems). The absorbances 
of the standard protein were used to construct a standard curve using Microsoft Excel (Microsoft 
Corporation, USA), by fitting the data to a straight line passing through the origin. The standard 
curve was then used to convert the absorbances of the diluted protein samples into 
concentrations. Finally, the concentrations were multiplied by the dilution factor to give the 
concentration of the original sample. 
2.11 Protein analysis by mass spectrometry 
RING finger domain samples were subjected to mass spectrometry to verify the mass of the 
purified proteins before embarking on NMR spectroscopy. Electrospray (ES) ionization 
spectrometry was perfomed by injecting 5 µl of the samples into a Proteomics CapLC HPLC 
system coupled to a Waters API Ultima Q-TOF mass spectrometer (Waters Corporation, 
Massachusetts, USA). The solvent used was 50 % LCMS grade acetonitrile in MilliQ water with 
0.1 % formic acid operating at a flow rate of 100 µl/min. Spectra scanning was done in the 
positive ion mode from m/z 100 to m/z 1990 at a cone voltage of 35 V. The ES capillary voltage 
was 3.5 kV and the source temperature was 100 °C. Processing of spectral data was performed 
using two algorithms: MaxInt1 and MaxInt3. 
2.12 NMR spectroscopy 
Lyophilized samples were re-dissolved in 600 µl of deionised water prior to use for NMR 
spectroscopy. 10 % Deuterium oxide (D2O) was added to act as a lock signal before the sample 
was transferred to a 5 mm glass NMR tube (Wilmod). 
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All NMR experiments were carried out at 298 K in NMR buffer (described in Section 2.1). A 
complete triple resonance dataset for the full length RING finger was generated using DRX700 
and DRX900 MHz Bruker Avance Spectrometers (Bruker Billerica, MA) at the Bijvoet Centre 
for Biomolecular Research, Utrecht University, Netherlands. A complete dataset for the 
shortened RING finger was generated using the 600 MHz Varian Unity Inova Spectrometer 
(Varian Inc. Palo Alto, USA) at the Department of Chemistry, University of Stellenbosch, South 
Africa using the Varian BioPack software suite. The spectra were referenced so that DSS 
corresponded to 0 ppm in the 1H dimension.  
 
NMR spectra were processed using the NMRPipe software package (Delaglio et al., 1995) while 
spectral analysis and display were performed using NMRView (Johnson, 2004). Structure 
calculations combined with fully-automated NOE assignment were carried out using the 
CANDID module of CYANA v2.1 (Guntert et al., 1997; Herrmann et al., 2002). MOLMOL 
(Koradi et al., 1996) was used to visualize structures and to calculate RSMD values while 
structure validation was carried out using WHATCHECK (Hooft et al., 1996) and PROCHECK-
NMR (Laskowski et al., 1996). Table 2.2 gives a listing of the NMR experiments performed. 
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Table 2.2 List of some NMR experiments performed on RING domain 
NMR Experiment Function of experiment 
1D 1H homonuclear Evaluation of sample integrity and folding state. 
15N-HSQC Evaluation of sample integrity and folding state; 1H and 15N chemical 
shifts 
13C-HSQC Evaluation of sample integrity and folding state; 1H and 13C chemical 
shifts 
1H-15N NOE Characterization of dynamical state of backbone 
HNCO Carbonyl carbon chemical shifts 
CBCA(CO)NH Sequential assignment of backbone resonances 
HNCACB Sequential assignment of backbone resonances 
H(CCO)NH Side-chain 1H chemical shift assignments 
C(CCO)NH Side-chain 13C chemical shift assignments 
HCCH-TOCSY Side-chain 1H and 13C chemical shift assignments 
HCCH-COSY Side-chain 1H and 13C chemical shift assignments 
15N-HSQC-NOESY HN-H NOE’s 
13C-HSQC-NOESY(aliphatic) HC(aliphatic)-HC(aliphatic) NOE’s 
13C-HSQC-NOESY(aromatic) HC(aromatic)-HC(aliphatic) NOE’s 
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CHAPTER 3: RECOMBINANT EXPRESSION, PURIFICATION 
AND PRELIMINARY CHARACTERIZATION OF RING 
DOMAIN 
3.1 Introduction  
The first objective was to produce a stable, soluble and natively-folded RING domain protein in 
sufficient concentration (0.5 mM and above) for structure determination using heteronuclear 
NMR spectroscopy. Hence, this chapter describes the heterologous overexpression, purification 
and preliminary NMR characterization of isotopically labelled recombinant RING domain. 
Following assignment of backbone 1H and 15N resonances, dynamical analysis using NMR 
showed that the protein was mostly folded, apart from a stretch of approximately 20 residues at 
the N-terminus. 
3.2 Recombinant expression and purification of GST-RING domain 
fusion protein 
An expression plasmid, pGEX-6P-RING, encoding residues 235-335 of the full length RBBP6 
(Accession number NM_006910), fused to Glutathione-S-transferase (GST) was previously 
constructed by Ms Nonku Ndabambi as part of her M.Sc research (PN Ndabambi, M.Sc thesis, 
University of the Western Cape, 2006). The RING domain sequence had been cloned into the 
Bam HI and Xho I sites of the pGEX-6P-2 multiple cloning cassette (see Fig. 3.1). pGEX-6P-2 
includes a tac promoter which is inducible by the addition of IPTG. The fusion protein encoded a 
recognition sequence for the 3C protease in the linker region between GST and the RING 
fragments. Following cleavage with 3C protease, the expected sequence of the RING fragment 
was as follows:  
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The underlined residues are the remainder from the linker region (3C protease recognition site) 
between the GST tag and RING fragments. The expected molecular weight of the cleaved RING 
fragment as calculated using the ExPASy online server (http://ca.expasy.org/cgi-bin/protparam) 
was 11.6 kDa. The molecular weight of GST is approximately 27 kDa, and that of the full GST-
RING fusion protein is 38.2 kDa. 
 
E. coli BL21 (DE3) pLysS cells were transformed with the pGEX-6P-2-RING construct and the 
resulting transformants screened for the expression of GST-RING domain fusion protein. SDS-
PAGE analysis of the total bacterial lysates from four randomly chosen colonies is shown in Fig. 
3.2. Lanes 2-9 contain alternating pairs of un-induced and induced samples; a prominent band in 
the vicinity of 40-50 kDa can be seen in the induced lanes but not in the un-induced lanes, which 
is likely to correspond to the GST-RING fusion protein. The apparent molecular weight of the 
fusion protein is slightly larger than the expected value of 38.2 kDa. 100 µl from the un-induced 
culture in lane 4 was used to inoculate a large-scale expression of GST-RING fusion protein as 
described in Section 2.8. Fig. 3.3A shows that a very high yield of fusion protein was obtained, 
and successfully purified using glutathione affinity chromatography. Fig. 3.3B shows that the 
fusion protein was efficiently cleaved by 3C protease, leaving very little residual fusion protein. 
 
G P L G S P P F L P E E P S S S S E E D D P I P D E L L C L I C K D I M T D A V V  
I P C C G N S Y C D E C I R T A L L E S D E H T C P T C H Q N D V S P D A L I A 
N K F L R Q A V N N F K N E T G Y T K R L R K Q 
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RING finger domain 
     
Fig. 3.1: A diagrammatic representation of the pGEX-6P-2-RING domain constructs. The diagram 
illustrates the insertion of the RING domain into the BamH I and Xho I sites of pGEX-6P-2 expression 
vector. 
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Fig. 3.2: Expression screen of colonies transformed with pGEX-6P-2-RING domain for GST-RING 
domain fusion protein expression. Lane 1 shows protein molecular weight marker, lanes 2, 4, 6 and 8 
shows total bacterial cell lysates before induction of protein expression while lanes 3, 5, 7 and 9 show the 
corresponding total bacterial cell lysates of the induced cultures upon the addition of 0.5 mM IPTG. The 
induced lanes (3, 5, 7 and 9) show a band of approximately 39.2 kDa, corresponding to the GST-RING 
domain fusion protein and the co-expression of an un-identified protein 27 kDa in size. 
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Note that while GST appears as a tight band, the cleaved RING fragment appears in the form of 
a long smear from approximately 18-25 kDa, indicating that it may form homo-oligomers. The 
same effect is probably responsible for the smearing of the fusion protein in lane 2. No reason 
could be adduced for this anomalous behaviour of the protein on the SDS PAGE gel. 
 
A number of different methods were investigated for removing GST, GST-3C and uncleaved 
fusion protein from the cleaved sample. The first method involved loading the cleaved sample 
back onto the glutathione-agarose column, collecting the RING domain in the flow-through and 
allowing all GST-linked proteins to be retained by the column. Note that all free glutathione 
from the previous affinity purification had been removed by dialysis during the cleavage process. 
The results of one such purification are shown in Fig. 3.4. While the majority of the GST was 
removed by the column, significant amounts remained in the flow-through along with all of the 
RING protein. As this is most likely to be due to overloading of the column, in subsequent runs 
the size of the column was either increased, or the sample was simply returned to the column a 
number of times until the amount of GST was reduced sufficiently for other methods to be 
effective. 
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Fig. 3.3: Large scale expression and affinity purification of full-length GST-RING domain fusion and 
its separation from GST by 3C protease. In (A) full-length RING domain was expressed in minimal 
media as a C-terminal fusion with GST and affinity purified. Lane 2 shows total bacterial cell lysate 
extracted after induction. Lane 3 corresponds to the flow through from glutathione-linked agarose affinity 
column; lane 4 corresponds to the GST column wash fraction prior to fusion protein elution while lanes 5, 6 
and 7 are GST-RING domain fusion protein elutes from the affinity column. A band corresponding to 
recombinant protein (approximately 30-40 kDa) can be seen in lanes 5, 6 and 7 (B) 3C protease digestion of 
affinity purified GST-RING domain fusion protein. Lane 2 corresponds to fusion protein before digestion 
while lane 3 depicts the cleavage products after an overnight digestion with 3C protease. Lane 1 in both 
diagrams corresponds to the protein molecular weight marker. 
7 6 5 4 3 2 1 
97.4 kDa 
66.2 kDa 
39.2 kDa 
26.6 kDa 
21.5 kDa 
14.4 kDa 
GST-RING domain 
fusion protein 
A  
RING domain 
GST  
97.4 kDa 
66.2 kDa 
39.2 kDa 
26.6 kDa 
21.5 kDa 
14.4 kDa 
GST-RING domain  
1 2 3 
B  
 
 
 
 
 
 
64 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.4: Affinity purification of cleaved RING domain protein. Lane 1 shows the protein molecular 
weight marker, lane 2 shows a fraction of the cleavage products upon digestion with 3C protease. Lane 3 is a 
fraction of the dialysate (cleavage products dialyzed into low salt concentration, 20 mM NaCl). Lane 4 and 5 
showed fractions of the unbound RING domain which elutes in the flow through and the GSH column wash 
(1) respectively. Lane 6 shows GSH column wash (2) fraction before GST elutions, which are depicted in 
lanes 7, 8 and 9. Lanes 2, 3, 7, 8 and 9 shows that cleavage was incomplete due to the presence of residual 
GST-RING domain fusion seen in those fractions. 
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Another method investigated was anion exchange chromatography. Fig. 3.5 shows the result of 
an analysis carried out at pH 6 using a 1.6 ml 20HQ anion exchange column (POROUS media), 
operated at a flow rate of 15 ml/minute using a BIOCAD Sprint Workstation. Since the 
isoelectric points (pI) of GST and the RING fragment are 4.9 and 4.7 respectively at pH 8.0, both 
are expected to be retained on an anion exchange column, with the RING finger being retained 
slightly more strongly. This is exactly what was observed, resulting in effective separation of the 
GST and the RING domain (Fig. 3.5B, lanes 5-8).    
 
Due to the small separation between the peaks, however, the method did not scale up well due to 
the overlapping of the peaks when larger quantities of proteins were loaded. Consequently, the 
method was most suitable for use as a final purification step after almost all of the GST had been 
removed. 
 
A third method investigated was size-exclusion chromatography. A typical chromatogram and 
the corresponding SDS-PAGE gel is shown in Fig. 3.6A&B respectively. As with anion 
exchange, size-exclusion chromatography was found to be useful for removing the last 5 % of 
GST from the sample, at the same time as exchanging the sample into NMR buffer. It was 
typically used as the final step before NMR analysis. 
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Fig. 3.5: Removal of residual GST from full-length RING domain by anion exchange 
chromatography. (A) Chromatogram showing anion exchange purification of affinity purified RING 
domain protein (Fig. 3.4, lanes 4 and 5) using a 20HQ anion column. The major peak on the chromatogram 
corresponds to unbound molecules which flow through the column before the start of the gradient while the 
two smaller peaks corresponds to GST and RING domain respectively. Both proteins with pI’s of 4.9 and 
4.67 were retained on the column but are eluted off with an increasing salt gradient. (B) SDS-PAGE analysis 
of the corresponding peaks in the anion exchange chromatogram. Lane 2 corresponds to pooled RING 
domain fractions before anion purification step; while lanes 3 and 4 correspond to fractions from the flow 
through peak (major peak). Lanes 5 and 6 shows a 26.6 kDa protein which corresponds to the GST peak, 
while lanes 7 and 8 show a smeary band at 21.5 kDa corresponding to the RING protein (the consistent form 
of the protein seen on SDS-PAGE gels). A small amount of GST, as well as some higher molecular weight 
proteins can be seen in lane 8. Lane 1 corresponds to the protein molecular weight marker. Fractions from 
lanes 5, 6, 7 and 8 confirms GST and RING are both immobilized unto the 20HQ column and only eluted 
using salt gradient.  
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Fig. 3.6: Removal of residual GST and other molecules from full length RING finger by size exclusion 
chromatography. (A) Chromatogram showing size exclusion chromatography profile of anion exchanged 
RING finger protein. Depicted in the chromatogram are two well-resolved peaks: a major peak (Peak 1) 
which corresponds to the RING protein and a smaller peak (Peak 2) which corresponds to the sample buffer 
salt. (B) SDS-PAGE analysis of fractions from under the peaks shown in the size exclusion chromatogram. 
Lane 2 shows RING finger fractions pooled under the major peak which corresponds to a highly purified 
RING sample. Lane 3 shows pooled fractions under the smaller peak which corresponds to buffer salts, 
while lane 4 is the pure RING protein after concentration to 600 µl and prior to NMR analysis. Lanes 2 and 
4 depicts the consistent form of the protein (dimeric) with an apparent molecular size of 21.5 kDa even 
though DTT concentration was increased 5-fold during size exclusion purification and electrophoresis. Lane 
1 shows the protein molecular weight marker 
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3.3 Preliminary NMR characterization of RING domain protein 
3.3.1 1D proton spectrum 
A one-dimensional proton NMR spectrum of the RING domain construct is shown in Fig. 3.7. 
Such a spectrum, acquired in less than a minute, provides enough information for assessing the 
state of folding of protein samples (Rehm et al., 2002). The chemical shift dispersion of the 
proton signals is a good indicator of protein folding: folded proteins are characterized by the 
presence of large chemical shift dispersions, especially in the methyl group region between 
1.0 ppm and -1.0 ppm and in the amide region downfield of 8.5 ppm (Cavanagh et al., 1996; 
Rehm et al., 2002; Woestenenk et al., 2003). Due to exchange with protons in the solvent, the 
signals of amide protons can become broadened and hence loose intensity, especially at non-
acidic pH’s. However, the presence of isolated methyl group signals up-field of 0.5 ppm is a 
sensitive and reliable indicator of protein folding. Methyl group resonances have higher 
intensities because three equivalent protons contribute rather than one proton of the amide group 
and unlike amide protons, are unaffected by chemical exchange broadening (Scheich et al., 
2004).  
 
In contrast, unfolded or denatured proteins exhibit minimal chemical shifts dispersions 
resembling random coil values (as seen in short linear peptides). In this case, amide (HN) 
resonances are confined to the region 8.0-8.5 ppm, Hα protons to the region 4.1-4.4 ppm 
(Cavanagh et al., 1996) and methyl groups to the region 0.8-1.1 ppm (Wüthrich, 1986). Hence, 
the presence of amide resonances in Fig. 3.7 up-field of 8.5 ppm, Hα proton resonances in the 
region 5.0-6.0 ppm and the large chemical dispersion of methyl resonances between -1.0 and 
1.0 ppm is clear evidence that the RING domain is natively folded.  
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1H 
Fig. 3.7: 1D 1H spectrum of full length RING domain at pH 6.0, 25 °C recorded at 700 MHz. The 
large chemical shift dispersion of resonances exhibited by the protein is indicative of its foldedness which 
is confirmed by the appearance of amide protons (HN) in the region 9.4-6.5 ppm, α-protons (Hα) in the 
region 6.5-4.5 ppm, β-protons (Hβ) in the region 4.5-3.5 ppm, and methyl protons in the region 3.5-0 ppm. 
The presence of a far-shifted methyl group (a distinct methyl with resonance < 0 ppm) further confirms the 
folded nature of this protein. 
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It can be concluded that the RING finger was folded and therefore likely to be amenable to 
structural analysis under the given experimental conditions. 
3.3.2 2D 15N-HSQC spectrum 
The 15N-HSQC spectrum of the RING domain is shown in Fig. 3.8A. The 15N-HSQC is regarded 
as a signature spectrum in protein NMR because it easily distinguishes one protein from another 
and is very sensitive, which means it can be acquired typically in less than an hour. It is also 
highly informative about the state of folding of the protein, with folded proteins having well-
dispersed spectra whereas unfolded proteins have spectra in which the amide proton resonances 
cluster around a value 8.3 ppm. The transfer of magnetic energy leading to the 15N-HSQC is 
shown in Fig. 3.8B. Each NH group on the backbone of the protein as well as the side-chain of 
arginine residues contributes a single resonance. NH2 groups on the side-chains of asparagine 
and glutamine residues each contribute a pair of resonances, with different proton shifts but the 
same nitrogen shift. These typically appear at the top right-hand corner of a 15N-HSQC 
spectrum; in Fig. 3.8A lines joining each pair of resonances have been drawn to guide the eye. 
 
The spectrum in Fig. 3.8A is generally well-dispersed, with resonances appearing as far up-field 
as 9.4 ppm, and good dispersion of the NH2 side-chains. However, a number of resonances with 
HN shifts in the range 8.0-8.5 ppm have amplitudes which are much stronger than the average, 
indicating that they might be highly flexible. More flexible nuclei tend to couple less strongly to 
other nuclei, leading to slower relaxation and sharper lines. Since all resonances have the same 
volume, sharper resonances have stronger amplitudes. Intense resonances not only obscure other 
resonances, but they also tend to introduce baseline artifacts and generally degrade the quality of 
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the data. There is also evidence of multiple conformations of some residues indicated by circles 
in Fig. 3.8A. 
 
Despite the non-optimal nature of the spectrum, a complete set of triple resonance data was 
collected at the Bijvoet Centre for Biomolecular Research at Utrecht University, Netherlands, 
and assignment of the 15N-HSQC spectrum attempted. The process of assignment will be 
discussed in more detail in Chapter 4. Complicating the assignment was the fact that of the 104 
residues in the protein, 10 were proline residues. Since proline residues do not have an NH 
group, they do not appear in NH-based triple resonance experiments, and therefore interrupt the 
sequential assignment procedure. The run of four consecutive serine residues (residues 14-18) 
was also very difficult to assign due to their almost identical chemical shifts and overlapped 
resonances. 
 
The assigned residue numbers are indicated next to the resonances in Fig. 3.8A. Many of the 
residues were found to have multiple assignments, including residues 4, 8, 9, 11, 14. Eighty-six 
of 94 backbone NH shifts (104 residues minus 10 proline residues) successfully assigned, as well 
as six out of nine NH2 groups.  Of particular interest is the NH2 group of asparagine 47 (circled) 
which has very unusual chemical shifts: the 15N chemical shift is 122.40 ppm, compared to the 
expected value of 112.82 ± 2.95 ppm, while the 1H chemical shifts are 8.90 ppm and 7.50 ppm, 
compared to the expected values of 7.35 ± 0.52 ppm and 7.14 ± 0.54 ppm respectively. The 
reason is likely to be connected to the involvement of the residue in the coordination of one of 
the two zinc ions since this residue is close to a number of cysteine residues (44, 45, 50 and 53). 
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Fig. 3.8: 15N HSQC spectrum of full length 15N-labelled RING domain recorded at pH 6.0, 25 °C, 
and acquired at 900 MHz 1H frequency. A total of 94 resonances were expected from the full length 
RING domain protein containing 105 amino acid residues. 10 proline residues and the N-terminal residue 
were excluded due to lack of an NH group, and hence do not give rise to cross-peaks. (A) Assignments 
were indicated by residue numbers. Solid horizontal lines connect 6 of the expected 9 pairs of side-chain 
NH2 proton frequencies of glutamine and asparagine residues. However, despite the presence of multiple 
conformers and some resonances having amplitudes greater than average, there was good dispersion of 
resonances in both dimensions of the RING domain spectrum, which is characteristic of a folded protein. 
(B) Magnetization transfer pathway in a 15N HSQC experiment showing through-bond transfer of 
magnetic energy between the backbone nitrogen atom and the attached amide proton made possible by 
the existence of a 95 Hz scalar coupling between both nuclei. 
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3.3.3 15N-NOE experiment 
Because of the evidence of unstructured residues in the 15N-HSQC, especially at the N-terminus 
of the protein, a 15N-NOE experiment was used to establish which parts of the protein were 
structured and which were unstructured. The 15N-NOE (or heteronuclear NOE experiment) can 
be used to distinguish unstructured from structured parts of a protein on a per residue basis due 
to the fact that they yield signals of opposite sign. The 15N-NOE spectrum has the same 
appearance as the 15N-HSQC, with resonances having identical 1H and 15N assignments, but in 
this case the amplitude contains information about the relaxation properties of the 15N nuclei 
induced by the changing orientation of the NH bond.   
 
Heteronuclear NOE values are obtained by recording spectra with (NOE experiment) and 
without (reference experiment) the use of 1H saturation applied before the start of the 
experiment, and dividing the volume of each saturated resonance by the volume of the 
corresponding resonance in the unsaturated spectrum. The theoretical analysis shows that a value 
of +1 corresponds to rigidity, with a value of -3 corresponding to total flexibility (Ishima and 
Nagayama, 1995). 
  
A plot of the resultant values as a function of residue number is shown in Fig. 3.9. Gaps 
correspond either to proline residues (which have no backbone NH groups), or to missing 
assignments. It is immediately clear that the first 20 residues of the protein are highly flexible, 
with the structured region corresponding to residues 21-103. 
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Fig. 3.9: Backbone 15N heteronuclear NOE rates of 15N-labelled full length RING domain at pH 6.0, 
25 °C recorded at 600 MHz 1H frequency. In (A) heteronuclear NOEs were acquired without proton 
saturation, while in (B) these NOEs were acquired using 120° pulses to saturate the protons after a 3 s 
delay. Red peaks in (B) correspond to flexible residues which tumble fast, whereas black peaks 
correspond to residues that tumble slowly and form part of a structured region. (C) Plot of NOE values as 
a function of residue number, showing the first twenty residues at the N-terminus and the last two residues 
at the C-terminus of the protein as having NOE values ≤0 which is indicative of these regions being 
flexible and unstructured. The plot in (C) was generated using MATLAB® (Math Works, Inc.)      
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CHAPTER 4: INVESTIGATION OF THE STRUCTURE AND 
ZINC-BINDING PROPERTIES OF RING DOMAIN USING NMR 
SPECTROSCOPY 
4.1 Introduction 
The results described in the previous chapter, in particular those shown in Fig. 3.9, show that 
although the original RING domain fragment was soluble, expressed at high levels and contained 
a stable and folded core, the first 20 residues were unstructured. This resulted in a loss of quality 
of the NMR spectra which would have greatly complicated both the determination of the 
structure and the investigation of the zinc ion binding properties of the domain. It was therefore 
decided to go back to the beginning and make a shortened version of the domain. Using the 
heteronuclear NOE values in Fig.3.9C as a guide, two shorter constructs were made by Ms 
Takalani Mulaudzi as part of her M.Sc project. The first omitted the first 19 residues (following 
the initial GPLGS which comes from the vector) and was termed “RING-short-short”. The 
second omitted the first 13 residues (following GPLGS) and was termed “RING-long-short”. 
 
Although both shortened constructs expressed at high levels and were soluble, 15N-HSQC 
analysis showed that RING-short-short was unfolded (Takalani Mulaudzi, MSc thesis, 
University of the Western Cape, 2008). On the other hand, the 15N-HSQC of RING-long-short 
(see Fig. 4.1) was found to be almost identical to that of the previous construct (full length), with 
the exception of the omitted residues, indicating that the structure of the RING finger had not 
been affected by the shortening. RING-long-short, which for the purpose of this thesis will be 
known as “the shortened RING domain”, was therefore used for all subsequent investigations. 
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15N 
HN 
Fig. 4.1: 1H-15N HSQC spectrum of 15N-labelled shortened RING domain recorded at pH 6.0, 25 ˚C, and 
acquired at 600 MHz 1H frequency. A total of 85 resonances were expected from the protein sample 
containing 92 amino acid residues (6 proline and the N-terminal glycine residues were excluded due to lack of 
NH group, and hence do not give rise to cross-peaks). Assignments are indicated by residue number. Solid 
horizontal lines connect the side-chain NH2 proton frequencies of glutamine and asparagine residues. The Hδ 
side-chain of asparagine 34 (circled red) shows up at an unusual proton and nitrogen frequencies. The spectrum 
contains more peaks but with less overlapped resonances which were well dispersed in both dimensions, 
indicative of a well folded protein suitable for structure determination by NMR spectroscopy.     
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Following cleavage of the fusion protein by 3C protease, the expected sequence of the shortened 
RING domain was as follows: 
 
  
 
 
corresponding to a molecular weight of 10.2 kDa. Expression and purification proceeded in the 
same manner as for the full length RING (see Fig. 4.2), with the cleaved RING domain 
continuing to migrate at a higher molecular weight than expected. Unlabelled, 15N-labelled and 
13C, 15N-(double) labelled samples were expressed and purified as described previously.  
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Fig. 4.2: Large scale expression and purification of shortened GST-RING domain fusion protein. 
15N-labelled shortened RING domain was expressed in minimal media and subsequently purified to 
homogeneity. Lane 2 corresponds to total bacterial cell lysate extracted after induction while lane 3 
corresponds to flow through from glutathione-linked affinity column. Lane 4 corresponds to GST 
column wash prior to fusion protein elution; lane 5 shows fusion protein elute from the affinity column. 
Lane 6 corresponds to fusion protein cleavage after an overnight digestion with 3C protease. Lane 7 
corresponds to flow through containing RING domain after a second round of glutathione affinity 
purification to remove GST from cleaved GST-RING domain, while eluted GST from this step is 
shown in lane 8. As shown in Fig. 3.5 & 3.6, residual GST was completely removed from the sample by 
anion exchange chromatography, while size exclusion chromatography was used to remove any small 
molecules in the protein and to exchange the protein into NMR buffer for analysis. Lane 1 corresponds 
to protein molecular weight marker.  
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4.2 Biochemical characterization of RING domain 
4.2.1 Bradford Assay 
Concentrations of samples were determined using the Bradford Assay (Bradford, 1976), as 
described in Section 2.15. Table 4.1 and Chart 4.1 show measurement of the concentration of a 
particularly concentrated sample. The equation describing the curve fit to the data is: 
 
                                             A595 = 0.055 [Standard] 
 
where the concentration of the standard is expressed in µg/ml. 
 
Following 3000-fold dilution in the same buffer, the shortened RING domain sample had an A595 
of 0.222. Applying the equation above gives [RING] = 3.82 µg/ml as shown by the dotted lines 
in Chart 4.1. Multiplying by the dilution factor (3000) gives the concentration of the sample as 
11.50 mg/ml. Since the molecular weight of the protein is 10.2 kDa, this corresponds to a molar 
concentration of 11.50/10.2 = 1.12 mM, given that a concentration of 10.2 mg/ml corresponds to 
1 mM. 
4.2.2 Extinction coefficient measurement 
According to the Beer-Lambert law, the absorbance of a protein sample at 280 nm is 
proportional both to the thickness (optical path length) and to the concentration of the sample. 
The constant of proportionality is called the extinction coefficient and is denoted ε. This law is 
mathematically represented as:  
                                                                 A280 = εCL,  
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where A280 is the absorbance at 280 nm, ε is the molar extinction coefficient, C is the molar 
concentration and L is the optical path length. A is defined as log10 I0/I where I0 is the intensity of 
the incident light and I is the intensity following absorption. 
 
The UV absorption spectrum of the shortened RING domain, measured using a NanoDrop® ND-
1000 Spectrophotometer (NanoDrop Technologies Inc.), is shown in Fig. 4.3. The value of A280, 
corresponding to the blue line in Fig. 4.3, was found to be 5.18 absorbance units. Note that 
although the NanoDrop automatically adjust the optical path length so that the absorbance falls 
within the linear range, the final result is extrapolated to an effective optical path length of 1 cm. 
Using the value of 1.0 mM for the concentration calculated above, the extinction coefficient was 
calculated to be: 
  
                               ε = A280 / (LC) = 5.18 / (1 cm x 1.12 x 10-3 M) = 4625 M-1cm-1.  
 
This value deviates considerably from the values of 3480 and 2980 M-1cm-1 (see Appendix IIB) 
predicted respectively for proteins in which all cysteines are involved in disulphide bonds, and in 
which none are involved in disulphide bonds (http://www.expasy.ch/tools/protparam.html). We 
were unable to ascertain from the literature what effect zinc coordination is expected to have on 
cysteine residues, and so cannot judge whether our value reflects the zinc binding properties of 
the protein or is simply inaccurate. However, the fact that the protein contains no Tryptophan 
residues may be sufficient explanation for the discrepancy, because the algorithm used is known 
to have an inaccuracy of >10 % on proteins containing no Tryptophans. 
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Table 4.1: Absorbance values obtained at 595 nm (A595) for RING domain and five different dilutions of the 
standard protein BSA 
 Concentration in mg/ml Absorbance at 595 nm 
2.0 0.134 
4.0 0.212 
6.0 0.342 
8.0 0.457 
10.0 0.545 
RING finger domain: 1/3000 dilution 0.222 
  
 
 
 
 
Chart 4.1: BSA standard curve used to determine the concentration of RING domain. The 
Bradford Assay standard curve was generated by drawing the line of best fit through the data points 
shown in Table 4.1 above. The absorbance (A595 nm) of RING domain (0.222) at 3000x dilution is 
represented by the horizontal dashed line while the corresponding concentration of the protein 
(11.5mg/ml) is extrapolated from the vertical dashed line, which corresponds to 1.12 mM. 
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Fig 4.3: The UV absorption spectrum of concentrated RING domain absorbance at 280 nm 
(A280 nm) recorded using NanoDrop® ND1000 Spectrophotometer (NanoDrop Technologies 
Inc.). The amount of the available protein is indicated by the value of the blue line, corresponding 
to A280 shown to 5.18 absorbance units, which was measured at an optical path length of 10 mm. 
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4.2.3 Mass spectrometric analysis 
Since the RING domain consistently migrates with an apparent molecular weight of more than 
twice its actual molecular weight, mass spectrometry was used to investigate whether it was 
subject to intermolecular disulphide bonding, as well as to assess the extent of isotope 
incorporation. The mass spectrogram of unlabelled shortened RING domain is shown in Fig. 
4.4A. The sample is clearly highly homogenous, consisting overwhelmingly of single species 
with molecular mass of 10229.5 Da which is in excellent agreement with the mass predicted on 
the basis of the amino acid sequence using the online Protein Parameter tool in the Expasy suite 
(http://www.expasy.ch/tools/protparam.html). We concluded that if the protein is dimeric in 
solution, it is as a result of non-covalent interactions. 
 
Using the Protein Parameter tool, it was further established that the shortened RING domain 
contains 122 nitrogen and 435 carbon atoms (see Appendix IIB). Hence, following replacement 
of all 14N atoms by 15N atoms, the molecular weight should increased by 122, giving a total mass 
of 10351.6 Da. The value of 10350.2 Da obtained from mass spectrometry (10350.2 Da) 
indicates that the protein is greater than 99 % 15N-labelled. Similarly, the observed mass of the 
double labelled sample (10776.0 Da) is in excellent agreement with the predicted mass (10229.6 
+ 122 + 435 = 10786.6 Da), indicating a >99 % incorporation of 13C (Fig. 4.4B). 
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Fig. 4.4: ESI Q-TOF mass spectrograms of purified and desalted shortened RING domain 
preparations. Depicted in (A) is the mass spectrum of the unlabelled shortened protein showing a major 
peak at 10229.5 Da which corresponds to the expected size of the protein on the basis of the amino acid 
sequence. Depicted in (B) is the mass spectrum of a mixture of the unlabelled, 15N-labelled and 13C/15N-
double labelled preparations of the shortened RING domain. A mass of 10350.2 Da was observed for the 
15N-labelled RING domain, which is in excellent agreement with the predicted mass of 10351.5 Da, 
which indicates > 99 % incorporation of 15N into the protein. The observed mass of 10776.0 Da having a 
mass difference of approximately 10.6 Da from the predicted mass for the double labelled protein 
(10786.6 Da) corresponds to > 98 % incorporation of 13C into the protein.         
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4.3 Assignment of backbone HN, N and CO resonances 
4.3.1 CBCA(CO)NH and HNCACB experiments 
The CBCA(CO)NH (Grzesiek and Bax, 1992) and HNCACB (Muhandiram and Kay, 1994) are 
two of a wide range of triple-resonance (1H, 15N, 13C) experiments (reviewed by Sattler et al., 
1999; Reid et al., 1997) used in the assignment of the individual resonances of the 15N-HSQC. 
These experiments employ the “sequence guided” approach of Wüthrich (Wüthrich, 1986) based 
on the through-bond scalar coupling transfer of magnetization on 15N- and 13C-labelled protein 
samples in establishing sequential backbone connectivity.  
 
Depicted in Fig. 4.5A is the CBCA(CO)NH experiment in which magnetization transfer from the 
Cα and Cβ nuclei is channeled through the carbonyl carbon (‘CO’) and then onto the N and HN of 
the following residue i.e. the N and HN of residue ‘i+1’ is correlated with the Cα and Cβ of 
residue ‘i-1’ (preceding residue). Conversely, in the HNCACB experiment (Fig. 4.5B), 
magnetization is transferred along two pathways: (i) through the CO to the HN of residue ‘i-1’, as 
before, and (ii) directly to the HN of the same residue i.e. the HN and N of residue ‘i’ are 
correlated with the Cα and Cβ of residue ‘i’ and residue ‘i-1’. The two experiments, when 
combined, were used to identify pairs of consecutive residues on the protein backbone and 
distinguish between peaks belonging to residue ‘i’ and residue ‘i-1’ (preceding residue).  
 
Two-dimensional ‘strip-plots’ were generated from the CBCA(CO)NH and HNCACB 
experiments by extracting tubes centered on each resonance in the 15N HSQC spectrum and 
extending it across the full 13C spectral width. This was achieved by taking cross-sections 
through the tubes either in the 1H or in the 15N dimensions. A section of the double strip-plot 
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generated from CBCA(CO)NH and HNCACB spectra corresponding to residues 56 to 59 of the 
RING domain backbone is shown in Fig. 4.6. The gold strips correspond to the CBCA(CO)NH 
spectrum, each one containing two peaks (both colored black) corresponding to the Cα and Cβ 
resonances of residue ‘i-1’. The blue strips correspond to the HNCACB spectrum; each contains 
four peaks corresponding to the Cα (black) and Cβ (red) resonances of residue ‘i’ in addition to 
the resonances of the CBCA(CO)NH spectrum which are of weaker intensity. A comparison 
between Cα and Cβ resonances with reference 13C chemical shifts (see Fig. 4.7) expected for a 
particular amino acid was used to connect the sequentially assigned strips to the protein 
backbone. 
4.3.2 Backbone sequential assignment 
The methodology for assigning the backbone HN, N and CO resonances is as follows: 
1. Auto-pick all peaks in the 15N-HSQC spectrum. 
2. Using the 15N-HSQC peak-list, set up double strip plots with the CBCA(CO)NH strip 
on the left and the HNCACB strip on the right of each pair. Colour the CBCA(CO)NH 
gold and the HNCACB blue. 
3. Arrange the pairs of strips so that the two peaks in the CBCA(CO)NH of one pair align 
with the two peaks in the HNCACB in the pair on the left hand side that do not appear in 
the CBCA(CO)NH of the same pair. Extend the chain as far as possible in both 
directions. 
4. Identify residues with characteristic Cα and Cβ shifts, such as Alanine, Threonine, 
Serine, and to a lesser extent Glycine, Proline, Leucine (see Fig. 4.7). Use them to match 
the disjoint chains to the amino acid sequence. 
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Fig. 4.5: Coherence transfer pathway in CBCA(CO)NH and HNCACB experiments for a pair of 
consecutive residues. In the CBCA(CO)NH depicted in (A), magnetization is transferred from the Cβ  to 
the Cα of residue ‘i-1’ (preceding residue) to the N and HN proton of residue ‘i’ having been channeled via 
the CO of the preceding residue, which is but not observed in the final spectra. In the HNCACB 
experiment shown in (B), magnetization is transferred from the Cβ and Cα of both residue ‘i-1’ (preceding 
residue) and residue ‘i’ to the N and HN proton of both residue ‘i-1’ (preceding residue) and residue ‘i’.    
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    5. Make the HN and N assignments by identifying the previously picked 15N-HSQC peak-list. 
    6. Auto-pick the HNCO spectrum and read off the CO assignment as discussed below. 
4.3.3 HNCO experiment 
The HNCO experiment (Kay et al., 1990) can be loosely interpreted as a 15N-HSQC experiment 
which has been separated into the third spatial dimension based on the precession frequency of 
the carbonyl carbon attached to each N-H group. Hence, a projection of the spectrum back onto 
the H-N plane produces a spectrum almost identical to the 15N-HSQC (see Fig. 4.8A). However, 
resonances that are overlapping in the 15N-HSQC are likely to be resolved in the HNCO, except 
in the unlikely event that their carbonyl resonances are also the same. The third spatial 
coordinate of each resonance corresponds to the resonance of the carbonyl carbon of the 
preceeding residue (see Fig. 4.8B). Carbonyl carbon (CO) chemical shifts of the shortened RING 
domain were extracted from the spectrum and are listed in Appendix III. Apart from being a 
source of carbonyl carbon chemical shifts used in structure calculations, the HNCO also serves 
in resolving overlapped resonances which might be a cause of ambiguity in sequential 
assignments.  
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Fig. 4.6: Double strip plots showing backbone sequential connectivities of residues 56-59 of shortened RING 
domain. Gold strips are taken from a CBCA(CO)NH spectrum while blue strips are taken from the corresponding 
HNCACB spectrum. Black arrows indicate magnetization transfer from a Cα or Cβ resonance to adjacent H-N 
groups of ‘residue i’, while green arrows indicate the route taken by magnetic energy from the Cα or Cβ resonance 
adjacent H-N groups of ‘residue i-1’ (preceding residue), thus permitting residue-specific sequential connectivity. 
The strips have thus been arranged in such a way that carbon shifts in adjacent strips correspond.    
HN 
13C 
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Fig. 4.7: (A) Average Cα and Cβ chemical shifts for all 20 naturally-occurring amino acid residues. 
(B) Aliphatic side-chain amide 1H chemical shifts. A database consisting of 13 proteins were used in 
calculating these values (from Cavanagh et al., 1996). 
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Fig. 4.8: 3D HNCO spectrum of 13C/15N-labelled RING domain acquired at pH 6.0, 25 °C, and 
600 MHZ 1H frequency projected onto the HN-N plane. In (A) the spectrum was overlaid with 1H-15N 
assigned HSQC resonances, hence depicting good separation of overlapped resonances which has been 
resolved in the 3rd (CO) dimension (B) Coherence transfer pathway in an HNCO experiment. Magnetic 
energy is transferred (blue arrows) from the HNi proton via the Ni atom to the directly attached COi-1 
(preceding residue) carbon atom and returns the same way to the HNi nucleus which is directly detected. 
The frequencies of all three nuclei (shown in red) are detected.  
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4.4 Assignment of side-chain 1H and 13C resonances 
4.4.1 C(CO)NH and H(CCO)NH spectra 
The side-chain carbon and proton resonances can be assigned in principle most conveniently 
using the C(CO)NH and H(CCO)NH spectra. They link a particular NH resonance in the 15N-
HSQC to all of the carbons (C(CO)NH) or all of the protons (H(CCO)NH) in the preceding 
residue side-chain. 
4.4.2 H(C)CH-TOCSY and H(C)CH-COSY spectra 
In practice, however, it is useful to combine the above spectra with H(C)CH-TOCSY and 
H(C)CH-COSY spectra, for most complete and accurate assignments. The H(C)CH-TOCSY 
spectrum is similar to the older homonuclear TOCSY spectrum, in that cross-peaks can be 
observed between each proton and all others in the side-chain, allowing for the identification of 
residues based on their characteristic chemical shift patterns (Wuthrich, 1986). The advantage of 
the H(C)CH-TOCSY is that the magnetization is transferred using the strong one-bond coupling 
between the carbon atoms, rather than the weaker three-bond coupling between adjacent protons. 
By the addition of a third time evolution period, the cross-peaks are labelled with the chemical 
shift of either the carbon attached to the directly-detected proton (HC(C)H-TOCSY) or to the 
carbon attached to the indirectly-detected proton (H(C)CH-TOCSY) (see Fig. 4.9B). 
 
Hence, the 2-dimensional 1H-1H plane corresponding to the chemical shift of a particular carbon 
will contain a horizontal line of cross-peaks with the attached proton on the diagonal. This is 
illustrated in Fig. 4.9A, where the panels correspond to the Cα, Cβ, Cγ and Cδ protons of Proline 
54. The corresponding carbon shifts were read off from the C(CO)NH spectrum at the HN and N 
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shifts corresponding to the following residue, Threonine 55 (see Fig. 4.10A). Each panel in Fig. 
4.9 contains the same pattern of peaks, confirming that all four carbons belong to the same side-
chain. The advantages of the H(C)CH-TOCSY are firstly that the same information appears 
multiple times corresponding to each carbon on the side-chain, and secondly that the higher 
resolution of the directly-detected proton dimension allows for accurate shifts to be read off. 
4.4.3 Side-chain assignment 
The methodology for the assignment of the side-chain carbon and proton resonances for each 
residue was as follows: 
1. For each residue, read off the proton and carbon shifts from the H(CCO)NH and 
C(CO)NH at the NH shifts corresponding to the following residue as shown in Fig. 4.10. 
2. If the following residue is a Proline, use the HNCACB to locate the Cα and Cβ shifts at 
the NH shifts corresponding to the residue itself. 
3. Simultaneously display planes of the H(C)CH-TOCSY corresponding to all of the 
available carbon shifts. Identify the same pattern of proton shifts in each and read off the 
proton shift values directly into the chemical shift list. Check that the chemical shifts are 
consistent with the expected ranges, as depicted in Fig. 4.7. 
4. Adjust the carbon shift of each plane until the pattern of proton shifts is most intense. 
Read off the carbon shift values directly into the chemical shift list. 
5. Use the H(C)CH-COSY to check side-chain topology, especially where Hβ, Hγ and Hδ are 
not well separated. 
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4.4.4 Side-chain ring assignment 
The side-chain rings of Tyrosine, Phenyalanine and Histidine residues typically make strong 
nuclear overhauser exchanges (NOEs) with other side-chains due to close packing in the core of 
the protein, making their correct assignment of great importance in NOE-based structure 
determination. Assignments of these resonances are effected with the aid of HCCH-TOCSY and 
HCCH-COSY spectra specifically optimized for the centre of aromatic region of the carbon 
spectrum, which is in the proximity of 120-130 ppm. But due to the fact that rings form closed 
systems under TOCSY and COSY transfer, 2D homonuclear and 13C-HSQC-NOESY spectra 
optimized for the aromatic region need to be used to link the ring spin systems to their 
corresponding side-chains, most typically to the side-chain Hβ protons. 
4.4.5 13C-HSQC 
The 13C-HSQC spectrum of the shortened RING finger is shown in Fig. 4.11. Analogous to the 
15N-HSQC, each resonance corresponds to a covalently bonded CH pair in the protein. Particular 
groups (Cα/Hα, Cβ/Hβ, etc) have characteristic chemical shift values, which are represented 
diagrammatically by the boxed regions drawn in Fig. 4.11. Essentially, the same information is 
contained in Fig. 4.7. 
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Fig. 4.9A: 3D H(C)CH-TOCSY spectra taken from F2 (13C) slices of Proline 54 of RING domain. A: Slice 
taken from the 13Cα plane having a carbon shift of 64.60 ppm and 1Hα proton shift of 4.41 ppm B: Slice taken 
from the 13Cβ plane with carbon shift of 32.21 ppm and 1Hβ1 proton shift of 2.23 ppm and 1Hβ2 proton shift of 
1.93 ppm C: Slice taken from the 13Cγ plane with carbon shift of 26.60 ppm and 1Hγ1 proton shift of 1.73 ppm 
and 1Hγ2 proton shift of 1.59 ppm D: Slice taken from the 13Cδ plane with carbon shift of 50.64 ppm and 1Hδ1 
proton shift of 4.02 ppm and 1Hδ2 proton shift of 3.46 ppm. These carbon and proton chemical shift values 
corresponds to reference values for a Proline as stated by Cavanagh et al., 1996 and shown in Fig. 4.7. Blue 
arrows indicate diagonal protons in each plane.      
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Fig. 4.9B: Coherence transfer pathway in an H(C)CH-TOCSY experiment. The direction of 
transfer of magnetic energy (blue arrows) which only occurs within ‘residue i’ only, starts from a 
side-chain proton (red) to the directly attached carbon atom via the small 1J coupling (35-55 Hz) to 
the neighbouring carbon atoms and their attached protons. The flow of magnetic energy is 
represented as follows:  1Hα(t1)                13Cα(t2)               13Cβ                1Hβ(t3) 
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Fig. 4.10: Side-chain assignment strategy used in assigning the complete spin system of resonances 
belonging to Proline 54 of RING domain. Slices taken at the backbone 15N frequency of Threonine 55 
at 121.39 ppm having an HN shift of 9.34 ppm through A: C(CO)NH showing tower of peaks 
corresponding to the different 13Carbon resonances of Pro54 with their respective chemical shifts: Cα 
= 64.64 ppm, Cβ = 32.64 ppm, Cγ = 27.24 ppm and Cδ = 51.46 ppm. B: H(CCO)NH showing the attached  
protons of Pro54: 1Hα at 4.43 ppm, 1Hβ1 at 2.24 ppm and 1Hβ2 at 1.95 ppm. The knowledge of the 
13Carbon and 1H resonances from these two correlated spectra serves as the starting point in the 
assignment of side-chain resonances using the H(C)CH-TOCSY spectrum.   
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Fig. 4.11: 13C-HSQC spectrum of double-labelled shortened RING domain at 25 °C, acquired at 
600 MHz. The spectrum confirms the incorporation of 13C isotope into the protein, yielding a good 
dispersion of resonances. The different position of specific spin systems have been mapped unto the 
spectrum as follows: A = Leucine & Isoleucine Hδ /Cδ; B = Alanine Hβ/Cβ; C = Leucine & Isoleucine 
Hγ/Cγ; D = Most residue Hβ/Cβ; E = Leucine Hβ/Cβ; F = All residue Hα/Cα; G = Threonine Hβ/Cβ; 
H = Proline Hδ/Cδ ; I = Glycine Hα/Cα; J = Histidine Hβ/Cβ; K = Cysteine Hβ/Cβ (reduced).   
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4.5 Generation of torsion angle restraints using TALOS 
The extracted HN, N, Cα, Cβ and CO chemical shifts (see Appendix III) were used to generate 
backbone torsion angle restraints using the software program TALOS (Cornilescu et al., 1999). 
TALOS is a simple knowledge-based algorithm that exploits the known relationship between 
chemical shift and secondary structural elements (Wishart and Sykes, 1994; Wishart et al., 
1992).  
 
For each consecutive triplet of amino acids (the “test triplet”), TALOS searches a database of 20 
(or more now) well-defined X-ray structures for the triplet with the closest matching set of 
chemical shifts. It then assigns the average of the (φ) and (ψ) torsion angles of the ten central 
residues to the central residue in the test triplet. Fig. 4.12 shows this procedure in action for the 
residue Ala44 of RBBP6 RING. The graphical interface lists the ten best triplets and the 
respective φ (phi) and ψ (psi) values, and shows their positions graphically on a Ramachandran 
plot. The user is able to review the list, exclude any outliers, and then categorize the resulting 
values as good, ambiguous or bad. At the end of the procedure, a list of restraints is written out 
that can be input into structure calculation routines. Only residues classified as “good” are 
written out. 
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B A 
Fig. 4.12: Graphical display of TALOS output for RING domain: (A) Sequence window showing 
residues in the protein whose backbone angles are being predicted. Residues highlighted in green depicts 
good matches to at least ten proteins in the TALOS database while those coloured gray are residues with no 
classification matching proteins in the database yet (B) Ramachandran window for residue Ala44 shows that 
the chemical shift values for Ala44 match those of database proteins in which the residue falls within an α-
helix with a predicted φ and ψ angles of -64° and -40° respectively (C) Prediction window for Ala44 listing 
the different proteins in the database with closely matching chemical shifts which were used to predict Ala44 
φ and ψ angles. 
C 
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4.6 Analysis of backbone hydrogen bonding using H2O/D2O 
exchange 
In the absence of hydrogen bonding, backbone HN protons exchange with protons in the solvent. 
At 25 °C and pH 6.0, the exchange time T = (exchange rate)-1 is of the order of 1000 s-1. In 
folded regions of secondary structure, however, such as α-helices or β-sheets, the HN is protected 
from exchange, resulting in exchange times orders of magnitude longer. Conversely, an HN 
proton with a long exchange time can be assumed to be involved in a stable hydrogen bond. If, in 
addition, structure calculations indicate the HN in question is able to make a hydrogen bond with 
a suitable acceptor (often backbone carbonyl oxygen), then a suitable restraint can be added to 
subsequent structure calculations. 
 
HN exchange times were measured by resuspending a lyophilized 15N-RING domain sample 
(previously in aqueous NMR buffer) in D2O and recording a series of twenty-one 15N-HSQC 
spectra over a period of two days (see Fig. 4.13). From each spectrum, a peak-list containing the 
intensity of each peak was generated and a Perl script was used to extract a series of intensities 
corresponding to each backbone HN. When each volume was plotted at a time corresponding to 
the midpoint of each 15N-HSQC experiment, the result was a series of decaying curves. Fitting 
each curve to a simple exponential of the form: I(t) = I0 e-t/t0, where I0 is the intensity in the 
absence of exchange and t0 is the decay time, allowed the value of t0 to be extracted. The results 
are tabulated in Table 4.2. Large values of t0 or those marked “inf” correspond to protected 
amides. A representative example of the data fitting is shown in Fig. 4.14.  
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Fig. 4.13: 1H-15N HSQC spectra of lyophilized 15N-labelled RING domain dissolved in 100 % deuterium oxide 
(D2O) recorded at pH 6.0, 25 °C, and acquired at 600 MHz 1H frequency. The panel labelled (A) corresponds to 
the spectrum recorded approximately 10-15 minutes after the dissolution of the lyophilized protein while (B) 
corresponds to the final 1H-15N HSQC spectrum acquired after allowing the experiment to run for approximately 2950 
minutes. A series of twenty-one (21) HSQC spectra were acquired in a time-course fashion in-between both spectra 
(data not shown).    
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Table 4.2: D2O/H2O exchange times for RING domain amino acid at 25 °C, pH 6.0 
 
Residue I0 (ppm) δI0 (ppm) t0 (mins) δt0 (mins) 
Leu15 3.0413 0.14 inf inf 
Ile18 4.25 0.0057 inf inf 
Cys19 3.4345 0.009 inf inf 
Lys20 3.1918 0.0059 5071 286 
Asp21 4.8645 0.0058 inf inf 
Ile22 0.7595 0.0081 279 67 
Met23 1.1805 0.0063 inf inf 
Thr24 1.6988 0.0061 213 17 
Ala26 4.2847 0.006 381 12 
Val27 2.4589 0.0038 inf inf 
Val28 2.4589 0.0038 inf inf 
Ile29 0.5071 0.0061 inf inf 
Cys31 4.1879 0.008 2112 62 
Cys32 2.1347 0.0064 12310 2538 
Asn34 1.9239 0.0038 6474 589 
Cys37 2.7302 0.0055 inf inf 
Asp38 3.9319 0.0074 inf inf 
Ile41 4.57 0.13 inf inf 
Arg42 5.6033 0.007 66868 29233 
Thr43 5.8483 0.1 352 13 
Ala44 7.3336 0.0068 3181 61 
Leu45 4.9009 0.0069 inf inf 
Leu46 7.3922 0.0043 12238 490 
Cys53 3.2662 0.006 16387 3196 
Thr55 3.9548 0.0049 8397 497 
Cys56 3.9652 0.0057 2425 59 
Val61 4.9629 0.0081 486 17 
Ala65 0.31 0.0037 3034 904 
Leu66 4.4174 0.0075 434 16 
Ile67 0.789 0.0037 5839 1162 
Asn69 1.0827 0.0055 274 31 
Arg73 3.221 0.01 351 24 
Ala75 2.5039 0.0066 81 5 
Val76 0.3751 0.0084 596 273 
Asn78 0.45 0.14 198 137 
Gln92 0.7721 0.003 inf inf 
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B A 
C D 
Fig. 4.14: Time-course hydrogen exchange behaviour of selected residues from RING domain 
dissolved in 100 % deuterium oxide (D2O). A and B respectively depicting Thr43 and Ala75 are fast-
exchanging amide protons while C and D depicting Val28 and Ile67 respectively, exhibits the slowly-
exchanging ones. The plots were generated by fitting cross-peak intensities of twenty-one (21) 1H-15N 
HSQC from individual amino acid residues to an exponential decay of the form  I(t) = I0 e-t/t0 using the 
software ProFit (www.bioinf.org.uk/software/proFit). The solid lines represent the best single exponential 
fits to the experimental data.     
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4.7 Cadmium exchange investigations 
Since there is no zinc isotope with a magnetic moment of ½, a number of studies have been 
conducted replacing Zn2+ with 113Cd2+ ions (Gourion-Arsiquaud et al., 2005; Houben et al., 
2005; Kellenberger et al., 2005; Hanzawa et al., 2001; Gardner et al., 1991). 113Cd2+ ions are 
only slightly larger than Zn2+ ions and can therefore replace Zn2+ ions without significantly 
disrupting the structure. Their presence can be monitored by observing the small changes 
produced in the 15N-HSQC spectrum. Hence, to determine the number of Zn2+ ions binding per 
RING finger molecule, as well as the coordination pattern, Zn2+/Cd2+ exchange experiment was 
carried out. When 113Cd-EDTA was added to a 0.5 mM sample of 15N-labelled RING finger to a 
final concentration of 4.0 mM, new peaks appeared and some of the original peaks disappeared, 
over the course of approximately 1 week for some peaks and 2 weeks for others.  Fig. 4.15A 
shows an overlay of spectra recorded before (black) and after exchange had taken place (red). 
 
The exchange of 113Cd2+ for Zn2+ was also observed directly using a directly-detected 1D 113Cd2+ 
spectrum (see Fig. 4.15B). The peak at 90 ppm corresponds to 113Cd2+ bound to EDTA, whereas 
the peaks at 729 ppm and 711 ppm correspond to 113Cd2+ bound to each of the two sites in the 
protein. These chemical shifts are consistent with the expected values of tetrahedrally-
coordinated proteins which are between -110 ppm and 750 ppm (Summers, 1988). Over the 
period of exchange, the protein-bound peaks grew from zero and the EDTA-bound peak 
decreased (data not shown). Hence, we conclude that RBBP6 RING domain binds two Zn2+ ions. 
 
 
 
 
 
 
 
 
 
106 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.15: (A) Overlay of 15N-HSQC spectra of Cd2+-bound RING finger (red resonances) and Zn2+-
bound RING (black resonances) recorded at pH 6.0, 25 °C, and acquired at 600 MHz 1H frequency. 
The existence of exchange was revealed by the replacement of Zn2+-bound form of the protein by the 
Cd2+-bound form over the course of two weeks after the addition of 4.0mM of 113Cd-EDTA. (B) 
Cadmium-zinc exchange monitored by 1D 113Cd2+-direct detection spectrum. 113Cd-EDTA resonance 
was observed at 90 ppm while the two far-shifted resonances at 729 ppm and 711 ppm correspond to the 
two 113Cd2+ ions bound to the protein, showing optimal occupancy of the metal ions sites after exchange 
has been completed.   
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The new peaks were assigned by comparing 15N-HSQC-NOESY spectra of the 113Cd2+- bound 
and Zn2+-bound samples, since the assignments of the Zn2+-bound form were already known. 
The 1H and 15N chemical shift changes (∆δ1H and ∆δ15N respectively) were combined to give a 
“composite shift” defined by: 
 
                                                 ∆δcomp = √(∆δHN)2 + (∆δN/6.5)2 
 
A clear correlation is apparent between the residues that shift the most and the positions of the 
zinc-coordinating residues as shown in Fig. 4.16A. 
 
To further investigate the two different exchange rates observed, a series of 12 15N-HSQC 
spectra were recorded over the course of 336 hours following the addition of 113Cd EDTA. The 
intensities of all peaks were picked and a Perl script used to extract the intensities of each 
resonance as a function of time. These were fitted to decaying exponentials of the form: I = Io℮-
t/T as is shown for selected residues in Fig. 4.16B. The distribution of the various exchange times 
is shown Fig. 4.17. It shows a definite bimodal distribution, indicating that the residues fall into 
two distinct groups, with decay times centred on 130 hrs and 67 hrs respectively. The most likely 
explanation is that the two group of residues corresponded to the metal binding sites, a 
conclusion that was later confirmed by the structure (see Section 4.9). 
 
In order to identify which cysteine residues were involved in coordinating which Zn2+/Cd2+ ion, 
an 113Cd-HMQC spectrum was recorded. This experiment uses the 3-bond coupling between the 
113Cd2+ ion and the Hβ protons of the coordinating cysteine residues, which has previously been 
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measured to be in the vicinity of 12 Hz. Initially, nothing was observed. However, at the 
suggestion of Dr. Dimitris Argyropolous (Varian Inc.), the coupling was increased to 30 Hz and 
the spectrum shown in Fig. 4.18A was observed. The two rows of peaks at 711 ppm and 
729 ppm respectively, corresponds to transfer of magnetic energy between protons in the protein 
and the two 113Cd2+ ions. A schematic representation showing the two metal binding sites of the 
RBBP6 RING finger as shown by the 1H-113Cd HMQC spectrum is shown in Fig. 4.18B.  
 
Fig. 4.19 shows carbon planes from the H(C)CH-TOCSY alongside the 113Cd-HMQC, to 
illustrate the assignment of the Cysteine Hβ resonances. Fig. 4.19(A) shows the assignment of 
Cys19, Cys37 and Cys40 to the 113Cd2+ ion at 708.215 Hz. There is no sign of Cys16. Cys19 and 
Cys40 appears to have shifted relative to their Zn2+-bound positions in the H(C)CH-TOCSY, 
which may be a result of the incorporation of the 113Cd2+ ion.  
Fig. 4.19(B) shows the assignment of Cys31, Cys32 and Cys56. There is no sign of Cys53. Here 
too, Cys31 and Cys32 appear to have shifted relative to their H(C)CH-TOCSY, which again is 
probably due to the incorporation of the 113Cd2+ ion. Most importantly, the presence of a cross-
peak at 3.0 ppm is evidence for the involvement of Cys32 in the coordination. While the same 
peak could also belong to Cys53, the absence of the downfield Hβ of Cys53 at 3.4 ppm suggests 
that the peak at 3.0 ppm belongs to Cys32. The direct observation of the correlation of Cys32 
with the second cadmium ion in the protein gives clear evidence that the RING finger domain of 
RBBP6 coordinates eight cysteine residues to two Zn2+ ions, exhibits the “cross-brace” topology 
of RING’s and is a bonafide C4C4 RING finger. 
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Fig. 4.16: Perturbation of 15N-HSQC chemical shifts upon Zn2+-Cd2+ ion exchange in RBBP6 RING 
domain. A: Composite proton (1H) and amide (15N) chemical shift changes (in ppm) upon complete Zn2+-
Cd2+ exchange. Shifts measured for cysteine residues belonging to sites 1 and 2 of metal coordination are 
labelled blue and red respectively. The composite shift is calculated as described in Houben et al., 2005 
thus: ∆δcomp = √(∆δHN)2 + (∆δN/6.5)2. B: Metal exchange kinetics for the two binding sites in the protein. 
The disappearance of 15N-HSQC cross-peaks from Zn2+-RING domain (red curves) and the corresponding 
appearance of cross-peaks belonging to Cd2+-RING domain (green curves) over time are shown for sites 1 
and 2 respectively. 
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Fig. 4.17: Histogram showing bimodal clustering of Zn2+/Cd2+ exchange time for RBBP6 RING 
domain. The distribution shown supports the existence of two Zn2+ ion coordinating centres in the 
protein, with exchange times of approximately 70 hours and 130 hours respectively.      
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Fig. 4.18: Zinc-cadmium replacement in RING domain. Depicted in (A) is 1H-113Cd HMQC spectrum 
of the cadmium-substituted RING domain depicting the three-bond J-coupling (3J) between 113Cd and β-
protons of the cysteine residues while a schematic representation of the two metal-binding sites with the 
coordinating cysteine residues is shown in (B).      
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Fig. 4.19(A): Strategy used in the assignment of site 1 cysteine β-protons (Hβs) of RING domain 
after complete metal ion exchange. Slices are taken from the H(C)CH-TOCSY 13Cβ planes of individual 
cysteine residues and directly correlated to the resonances observed on the 113Cd-HMQC spectrum. Aside 
resonances corresponding to Cys16, other resonances belonging to site 1 were conveniently found and 
assigned accordingly.       
 
1H (ppm) 
13
C
β  (
pp
m
) 
C16 
C19 C37 
C40 
11
3 C
d 
(p
pm
) 
 
 
 
 
 
 
113 
1H (ppm) 
C32 
C53 
C56 
C31 
13
C
β  (
pp
m
) 
11
3 C
d 
(p
pm
) 
Fig. 4.19(B): Strategy used in the assignment of site 2 cysteine β-protons (Hβs) of RING domain 
after complete metal ion exchange. Slices are taken from the H(C)CH-TOCSY 13Cβ planes of individual 
cysteine residues and directly correlated to the resonances observed on the 113Cd-HMQC spectrum. Aside 
resonances corresponding to Cys53, other resonances belonging to site 2 were conveniently found and 
assigned accordingly.       
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4.8 Investigation of the oligomeric state of RING domain using 
chemical shift perturbation method 
SDS-PAGE analysis of RING domain samples revealed that the protein migrates with an 
apparent molecular weight of 18-25 kDa (see Fig. 3.6 and 4.2), which suggests that it has 
tendency to form homodimers. Homodimers are often accompanied by chemical shift changes of 
amino acid residues that are either directly involved in the binding interface or involved in 
induced conformational rearrangements. The binding interface can be identified using a 2D 15N-
HSQC experiment since it is very sensitive to small changes in the protein environmental 
conditions (Vaynberg and Qin, 2006).  
 
Starting with a 2 mM sample of 15N-labelled RING domain in NMR buffer, eight samples of 
concentration 1000, 800, 600, 400, 200, 100, 50, 25 µM were prepared by diluting with NMR 
buffer. 15N-HSQCs were recorded for each sample; for the lowest three dilutions a cryoprobe was 
used in order to reduce the measurement time and increase the sensitivity. Overlaying the spectra 
as shown in Fig. 4.20, reveals a significant concentration-dependent effect, with most resonances 
showing some effect and others, such as residues 27-29, showing total composite shifts of greater 
than 0.1 ppm.  
 
In addition to the concentration-induced effects, the spectrum in Fig. 4.20 shows evidence of 
duplication of peaks. Compare for example, the single resonance corresponding to Thr83 at the 
very top of Fig. 4.1 which has been replaced by the pair of resonances in Fig. 4.20. Since the new 
peaks are present at all concentrations, the effect is not related to the monomer/dimer effect. The 
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resonances which split in this way are Cys31, Arg73, Gln74, Ala75, Tyr85 and Lys87. It is likely 
that this corresponds to an alternative conformation involving these residues.  
 
To quantify the shifts, the peaks in each spectrum (including the new peaks) were picked and 
assigned and the chemical shifts of the centres extracted as a function of concentration. Taking 
the position of a given resonance at the lowest concentration (δH0, δN0) as the origin, the 
composite chemical shift at any other concentration was calculated using the formula: 
  
                    ∆δ = √(δH-δH0)2 + (δN-δN0/6.5)2………………..Equation (1)  
 
where δH, δN are the chemical shifts at the appropriate concentration. Note that this formula 
scales the N chemical shifts by a factor of 6.5 to take account of the relative widths of the 1H and 
15N spectra. Plots of ∆δ against concentration for selected residues are shown in Fig. 4.21. 
 
Treating homodimerization as a fast-exchange process in which the on/off rate is much faster 
than the time taken to make an NMR measurement, the chemical shift ∆δ can be interpreted as a 
population-weighted average of the initial and final chemical shifts, which correspond to the 
fully monomeric and fully dimeric states respectively. Hence we can say that: 
  
             ∆δ= ∆δtotal[protein]/(KD + [protein]) + ∆δ0………………..Equation (2) 
  
where KD is the Dissociation constant for the interaction, ∆δtotal is the total composite shift 
change and ∆δ0 takes account of the shift change between the lowest measurable concentration 
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and zero concentration. The equation was fitted to each residue with measureable shift and 
values of KD and ∆δ0 extracted. The value of ∆δ0 was then added to ∆δtotal to give the total shift 
change and the values of ∆δtotal and KD tabulated in Table 4.3. The values of KD fall 
predominantly in the range 150-250 µM. 
 
As can be seen from Equation 2, KD corresponds to the concentration at which half of the 
molecules are in the monomeric and half are in the dimeric state i.e. the midpoint of the 
monomer/dimer transition. Since all of the data for structural work was recorded on samples in 
the range 0.5-1.0 mM, it can be concluded that these samples were predominantly dimeric. This 
raises the question as to whether the NMR data should be fitted to a dimeric structure to allow 
for the possibility that structural changes occur on dimerization. However, significant protein-
protein interactions typically have KD values in the nanomolecular range (smaller KD means 
stronger interaction) with interactions with KD > 10 µM being considered weak (Vaynberg and 
Qin, 2006). Weak interactions are unlikely to perturb the structure of the mononmer and are 
likely to give rise to only very-weak NOEs in NOESY spectra. Hence, it can be concluded that 
the dimerization is not likely to perturb the structure of the monomer, and that the structure can 
be determined using a monomeric model rather than a dimeric complex.  
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Fig. 4.20: Overlay of eight 1H-15N HSQC spectra acquired by concentration-dependent dilution of 
lyophilized RING domain at pH 6.0, 25 °C. The resonances were colour-coded according to the 
concentration of individual spectrum as follows: 1000 µM (black), 800 µM (red), 600 µM (green), 400 µM 
(blue), 200 µM (yellow), 100 µM (magenta), 50 µM (cyan), 25 µM (black). Small chemical perturbations 
can be seen in resonances belonging to Leu15, Cys16, Met23, Ala26, Val27, Val28, Ile29, Cys32, Gly33, 
Asn34, Tyr36, Cys37, Glu39, Leu66, Ile41, Arg42 and Ala68. Heavily perturbed residues resulting in 
splitted resonances can be seen in Cys31, Arg73, Gln74, Ala75, Tyr85 and Lys87.       
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Table 4.3: Results of concentration-dependent composite shift fittings for RING domain at 25 °C 
  
Residue KD±SD (µM) ∆δtotal±SD (ppm) 
Leu15 243±66 0.060±0.003 
Met23 258±34 0.147±0.004 
Val27 152±25 0.196±0.006 
Val28 266±26 0.186±0.004 
Ile29 220±43 0.351±0.013 
Cys31 (Peak37) 209±25 0.149±0.003 
Cys31 (Peak40) 150±17 0.098±0.002 
Cys32 219±22 0.130±0.002 
Gly33 234±52 0.154±0.006 
Asn34 202±39 0.153±0.005 
Tyr36 382±107 0.235±0.002 
Cys37 188±36 0.087±0.003 
Glu39 218±31 0.051±0.001 
Ile41 135±49 0.023±0.002 
Arg42 229±73 0.044±0.003 
Leu66 234±27 0.183±0.004 
Ala68 217±32 0.212±0.006 
Arg73 (Peak87) 198±46 0.083±0.003 
Arg73 (Peak103) 190±53 0.135±0.007 
Gln74 (Peak89) 158±47 0.095±0.005 
Gln74 (Peak90) 183±53 0.072±0.004 
Ala75 (Peak62) 169±79 0.034±0.003 
Ala75 (Peak70) 211±133 0.020±0.002 
Tyr85 (Peak79) 72±35 0.045±0.006 
Tyr85 (Peak126) 260±69 0.083±0.004 
Lys87 (Peak49) 147±136 0.013±0.002 
Lys87 (Peak71) 195±43 0.053±0.002 
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Fig. 4.21: Concentration-dependent composite shift behaviours of three selected residues of RING 
domain shown to undergo perturbations during dilution. A, B and C corresponds to Val27, Asn34 and 
Ala68 respectively revealing a weak protein-protein interaction. The plots were generated by fitting 
composite shifts of eight (8) 1H-15N HSQC spectra from individual amino acid residues to a hyperbolic 
curve equation using the software, proFit (www.bioinf.org.uk/software/proFit ). The solid lines represent the 
best single hyperbolic fits to the experimental data.     
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4.9 Determination of the structure of the RING domain 
Structure calculations were carried out in collaboration with Dr Eiso AB at Utrecht University 
using the CYANA v2.1 package (Guntert et al., 1997; Herrmann et al., 2002). As input the 
program used the following: unassigned NOE-derived distance restraints generated from 2D 1H-
1H NOESY, 3D 15N-HSQC-NOESY and 3D 13C-HSQC-NOESY spectra, dihedral angles (φ and 
ψ) generated from backbone chemical shifts using the TALOS algorithm (Cornilescu et al., 
1999), and hydrogen bond restraints generated from hydrogen-deuterium exchange experiments. 
The NOE-derived restraints were automatically assigned using the CANDID module of 
CYANA; the routine ran through 8 cycles of simulated annealing, each one generating 100 
structures beginning with ambiguous restraints and progressively reducing the ambiguity based 
on convergence of the structures. Of the final 100 structures, the 20 with the lowest target 
energies were selected. Since the geometry of the zinc coordination to the four sulphur atoms is 
known to be tetrahedral, with average bond length of 2.3 Å, restraints were added corresponding 
to Zn-S distances of 2.3 Å and S-S distances of 3.8 Å. A summary of the structural statistics is 
given in Table 4.4. Backbone dihedral angles were visualized using the Ramachandran plot 
shown in Fig. 4.23B.   
 
As shown in Fig. 4.22, the structure contains the β-β-α-β motif typical of RING finger domains, 
consisting of a triple-stranded β-sheet: β1 (residues 27-29), β2 (residues 33-36) and β3 (residues 
67-68) and α-helix: α1 (residues 38-47). Two loops: L2 (residues 15-22) and L3 (residues 50-60) 
are stabilized by one zinc ion each.  
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Fig. 4.22: Cartoon representation of the three dimensional structure of the RING domain from 
human RBBP6. The secondary structure elements consist of two helices designated α1and α2; and three-
stranded antiparallel β-sheets comprising of β1, β2 and β3 strands. The two zinc ligation sites (ZnI and ZnII) 
are shown in magenta. The figure was generated using MOLMOL (Koradi et al., 1996). 
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Table 4.4: Structural statistics of the 20 lowest energy conformers of RING domain 
Restraints for structure calculation  
Restraints  
NOE-derived restraints (total) 2791 
Short-range, (|i-j|<=1) 1243 
Medium-range, (1<|i-j|<5) 556 
Long-range, (|i-j|>5) 992 
Zinc restraints 2 
Dihedral restraints (TALOS)  
Φ angle 46 
Ψ angle 46 
Final structures statistics  
Pairwise superposition of backbone atoms (Å) 
RMSD over backbone heavy atoms 0.11 
RMSD over all heavy atoms 0.43 
Ramachandran plot appearrance  
Residues in allowed φ/ψ regions of the Ramachandran plot (%) 
Most favoured region 72.4 
Additionally allowed region 20.4 
Generously allowed region 4.8 
Disallowed regions 2.4 
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Fig. 4.23: (A) Superposition of the ensemble of twenty representative lowest energy structures of 
RING domain showing zinc coordination by cysteine residues. Secondary structure elements are shown 
in blue, zinc atoms as magenta spheres while the ligating cysteine residues are shown as yellow spheres. 
The figure was generated using MOLMOL (Koradi et al., 1996). (B) Ramachandran plot of the final 
twenty structures of RING domain. The blue shading seen in the plot is indicative of the favourable and 
unfavourable regions, while the small black circles represent residues. The darker the shading the more 
favourable is the region. This figure was generated using MOLMOL (Koradi et al., 1996).  
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The core is stabilized by the presence of many hydrophobic residues within the core of the 
protein and within the zinc binding sites including Val27, Ile29, Tyr36, Ile41, Leu45, Val61 and 
Leu66, all of which are conserved across all RING fingers and U-box domains. In addition to the 
ββαβ core, the structure possesses a second core made up of the C-terminal helix α2 (residues 71-
82) packing against an N-terminal loop L1 (residues 2-14). The C-terminal helix is typical of U-
boxes, where it plays an important role in dimerization of U-box domains (Vander Kooi et al., 
2006; Xu et al., 2006; Zhang et al., 2005; Andersen et al., 2004). Since residues whose 
resonances are affected by dilution are likely to be situated close to the dimerization interface, 
we mapped residues with a total composite chemical shift change of more than 0.1 ppm onto the 
surface of the molecule. Together they make up an adjacent surface comprising the outer face of 
the C-terminal helix and the triple-stranded β-sheet (see Fig 4.24). This is in excellent agreement 
with the dimerization interface identified in a number of U-boxes.  
 
Protein database search using the DALI server (http://ekhidna.biocenter.helsinki.fi/dali_server) 
showed that the structure of the RING domain most closely resembles the U-box from the 
protein CHIP (C-terminus of Hsp70-interacting protein), with a highly significant Z-score of 
10.3. A number of other U-box structures also gave high Z-scores, with the highest scoring 
RING finger domain being that of Polycomb group RING finger protein 4 with a Z-score of 8.5.  
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Fig. 4.24: Molecular surface representation of the dimerization interface of RBBP6 RING finger 
domain. Amides experiencing 1H-15N chemical shift perturbations of more than 0.1 ppm upon dilution 
of the protein concentration from 1000-25 µM were modelled unto the structure. The dimerization 
interface lies along a hydrophobic patch involving residues from the three-stranded β-sheet (shown in 
yellow) and the outer face of the C-terminal α-helix (shown in red). One of the two coordinating zinc 
ions is shown in purple. The figure was created using PyMOL Molecular Graphics System (2003). 
DeLano Scientific, San Carlos, CA, USA. http://www.pymol.org 
     
 
 
 
 
 
 
126 
CHAPTER 5: DISCUSSION AND CONCLUSION 
The RBBP6 is a 250 kDa multi-domain protein known to perform a diverse set of functions 
including E3 ubiquitin ligase activity, E4 activity, modulation of the activity of p53, pRb and 
YB-1 as well as a role in mRNA processing and apoptosis. The protein contain a RING finger 
domain which is essential for the ubiquitination activity, a zinc knuckle which most probably 
interacts with mRNA, an ubiquitin-like N-terminal domain (the DWNN domain) which most 
probably plays a role in substrate recognition for the purpose of ubiquitination.  
 
In recent years, yeast-two hybrid screens have been carried out in our laboratory to identify 
proteins interacting with the RING finger domain from RBBP6. Two proteins identified in this 
way are YB-1 and ZBTB38 (Chibi et al., 2008). Studies are underway to characterize these 
interactions from a structural point of view, by identifying the exact sites of interaction, and 
identifying residues that can be mutated in order to abolish the interaction. The main goal of this 
work was the determination of the structure of the RING finger domain so that it can serve as a 
framework for future interaction studies.  
 
Full-length RING domain was heterologously over-expressed at high levels in bacteria as a GST-
RING domain fusion using the pGEX-6P-2 gene fusion system. Fusion protein was purified by 
glutathione-affinity purification and the GST fusion partner was proteolytically removed from 
the protein. The protein was subsequently purified to homogeneity using a combination of 
affinity chromatography, anion exchange chromatography and size-exclusion chromatography to 
yield RING domain samples suitable for NMR analysis having a final concentration of 0.5-
1.0 mM.  The protein was found to be stable for long periods of time (one sample remained 
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unaffected after more than a year in solution at 4 °C) and to be amenable to concentration up to 
2 mM without any sign of precipitation.  
 
15N-enriched and 15N, 13C-enriched RING domain for NMR analysis were expressed in minimal 
media containing 13C-glucose and 15NH4Cl, and were purified as aforementioned. 1D proton and 
2D 15N-HSQC spectra both showed RING domain to be folded and amenable to structure 
determination by heteronuclear NMR spectroscopy. Partial backbone assignment was carried out 
following collection of triple-resonance data at Utrecht University, the Netherlands. However, 
the presence of multiple resonances for residues near the N-terminus suggested that this region 
was unstructured, a conclusion which was confirmed by an NMR dynamics study. Based on this 
information, a shortened construct was designed and cloned, which was then used for all further 
analysis. 
 
Expression, purification and preliminary NMR analysis proceeded as for the longer RING 
domain. However, the shortened RING domain migrates on SDS PAGE as a fragment having an 
apparent molecular size between 18-25 kDa, instead of the expected 10.2 kDa. Mass 
spectrometry confirmed the molecular size of the unlabelled protein to be 10.2 kDa while further 
confirming the degree of isotopic labeling of the single-labelled and double-labelled proteins. 
Since the protein migrates on SDS-PAGE gels at a higher molecular weight than expected (18-
25 kDa rather than the expected 10.2 kDa), it was hypothesized that the domain may form 
homodimers, but the measured KD suggested the interaction was too weak hence, we conclude 
that the reason for this anomalous behaviour of the protein on SDS PAGE gel is unknown.   
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Eighty-three out of a possible 85 backbone resonances were assigned using standard triple-
resonance experiments, while over 95 % of all side chain resonances were successfully assigned. 
Carbonyl chemical shifts were extracted from the HNCO experiment, while an HCCH-TOCSY 
optimized for the aromatic regions was used to assign side chain aromatics. Chemical shifts from 
all the above-mentioned spectra were extracted into a shift table shown in Appendix III. 15N-
separated, 13C-separated and 1H-1H NOESY spectra were recorded, from which large numbers of 
unassigned distance restraints were extracted. Restraints on backbone torsion angles (φ and ψ) 
were generated using the TALOS algorithm. A D2O/H2O exchange experiment was carried out 
to identify slowly-exchanging amides, which were used in conjunction with preliminary 
structures to generate hydrogen bond restraints. 
 
Structure calculations were carried out using CYANA, with automated assignment of NOE’s 
provided by the CANDID algorithm. The structure contains the ββαβ secondary structure found 
in many RING fingers, but in addition contains the long C-terminal helix found in many U-
boxes. The C-terminal α-helix packs against the N-terminal loop as has been shown in two 
previously solved U-box proteins, CHIP and PUB14 (Xu et al., 2008; Andersen et al., 2004). 
The core of the RBBP6 RING domain is stabilized by a cluster of hydrophobic residues 
including Val27, Ile29, Tyr36, Ile41, Leu45, Val61 and Leu66 which has been shown to be 
conserved across the whole family of RING and U-box domains. 
 
The hypothesis that the RBBP6 RING domain might have the propensity of forming homo-
oligomers was investigated using a dilution series. A number of residues were found to shift by 
more than 0.1 ppm, with a KD for the monomer/dimer interaction of around 200 µM. When these 
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residues were mapped onto the surface of the protein, they were found to define a dimerization 
interface involving the C-terminal helix and the triple-stranded β-sheet, in line with interfaces 
found for other U-box homodimers. Due to the large value of KD, it was concluded that 
homodimerization is weak and has no conformation-changing effect on the structure of the 
monomer, validating our decision to model the NMR data as a monomer. This deduction was 
supported by results from various other studies (Vaynberg and Qin, 2006; Ali and Imperiali, 
2005; Nooren and Thornton, 2003). Further confirmation for this comes from a NOESY-based 
experiment, which found no intermolecular NOE’s using an isotope-filtered 13C-separated 
NOESY spectrum on a 50:50 mixture of 13C,15N-labelled:unlabelled RING finger domain (data 
not shown). 
 
A search of the Protein Database revealed that the structure of the RING finger most closely 
resembled those of a number of U-boxes rather than those of RING fingers. U-boxes has been 
found to involved in protein quality control, cooperating with heat shock proteins such as Hsp70 
to either refold unfolded proteins or to tag them for degradation in the proteasome if they cannot 
be refolded. The similarity between the RING finger and those U-boxes suggests a role for 
RBBP6 in similar processes. The results of this thesis therefore open up a number of new lines of 
enquiry regarding the function of RBBP6, based on results attained for similar U-box containing 
proteins. One is an investigation of the role played by homodimerization in the function of the 
protein; the function of CHIP has been shown to be dependent on its ability to dimerize. Another 
is whether RBBP6 interacts directly with heat shock proteins such as Hsp70. 
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In the course of write up of this thesis, another structure of the RING finger domain from human 
RBBP6 was deposited into the Protein Data Bank (PDB) under accession number 2YUR. This 
structure corresponds to residues 249-309 of full length RBBP6, or residues 6-66 of the structure 
reported here. As a result it excludes both the last -strand and the C-terminal helix. Structural 
superposition of the RIKEN RING finger domain (2YUR) with the RBBP6 RING domain using 
the DaliLite server (http://www.ebi.ac.uk/Tools/dalilite/index.html) (Holm and Park, 2000), a Z-
score of only 5.9 was found, compared to a score of 9.8 between our structure and human CHIP 
PDB: 2C2V, chain T). Since the results of the heteronuclear NOE experiment shown in Fig. 3.9 
indicate that the structured region extends all the way to the end of the C-terminal helix, it is 
likely that structure 2YUR does not represent the complete biologically functional unit. In 
particular, it excludes most of the homo-dimerization interface found in the U-box family that is 
likely to be essential for function.  
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APPENDIX I: GENERAL CHEMICALS AND ENZYMES 
 
Chemical Company 
40 % 37.5:1 Acrylamide:bis-acrylamide Biorad 
Agarose Promega 
Ammonium Chloride Sigma 
Ampicillin Roche 
Bacteriological Agar Merck 
Boric Acid Merck 
Bromophenol Blue Sigma 
Buffer Saturated Phenol Invitrogen 
1-Butanol Sigma 
Cadmium Chloride Cambridge Isotopes 
Calcium Chloride BDH 
Cesium Chloride Roche 
Chloramphenicol Sigma 
Chloroform BDH 
Coomassie Brilliant Blue R 250 Sigma 
Disodium Hydrogen Phosphate Heptahydrate Merck 
Dithiothreitol (DTT) Roche 
DNAse 1 Roche 
Ethanol BDH 
Ethidium Chloride Promega 
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Ethylene diamine tetra Acetic Acid Merck 
Glacial Acetic Acid Merck 
Glucose Merck 
Glutathione Sigma 
Glutathione Agarose Sigma 
Glycerol Merck 
Glycine Merck 
Hydrochloric Acid BDH 
Isopropanol Merck 
Isopropyl β-D-thiogalactopyranoside (IPTG) Roche 
Lysozyme Sigma 
Magnesium Chloride Merck 
Magnesium Sulphate Merck 
Methanol Merck 
Phenyl Methyl Sulphonyl Fluoride (PMSF) Roche 
Potassium Acetate Merck 
Potassium Chloride Merck 
Potassium Dihydrogen Phosphate Merck 
Premixed Protein molecular weight marker Roche 
Sodium Azide Sigma 
Sodium Chloride Merck 
Sodium Dodecyl Sulphate (SDS) Promega 
Sodium Hydroxide Merck 
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TEMED (N,N,N’,N’-Tetra methyl ethylene diamine) Promega 
Tris (Tris[hydroxymethyl]amino ethane) Merck 
Triton X-100 (iso-octylphenoxypolyethoxyethanol) BDH 
Tryptone powder Merck 
Tween 20 (Polyoxyethylene[20]sorbitan) Merck 
Yeast extract Merck 
Zinc Sulphate Merck 
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APPENDIX II: PREDICTION OF PROTEIN PARAMETERS 
A. Parameters for full length RING domain 
ProtParam user-provided sequence: 
GPLGSPPFLP EEPSSSSEED DPIPDELLCL ICKDIMTDAV VIPCCGNSYC DECIRTALLE 
SDEHTCPTCH QNDVSPDALI ANKFLRQAVN NFKNETGYTK RLRKQ  
Number of amino acids: 105 
Molecular weight: 11614.0  
Theoretical pI: 4.46 
Amino acid composition: 
Ala (A) 5 4.8% Arg (R) 4 3.8% Asn (N) 6 5.7% Asp (D) 9 8.6% Cys (C) 8 7.6% Gln (Q) 3  
2.9% Glu (E) 9 8.6% Gly (G) 4 3.8% His (H) 2 1.9% Ile (I) 6 5.7% Leu (L) 10 9.5% Lys (K) 5   
4.8% Met (M) 1 1.0% Phe (F) 3 2.9% Pro (P) 10 9.5% Ser (S) 8 7.6% Thr (T) 6 5.7% Trp (W)   
0 0.0% Tyr (Y) 2 1.9% Val (V) 4 3.8% Pyl (O) 0 0.0% Sec (U) 0 0.0% Asx (B) 0 0.0% Glx (Z) 0 
0.0% Xaa (X) 0 0.0% 
Total number of negatively charged residues (Asp + Glu): 18 
Total number of positively charged residues (Arg + Lys): 9 
 
Atomic composition: 
Carbon      C        497 
Hydrogen    H        787 
Nitrogen    N        135 
Oxygen      O        167 
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Sulfur      S          9 
Formula: C497H787N135O167S9 
Total number of atoms: 1595 
 
Extinction coefficients: 
This protein does not contain any Trp residues. Experience shows that this could result in more 
than 10% error in the computed extinction coefficient. 
Extinction coefficients are in units of M-1 cm-1, at 280 nm measured in water. 
Ext. coefficient     3480 
Abs 0.1% (=1 g/l)   0.300, assuming ALL Cys residues appear as half cystines 
Ext. coefficient     2980 
Abs 0.1% (=1 g/l)   0.257, assuming NO Cys residues appear as half cystines 
Estimated half-life: 
The N-terminal of the sequence considered is G (Gly). 
The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro). 
                            >20 hours (yeast, in vivo). 
                            >10 hours (Escherichia coli, in vivo).  
Instability index: 
The instability index (II) is computed to be 61.72 
This classifies the protein as unstable. 
Aliphatic index: 75.24 
Grand average of hydropathicity (GRAVY): -0.458 
 
 
 
 
 
 
 
153 
B. Parameters for shortened RING domain 
ProtParam user-provided sequence: 
GPLGSEDDPI PDELLCLICK DIMTDAVVIP CCGNSYCDEC IRTALLESDE 
HTCPTCHQND VSPDALIANK FLRQAVNNFK NETGYTKRLR KQ 
Number of amino acids: 92 
Molecular weight: 10229.6 
Theoretical pI: 4.67 
Amino acid composition: 
Ala (A) 5 5.4% Arg (R) 4 4.3% Asn (N) 6 6.5% Asp (D) 9 9.8% Cys (C) 8 8.7% Gln (Q) 3 3.3% 
Glu (E) 6 6.5% Gly (G) 4 4.3% His (H) 2 2.2% Ile (I) 6 6.5% Leu (L) 9 9.8% Lys (K) 5 5.4% 
Met (M) 1 1.1% Phe (F) 2 2.2% Pro (P) 6 6.5% Ser (S) 4 4.3% Thr (T) 6 6.5% Trp (W) 0 0.0% 
Tyr (Y) 2 2.2% Val (V) 4 4.3% Pyl (O) 0 0.0% Sec (U) 0 0.0% Asx (B) 0 0.0% Glx (Z) 0 0.0%  
Xaa (X) 0 0.0% 
Total number of negatively charged residues (Asp + Glu): 15 
Total number of positively charged residues (Arg + Lys): 9 
Atomic composition: 
Carbon        C        435 
Hydrogen    H        698 
Nitrogen      N        122 
Oxygen       O        144 
Sulfur          S          9 
Formula: C435H698N122O144S9 
Total number of atoms: 1408 
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Extinction coefficients: 
This protein does not contain any Trp residues. Experience shows that this could result in more 
than 10% error in the computed extinction coefficient. 
Extinction coefficients are in units of M-1 cm-1, at 280 nm measured in water. 
Ext. coefficient     3480 
Abs 0.1% (=1 g/l)   0.340, assuming ALL Cys residues appear as half cystines 
Ext. coefficient     2980 
Abs 0.1% (=1 g/l)   0.291, assuming NO Cys residues appear as half cystines 
Estimated half-life: 
The N-terminal of the sequence considered is G (Gly). 
The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro). 
                            >20 hours (yeast, in vivo). 
                            >10 hours (Escherichia coli, in vivo). 
Instability index: 
The instability index (II) is computed to be 38.52 
This classifies the protein as stable. 
Aliphatic index: 81.63 
Grand average of hydropathicity (GRAVY): -0.376 
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APPENDIX ІІI: RING FINGER DOMAIN CHEMICAL SHIFTS 
Residue number Residue name Atom name Chemical shift 
2 PRO C 177.096 
2 PRO CA 63.249 
2 PRO CB 32.441 
2 PRO CD 49.730 
2 PRO CG 27.150 
2 PRO HA 4.496 
2 PRO HB2 1.977 
2 PRO HB3 2.335 
2 PRO HD2 3.592 
2 PRO HD3 3.609 
2 PRO HG2 1.998 
2 PRO HG3 2.031 
3 LEU C 178.012 
3 LEU CA 55.619 
3 LEU CB 42.163 
3 LEU CD1 24.998 
3 LEU CD2 23.702 
3 LEU CG 27.525 
3 LEU H 8.649 
3 LEU HA 4.397 
3 LEU HB2 1.644 
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3 LEU HB3 1.667 
3 LEU HG 1.826 
3 LEU N 122.886 
3 LEU QD1 0.945 
3 LEU QD2 0.910 
4 GLY C 174.363 
4 GLY CA 45.376 
4 GLY H 8.587 
4 GLY HA2 3.976 
4 GLY HA3 4.119 
4 GLY N 111.356 
5 SER C 174.982 
5 SER CA 58.321 
5 SER CB 64.289 
5 SER H 8.179 
5 SER HA 4.522 
5 SER HB2 3.870 
5 SER HB3 3.961 
5 SER N 116.547 
6 GLU C 176.359 
6 GLU CA 57.264 
6 GLU CB 29.932 
6 GLU CG 36.276 
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6 GLU H 8.730 
6 GLU HA 4.278 
6 GLU HB2 1.959 
6 GLU HB3 2.098 
6 GLU HG2 2.298 
6 GLU HG3 2.298 
6 GLU N 122.843 
7 ASP C 175.747 
7 ASP CA 54.359 
7 ASP CB 41.459 
7 ASP H 8.195 
7 ASP HA 4.636 
7 ASP HB2 2.555 
7 ASP HB3 2.731 
7 ASP N 120.371 
8 ASP C 173.738 
8 ASP CA 52.827 
8 ASP CB 40.742 
8 ASP H 8.138 
8 ASP HA 4.892 
8 ASP HB2 2.540 
8 ASP HB3 2.732 
8 ASP N 122.308 
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9 PRO C 176.668 
9 PRO CA 62.877 
9 PRO CB 32.158 
9 PRO CD 50.529 
9 PRO CG 27.283 
9 PRO HA 4.464 
9 PRO HB2 1.854 
9 PRO HB3 2.243 
9 PRO HD2 3.715 
9 PRO HD3 3.774 
9 PRO HG2 2.019 
9 PRO HG3 2.020 
10 ILE CA 58.687 
10 ILE CB 39.346 
10 ILE CD1 13.161 
10 ILE CG1 27.756 
10 ILE CG2 16.955 
10 ILE H 8.194 
10 ILE HA 4.027 
10 ILE HB 1.549 
10 ILE HG12 0.944 
10 ILE HG13 1.489 
10 ILE N 123.735 
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10 ILE QD1 0.690 
10 ILE QG2 0.509 
11 PRO C 177.071 
11 PRO CA 63.397 
11 PRO CB 32.479 
11 PRO CD 51.404 
11 PRO CG 27.479 
11 PRO HA 4.198 
11 PRO HB2 1.562 
11 PRO HB3 2.311 
11 PRO HD2 2.683 
11 PRO HD3 3.722 
11 PRO HG2 1.732 
11 PRO HG3 1.865 
12 ASP C 178.367 
12 ASP CA 57.715 
12 ASP CB 41.396 
12 ASP H 8.254 
12 ASP HA 4.069 
12 ASP HB2 2.523 
12 ASP HB3 2.523 
12 ASP N 123.732 
13 GLU C 174.898 
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13 GLU CA 57.205 
13 GLU CB 28.797 
13 GLU CG 35.831 
13 GLU H 9.685 
13 GLU HA 4.009 
13 GLU HB2 2.336 
13 GLU HB3 2.413 
13 GLU HG2 2.121 
13 GLU HG3 2.279 
13 GLU N 117.472 
14 LEU C 175.698 
14 LEU CA 53.787 
14 LEU CB 41.175 
14 LEU CD1 21.777 
14 LEU CD2 25.903 
14 LEU CG 27.260 
14 LEU H 7.434 
14 LEU HA 4.210 
14 LEU HB2 1.270 
14 LEU HB3 1.457 
14 LEU HG 1.293 
14 LEU N 114.466 
14 LEU QD1 0.529 
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14 LEU QD2 0.358 
15 LEU C 176.371 
15 LEU CA 53.710 
15 LEU CB 43.599 
15 LEU CD1 25.536 
15 LEU CD2 23.467 
15 LEU CG 25.732 
15 LEU H 7.182 
15 LEU HA 4.237 
15 LEU HB2 0.985 
15 LEU HB3 1.678 
15 LEU HG 1.446 
15 LEU N 119.188 
15 LEU QD1 0.726 
15 LEU QD2 0.518 
16 CYSS CA 59.815 
16 CYSS CB 34.011 
16 CYSS H 8.922 
16 CYSS HA 4.261 
16 CYSS HB2 3.213 
16 CYSS HB3 3.732 
16 CYSS N 128.041 
17 LEU C 177.950 
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17 LEU CA 57.488 
17 LEU CB 43.161 
17 LEU CD1 25.335 
17 LEU CD2 23.127 
17 LEU CG 27.398 
17 LEU H 7.782 
17 LEU HA 4.154 
17 LEU HB2 1.722 
17 LEU HB3 1.840 
17 LEU HG 1.937 
17 LEU N 128.965 
17 LEU QD1 0.915 
17 LEU QD2 0.918 
18 ILE C 176.844 
18 ILE CA 64.543 
18 ILE CB 39.505 
18 ILE CD1 14.350 
18 ILE CG1 28.242 
18 ILE CG2 16.552 
18 ILE H 9.382 
18 ILE HA 4.110 
18 ILE HB 1.886 
18 ILE HG12 1.040 
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18 ILE HG13 1.714 
18 ILE N 121.644 
18 ILE QD1 0.486 
18 ILE QG2 0.969 
19 CYSS CA 59.794 
19 CYSS CB 31.616 
19 CYSS H 8.529 
19 CYSS HA 4.731 
19 CYSS HB2 3.211 
19 CYSS HB3 3.211 
19 CYSS N 119.844 
20 LYS C 173.475 
20 LYS CA 57.185 
20 LYS CB 28.749 
20 LYS CD 28.684 
20 LYS CE 42.499 
20 LYS CG 24.909 
20 LYS H 7.896 
20 LYS HA 4.014 
20 LYS HB2 2.005 
20 LYS HB3 2.140 
20 LYS HD2 1.596 
20 LYS HD3 1.663 
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20 LYS HE2 2.994 
20 LYS HE3 2.989 
20 LYS HG2 1.272 
20 LYS HG3 1.356 
20 LYS N 117.424 
21 ASP C 175.244 
21 ASP CA 51.048 
21 ASP CB 44.411 
21 ASP H 8.286 
21 ASP HA 4.985 
21 ASP HB2 2.569 
21 ASP HB3 2.949 
21 ASP N 122.035 
22 ILE C 175.602 
22 ILE CA 61.591 
22 ILE CB 38.708 
22 ILE CD1 15.380 
22 ILE CG1 29.494 
22 ILE CG2 17.055 
22 ILE H 9.304 
22 ILE HA 4.105 
22 ILE HB 1.549 
22 ILE HG12 1.200 
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22 ILE HG13 1.545 
22 ILE N 122.320 
22 ILE QD1 0.820 
22 ILE QG2 0.915 
23 MET C 178.153 
23 MET CA 57.627 
23 MET CB 35.740 
23 MET CE 19.217 
23 MET CG 33.564 
23 MET H 7.821 
23 MET HA 5.041 
23 MET HB2 1.348 
23 MET HB3 1.813 
23 MET HG2 2.420 
23 MET HG3 2.633 
23 MET N 124.632 
23 MET QE 1.661 
24 THR C 174.592 
24 THR CA 61.952 
24 THR CB 69.541 
24 THR CG2 21.611 
24 THR H 9.011 
24 THR HA 4.521 
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24 THR HB 4.170 
24 THR N 125.509 
24 THR QG2 1.249 
25 ASP C 175.184 
25 ASP CA 55.282 
25 ASP CB 39.266 
25 ASP H 9.068 
25 ASP HA 4.100 
25 ASP HB2 2.732 
25 ASP HB3 2.839 
25 ASP N 130.395 
26 ALA C 179.894 
26 ALA CA 53.559 
26 ALA CB 21.599 
26 ALA H 8.308 
26 ALA HA 4.482 
26 ALA N 120.827 
26 ALA QB 1.297 
27 VAL C 173.146 
27 VAL CA 58.936 
27 VAL CB 35.995 
27 VAL CG1 21.329 
27 VAL CG2 20.738 
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27 VAL H 9.399 
27 VAL HA 5.186 
27 VAL HB 1.972 
27 VAL N 119.480 
27 VAL QG1 1.023 
27 VAL QG2 0.992 
28 VAL C 173.937 
28 VAL CA 59.234 
28 VAL CB 35.285 
28 VAL CG1 22.319 
28 VAL CG2 21.064 
28 VAL H 9.447 
28 VAL HA 5.087 
28 VAL HB 1.823 
28 VAL N 119.654 
28 VAL QG1 0.885 
28 VAL QG2 0.873 
29 ILE C 175.620 
29 ILE CA 57.028 
29 ILE CB 44.363 
29 ILE CD1 15.043 
29 ILE CG1 30.592 
29 ILE CG2 19.514 
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29 ILE H 8.615 
29 ILE HA 5.108 
29 ILE HB 1.682 
29 ILE HG12 1.519 
29 ILE HG13 2.422 
29 ILE N 129.312 
29 ILE QD1 1.142 
29 ILE QG2 1.732 
30 PRO C 176.491 
30 PRO CA 64.949 
30 PRO CB 32.349 
30 PRO CD 51.330 
30 PRO CG 27.831 
30 PRO HA 4.392 
30 PRO HB2 2.090 
30 PRO HB3 2.265 
30 PRO HD2 3.710 
30 PRO HD3 3.790 
30 PRO HG2 2.075 
30 PRO HG3 2.046 
31 CYSS CA 56.806 
31 CYSS CB 29.139 
31 CYSS H 8.488 
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31 CYSS HA 4.255 
31 CYSS HB2 2.717 
31 CYSS HB3 2.834 
31 CYSS N 123.114 
32 CYSS CA 57.117 
32 CYSS CB 32.084 
32 CYSS H 8.308 
32 CYSS HA 4.979 
32 CYSS HB2 2.757 
32 CYSS HB3 3.012 
32 CYSS N 116.576 
33 GLY C 174.765 
33 GLY CA 47.202 
33 GLY H 8.098 
33 GLY HA2 3.899 
33 GLY HA3 4.343 
33 GLY N 112.250 
34 ASN CA 55.047 
34 ASN CB 40.948 
34 ASN H 7.337 
34 ASN HA 4.656 
34 ASN HB2 2.245 
34 ASN HB3 3.026 
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34 ASN HD21 8.930 
34 ASN HD22 7.501 
34 ASN N 119.929 
34 ASN ND2 121.827 
35 SER C 170.934 
35 SER CA 57.910 
35 SER CB 67.097 
35 SER H 8.081 
35 SER HA 6.080 
35 SER HB2 2.974 
35 SER HB3 3.407 
35 SER N 122.355 
36 TYR C 175.923 
36 TYR CA 55.337 
36 TYR CB 44.956 
36 TYR CD1 133.384 
36 TYR CE1 117.376 
36 TYR H 8.382 
36 TYR HA 5.041 
36 TYR HB2 2.274 
36 TYR HB3 3.353 
36 TYR HH 5.988 
36 TYR N 116.266 
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36 TYR QD 6.845 
36 TYR QE 6.484 
37 CYSS CA 60.971 
37 CYSS CB 31.861 
37 CYSS H 8.834 
37 CYSS HA 4.258 
37 CYSS HB2 3.359 
37 CYSS HB3 3.633 
37 CYSS N 122.941 
38 ASP C 177.248 
38 ASP CA 59.062 
38 ASP CB 42.404 
38 ASP H 7.220 
38 ASP HA 4.255 
38 ASP HB2 2.707 
38 ASP HB3 3.342 
38 ASP N 123.883 
39 GLU C 177.090 
39 GLU CA 59.695 
39 GLU CB 30.037 
39 GLU CG 36.196 
39 GLU H 8.933 
39 GLU HA 3.950 
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39 GLU HB2 2.046 
39 GLU HB3 2.090 
39 GLU HG2 2.296 
39 GLU HG3 2.328 
39 GLU N 114.086 
40 CYSS CA 63.993 
40 CYSS CB 30.120 
40 CYSS H 6.892 
40 CYSS HA 3.971 
40 CYSS HB2 2.931 
40 CYSS HB3 2.924 
40 CYSS N 117.477 
41 ILE C 175.448 
41 ILE CA 58.759 
41 ILE CB 37.589 
41 ILE CD1 13.842 
41 ILE CG1 30.676 
41 ILE CG2 21.374 
41 ILE H 7.710 
41 ILE HA 4.059 
41 ILE HB 1.051 
41 ILE HG12 0.865 
41 ILE HG13 0.956 
 
 
 
 
 
 
173 
41 ILE N 117.952 
41 ILE QD1 0.188 
41 ILE QG2 1.048 
42 ARG C 178.237 
42 ARG CA 61.718 
42 ARG CB 30.524 
42 ARG CD 42.785 
42 ARG CG 29.097 
42 ARG H 8.384 
42 ARG HA 3.649 
42 ARG HB2 1.716 
42 ARG HB3 1.832 
42 ARG HD2 2.942 
42 ARG HD3 3.259 
42 ARG HE 8.467 
42 ARG HG2 1.419 
42 ARG HG3 1.644 
42 ARG HH11 7.006 
42 ARG HH21 6.665 
42 ARG N 126.302 
42 ARG NE 85.428 
43 THR C 175.945 
43 THR CA 66.815 
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43 THR CB 68.808 
43 THR CG2 21.561 
43 THR H 7.681 
43 THR HA 3.819 
43 THR HB 4.237 
43 THR N 112.719 
43 THR QG2 1.206 
44 ALA C 181.298 
44 ALA CA 55.297 
44 ALA CB 18.144 
44 ALA H 7.474 
44 ALA HA 4.117 
44 ALA N 123.181 
44 ALA QB 1.421 
45 LEU C 179.565 
45 LEU CA 57.922 
45 LEU CB 42.759 
45 LEU CD1 25.385 
45 LEU CD2 20.780 
45 LEU CG 26.367 
45 LEU H 8.397 
45 LEU HA 3.999 
45 LEU HB2 1.077 
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45 LEU HB3 1.858 
45 LEU HG 1.756 
45 LEU N 117.577 
45 LEU QD1 0.613 
45 LEU QD2 0.645 
46 LEU C 179.124 
46 LEU CA 57.149 
46 LEU CB 42.193 
46 LEU CD1 25.255 
46 LEU CD2 23.142 
46 LEU CG 27.119 
46 LEU H 7.932 
46 LEU HA 4.190 
46 LEU HB2 1.578 
46 LEU HB3 1.640 
46 LEU HG 1.767 
46 LEU N 118.062 
46 LEU QD1 0.859 
46 LEU QD2 0.861 
47 GLU C 176.352 
47 GLU CA 57.630 
47 GLU CB 29.766 
47 GLU CG 36.587 
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47 GLU H 7.912 
47 GLU HA 4.175 
47 GLU HB2 2.080 
47 GLU HB3 2.134 
47 GLU HG2 2.346 
47 GLU HG3 2.558 
47 GLU N 118.444 
48 SER C 175.681 
48 SER CA 56.588 
48 SER CB 64.915 
48 SER H 7.413 
48 SER HA 4.723 
48 SER HB2 4.049 
48 SER HB3 4.185 
48 SER N 113.592 
49 ASP C 176.982 
49 ASP CA 56.881 
49 ASP CB 40.511 
49 ASP H 8.903 
49 ASP HA 4.265 
49 ASP HB2 2.631 
49 ASP HB3 2.631 
49 ASP N 126.634 
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50 GLU C 175.322 
50 GLU CA 56.214 
50 GLU CB 29.581 
50 GLU CG 36.762 
50 GLU H 7.903 
50 GLU HA 4.220 
50 GLU HB2 1.716 
50 GLU HB3 2.138 
50 GLU HG2 2.145 
50 GLU HG3 2.145 
50 GLU N 116.471 
51 HIS C 172.145 
51 HIS CA 55.119 
51 HIS CB 26.493 
51 HIS CD2 119.264 
51 HIS CE1 136.153 
51 HIS H 7.830 
51 HIS HA 4.695 
51 HIS HB2 3.226 
51 HIS HB3 3.756 
51 HIS HD2 7.698 
51 HIS HE1 8.652 
51 HIS N 116.375 
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52 THR C 174.337 
52 THR CA 61.898 
52 THR CB 70.587 
52 THR CG2 21.469 
52 THR H 7.961 
52 THR HA 4.805 
52 THR HB 3.620 
52 THR N 115.934 
52 THR QG2 1.038 
53 CYSS CA 57.130 
53 CYSS CB 32.686 
53 CYSS H 8.827 
53 CYSS HA 4.228 
53 CYSS HB2 3.018 
53 CYSS HB3 3.413 
53 CYSS N 131.616 
54 PRO C 176.368 
54 PRO CA 63.867 
54 PRO CB 32.002 
54 PRO CD 50.724 
54 PRO CG 26.556 
54 PRO HA 4.398 
54 PRO HB2 1.932 
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54 PRO HB3 2.239 
54 PRO HD2 3.464 
54 PRO HD3 4.022 
54 PRO HG2 1.590 
54 PRO HG3 1.728 
55 THR C 174.785 
55 THR CA 65.206 
55 THR CB 68.864 
55 THR CG2 22.773 
55 THR H 9.338 
55 THR HA 4.264 
55 THR HB 4.008 
55 THR N 121.431 
55 THR QG2 1.184 
56 CYSS CA 58.987 
56 CYSS CB 31.054 
56 CYSS H 9.362 
56 CYSS HA 4.754 
56 CYSS HB2 2.379 
56 CYSS HB3 3.173 
56 CYSS N 124.692 
57 HIS C 173.421 
57 HIS CA 56.674 
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57 HIS CB 25.911 
57 HIS CD2 119.689 
57 HIS CE1 136.139 
57 HIS H 7.295 
57 HIS HA 4.526 
57 HIS HB2 3.385 
57 HIS HB3 3.526 
57 HIS HD2 7.133 
57 HIS HE1 8.443 
57 HIS N 115.438 
58 GLN C 174.701 
58 GLN CA 57.785 
58 GLN CB 29.684 
58 GLN CG 34.233 
58 GLN H 8.590 
58 GLN HA 4.164 
58 GLN HB2 1.848 
58 GLN HB3 2.291 
58 GLN HE21 7.865 
58 GLN HE22 6.910 
58 GLN HG2 2.505 
58 GLN HG3 2.446 
58 GLN N 124.369 
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58 GLN NE2 114.974 
59 ASN C 175.128 
59 ASN CA 52.601 
59 ASN CB 40.503 
59 ASN H 8.300 
59 ASN HA 4.885 
59 ASN HB2 2.760 
59 ASN HB3 2.866 
59 ASN HD21 7.548 
59 ASN HD22 6.778 
59 ASN N 122.731 
59 ASN ND2 113.067 
60 ASP C 175.009 
60 ASP CA 55.434 
60 ASP CB 39.389 
60 ASP H 8.881 
60 ASP HA 4.256 
60 ASP HB2 2.619 
60 ASP HB3 3.051 
60 ASP N 116.350 
61 VAL C 174.612 
61 VAL CA 63.066 
61 VAL CB 31.133 
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61 VAL CG1 20.862 
61 VAL CG2 20.398 
61 VAL H 9.029 
61 VAL HA 3.859 
61 VAL HB 2.098 
61 VAL N 123.835 
61 VAL QG1 0.837 
61 VAL QG2 0.965 
62 SER CA 55.243 
62 SER CB 64.359 
62 SER H 8.124 
62 SER HA 4.495 
62 SER HB2 3.770 
62 SER HB3 4.018 
62 SER N 119.772 
63 PRO C 177.055 
63 PRO CA 64.265 
63 PRO CB 31.966 
63 PRO CD 49.975 
63 PRO CG 27.423 
63 PRO HA 4.094 
63 PRO HB2 2.048 
63 PRO HB3 2.121 
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63 PRO HD2 3.500 
63 PRO HD3 3.760 
63 PRO HG2 1.721 
63 PRO HG3 1.985 
64 ASP C 176.259 
64 ASP CA 55.518 
64 ASP CB 40.373 
64 ASP H 7.820 
64 ASP HA 4.528 
64 ASP HB2 2.514 
64 ASP HB3 2.762 
64 ASP N 115.409 
65 ALA C 179.654 
65 ALA CA 51.719 
65 ALA CB 19.765 
65 ALA H 8.050 
65 ALA HA 4.410 
65 ALA N 122.285 
65 ALA QB 1.558 
66 LEU C 177.364 
66 LEU CA 55.559 
66 LEU CB 42.125 
66 LEU CD1 26.550 
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66 LEU CD2 22.860 
66 LEU CG 27.111 
66 LEU H 6.877 
66 LEU HA 4.379 
66 LEU HB2 1.042 
66 LEU HB3 1.929 
66 LEU HG 1.847 
66 LEU N 117.570 
66 LEU QD1 0.944 
66 LEU QD2 0.851 
67 ILE C 175.578 
67 ILE CA 59.129 
67 ILE CB 41.581 
67 ILE CD1 14.033 
67 ILE CG1 27.117 
67 ILE CG2 17.789 
67 ILE H 8.108 
67 ILE HA 4.437 
67 ILE HB 1.684 
67 ILE HG12 1.169 
67 ILE HG13 1.669 
67 ILE N 122.877 
67 ILE QD1 0.856 
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67 ILE QG2 0.970 
68 ALA C 175.897 
68 ALA CA 53.992 
68 ALA CB 18.400 
68 ALA H 8.870 
68 ALA HA 4.130 
68 ALA N 129.158 
68 ALA QB 1.239 
69 ASN C 175.530 
69 ASN CA 50.329 
69 ASN CB 36.926 
69 ASN H 8.044 
69 ASN HA 4.818 
69 ASN HB2 2.279 
69 ASN HB3 3.067 
69 ASN HD21 7.560 
69 ASN HD22 7.039 
69 ASN N 120.109 
69 ASN ND2 115.009 
70 LYS CA 61.447 
70 LYS CB 32.379 
70 LYS CG 25.708 
70 LYS H 8.200 
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70 LYS HA 3.776 
70 LYS HB2 1.853 
70 LYS HB3 1.855 
70 LYS HD2 1.710 
70 LYS HD3 1.624 
70 LYS HE2 2.942 
70 LYS HE3 2.997 
70 LYS HG2 1.305 
70 LYS HG3 1.541 
70 LYS N 123.726 
71 PHE CA 61.058 
71 PHE CB 38.558 
71 PHE CD1 131.573 
71 PHE CE1 131.529 
71 PHE HA 4.327 
71 PHE HB2 3.093 
71 PHE HB3 3.223 
71 PHE QD 7.345 
71 PHE QE 7.371 
72 LEU C 178.426 
72 LEU CA 56.658 
72 LEU CB 42.622 
72 LEU CD1 25.519 
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72 LEU CD2 24.319 
72 LEU CG 27.468 
72 LEU HA 3.834 
72 LEU HB2 1.166 
72 LEU HB3 1.310 
72 LEU HG 1.304 
72 LEU QD1 0.746 
72 LEU QD2 0.623 
73 ARG C 179.368 
73 ARG CA 59.901 
73 ARG CB 31.889 
73 ARG CD 44.313 
73 ARG CG 29.776 
73 ARG H 8.358 
73 ARG HA 4.094 
73 ARG HB2 2.088 
73 ARG HB3 2.088 
73 ARG HD2 2.769 
73 ARG HD3 3.449 
73 ARG HE 7.853 
73 ARG HG2 1.766 
73 ARG HG3 1.889 
73 ARG N 118.510 
 
 
 
 
 
 
188 
73 ARG NE 85.703 
74 GLN C 177.583 
74 GLN CA 58.721 
74 GLN CB 28.312 
74 GLN CG 33.785 
74 GLN H 7.719 
74 GLN HA 4.069 
74 GLN HB2 2.131 
74 GLN HB3 2.131 
74 GLN HE21 7.361 
74 GLN HE22 6.873 
74 GLN HG2 2.350 
74 GLN HG3 2.382 
74 GLN N 119.268 
74 GLN NE2 112.993 
75 ALA C 181.199 
75 ALA CA 55.412 
75 ALA CB 18.210 
75 ALA H 7.849 
75 ALA HA 4.134 
75 ALA N 124.102 
75 ALA QB 1.404 
76 VAL C 178.710 
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76 VAL CA 67.581 
76 VAL CB 32.022 
76 VAL CG1 23.947 
76 VAL CG2 20.814 
76 VAL H 8.762 
76 VAL HA 3.592 
76 VAL HB 2.281 
76 VAL N 121.320 
76 VAL QG1 1.140 
76 VAL QG2 1.140 
77 ASN C 178.135 
77 ASN CA 56.432 
77 ASN CB 37.605 
77 ASN H 8.127 
77 ASN HA 4.411 
77 ASN HB2 2.891 
77 ASN HB3 2.875 
77 ASN HD21 7.530 
77 ASN HD22 6.915 
77 ASN N 119.887 
77 ASN ND2 112.379 
78 ASN C 177.285 
78 ASN CA 55.927 
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78 ASN CB 37.551 
78 ASN H 8.730 
78 ASN HA 4.496 
78 ASN HB2 2.950 
78 ASN HB3 2.950 
78 ASN HD21 7.799 
78 ASN HD22 7.025 
78 ASN N 119.864 
78 ASN ND2 112.667 
79 PHE C 179.379 
79 PHE CA 62.034 
79 PHE CB 39.774 
79 PHE CD1 131.700 
79 PHE CE1 131.693 
79 PHE CZ 130.528 
79 PHE H 8.294 
79 PHE HA 4.267 
79 PHE HB2 3.189 
79 PHE HB3 3.189 
79 PHE HZ 7.251 
79 PHE N 122.588 
79 PHE QD 7.068 
79 PHE QE 7.177 
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80 LYS C 178.728 
80 LYS CA 60.496 
80 LYS CB 32.357 
80 LYS CD 29.965 
80 LYS CE 41.960 
80 LYS CG 26.281 
80 LYS H 8.795 
80 LYS HA 3.795 
80 LYS HB2 1.994 
80 LYS HD2 1.749 
80 LYS HD3 1.811 
80 LYS HE2 2.942 
80 LYS HG2 1.479 
80 LYS HG3 1.993 
80 LYS N 121.129 
81 ASN C 176.755 
81 ASN CA 55.186 
81 ASN CB 38.716 
81 ASN H 8.148 
81 ASN HA 4.540 
81 ASN HB2 2.928 
81 ASN HB3 2.928 
81 ASN HD21 7.710 
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81 ASN HD22 6.857 
81 ASN N 118.197 
81 ASN ND2 113.401 
82 GLU C 177.686 
82 GLU CA 58.268 
82 GLU CB 29.715 
82 GLU CG 36.146 
82 GLU H 8.102 
82 GLU HA 4.092 
82 GLU HB2 2.065 
82 GLU HB3 2.065 
82 GLU HG2 2.298 
82 GLU HG3 2.298 
82 GLU N 118.396 
83 THR C 176.139 
83 THR CA 62.112 
83 THR CB 71.082 
83 THR CG2 20.811 
83 THR H 7.797 
83 THR HA 4.329 
83 THR HB 4.062 
83 THR N 108.310 
83 THR QG2 0.868 
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84 GLY C 174.782 
84 GLY CA 45.893 
84 GLY H 8.099 
84 GLY HA2 3.928 
84 GLY HA3 4.106 
84 GLY N 111.713 
85 TYR C 175.703 
85 TYR CA 60.318 
85 TYR CB 39.468 
85 TYR CD1 132.880 
85 TYR CE1 118.463 
85 TYR H 7.881 
85 TYR HA 4.173 
85 TYR HB2 2.646 
85 TYR HB3 3.073 
85 TYR N 121.274 
85 TYR QD 7.062 
85 TYR QE 6.806 
86 THR C 173.547 
86 THR CA 61.471 
86 THR CB 70.345 
86 THR CG2 21.436 
86 THR H 7.550 
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86 THR HA 4.171 
86 THR HB 4.045 
86 THR N 117.874 
86 THR QG2 1.079 
87 LYS C 176.625 
87 LYS CA 56.560 
87 LYS CB 33.129 
87 LYS CD 29.227 
87 LYS CE 42.403 
87 LYS CG 24.934 
87 LYS H 7.953 
87 LYS HA 4.212 
87 LYS HB2 1.703 
87 LYS HB3 1.804 
87 LYS HD2 1.666 
87 LYS HD3 1.679 
87 LYS HE2 2.968 
87 LYS HG2 1.411 
87 LYS HG3 1.411 
87 LYS N 123.140 
88 ARG C 176.537 
88 ARG CA 56.388 
88 ARG CB 30.814 
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88 ARG CD 43.434 
88 ARG CG 27.210 
88 ARG H 8.575 
88 ARG HA 4.272 
88 ARG HB2 1.748 
88 ARG HB3 1.836 
88 ARG HD2 3.222 
88 ARG HD3 3.222 
88 ARG HE 7.330 
88 ARG HG2 0.819 
88 ARG HG3 1.638 
88 ARG N 123.860 
88 ARG NE 85.381 
89 LEU C 177.176 
89 LEU CA 55.232 
89 LEU CB 42.257 
89 LEU CD1 24.987 
89 LEU CD2 23.572 
89 LEU CG 27.040 
89 LEU H 8.187 
89 LEU HA 4.310 
89 LEU HB2 1.568 
89 LEU HB3 1.657 
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89 LEU HG 1.656 
89 LEU N 123.683 
89 LEU QD1 0.940 
89 LEU QD2 0.870 
90 ARG C 176.028 
90 ARG CA 55.860 
90 ARG CB 30.981 
90 ARG CD 43.449 
90 ARG CG 27.212 
90 ARG H 8.276 
90 ARG HA 4.344 
90 ARG HB2 1.774 
90 ARG HB3 1.856 
90 ARG HD2 3.210 
90 ARG HD3 3.210 
90 ARG HE 7.259 
90 ARG HG2 1.635 
90 ARG HG3 1.635 
90 ARG N 122.842 
90 ARG NE 85.613 
91 LYS C 175.701 
91 LYS CA 56.491 
91 LYS CB 33.066 
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91 LYS CD 29.135 
91 LYS CE 42.220 
91 LYS CG 24.742 
91 LYS H 8.373 
91 LYS HA 4.310 
91 LYS HB2 1.776 
91 LYS HB3 1.859 
91 LYS HD2 1.689 
91 LYS HE2 3.006 
91 LYS HG2 1.449 
91 LYS N 124.329 
92 GLN C 180.521 
92 GLN CA 57.313 
92 GLN CB 30.527 
92 GLN CD 21.343 
92 GLN CG 34.383 
92 GLN H 8.044 
92 GLN HA 4.164 
92 GLN HB2 1.911 
92 GLN HB3 2.101 
92 GLN HE21 7.542 
92 GLN HE22 6.830 
92 GLN HG2 2.292 
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92 GLN HG3 2.292 
92 GLN N 127.663 
92 GLN NE2 113.025 
 
 
 
 
 
 
 
 
199 
APPENDIX IV: TALOS PHI AND PSI ANGLE PREDICTIONS 
FOR RING DOMAIN 
Residue number Residue name Φ angle Ψ angle Classification 
1 G 9999.000 9999.000 None 
2 P -64.430 -27.270 New 
3 L -103.640 135.580 New 
4 G -68.480 -33.660 New 
5 S -118.850 144.000 New 
6 E -77.460 -23.890 New 
7 D -94.120 -10.170 New 
8 D -87.300 134.800 New 
9 P -68.110 138.520 Good 
10 I -86.750 128.170 Good 
11 P -56.570 140.330 Good 
12 D -59.890 -28.350 Good 
13 E -79.780 -8.640 Good 
14 L -97.710 -4.560 New 
15 L -91.410 126.230 Good 
16 C -76.190 107.770 New 
17 L -68.720 -25.400 Good 
18 I -72.550 -40.440 Good 
19 C -90.540 -14.880 New 
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20 K 60.400 37.060 New 
21 D -110.500 145.780 Good 
22 I -80.810 129.170 Good 
23 M -88.330 128.090 Good 
24 T -92.270 127.660 Good 
25 D -85.870 127.340 New 
26 A -102.140 -14.720 New 
27 V -133.780 147.300 Good 
28 V -130.330 133.43 Good 
29 I -126.380 141.690 Good 
30 P -78.890 134.360 Good 
31 C -86.950 139.240 New 
32 C -107.990 -6.180 New 
33 G 74.480 9.620 New 
34 N -105.370 136.660 Good 
35 S -138.960 153.840 Good 
36 Y -129.530 144.670 Good 
37 C -68.990 -31.480 New 
38 D -62.360 -44.140 Good 
39 E -63.260 -38.980 Good 
40 C -64.540 -31.710 Good 
41 I -87.430 -12.300 Good 
42 R -56.370 -43.540 Good 
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43 T -61.910 -44.160 Good 
44 A -63.790 -40.290 Good 
45 L -62.780 -42.640 Good 
46 L -68.350 -33.140 Good 
47 E -70.830 -25.680 Good 
48 S -107.600 146.360 New 
49 D -62.070 -23.370 Good 
50 E -84.580 -1.440 Good 
51 H -111.370 118.030 New 
52 T -94.700 124.030 Good 
53 C -100.200 144.290 Good 
54 P -88.180 133.420 New 
55 T -76.180 127.580 New 
56 C -93.300 -22.190 New 
57 H -76.390 -6.600 New 
58 Q -69.420 136.270 New 
59 N -108.110 156.220 New 
60 D -86.790 135.060 New 
61 V -83.140 128.200 New 
62 S -85.020 146.350 New 
63 P -58.170 -29.970 New 
64 D -72.540 -25.020 Good 
65 A -79.380 -27.160 Good 
 
 
 
 
 
 
202 
66 L -87.160 139.600 New 
67 I -128.820 148.240 New 
68 A -80.050 125.680 Good 
69 N -106.410 106.97 New 
70 K -55.670 -34.320 New 
71 F -62.000 -39.490 Good 
72 L -61.100 -42.940 Good 
73 R -65.880 -42.100 Good 
74 Q -64.000 -42.590 Good 
75 A -64.120 -38.090 Good 
76 V -65.130 -43.390 Good 
77 N -63.590 -38.450 Good 
78 N -66.220 -42.110 Good 
79 F -63.030 -44.020 Good 
80 K -66.870 -39.660 Good 
81 N -69.060 -40.110 Good 
82 E -72.140 -28.160 Good 
83 T -99.770 -3.270 Good 
84 G 85.000 4.470 New 
85 Y -85.960 131.590 New 
86 T -124.690 146.690 New 
87 K -85.590 147.280 New 
88 R -80.640 -23.070 New 
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89 L -87.590 139.630 New 
90 R -90.070 137.030 New 
91 K -99.870 140.940 New 
92 Q 9999.000 9999.000 None 
 
 
 
 
 
 
 
